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 แตงโม (Citrullus lanatus) มีแอล-ซิทูไลน์และแอล-อาร์จินีนในปริมาณสูง สารดงักล่าวมี
ความสาํคญัในการสร้างไนตริคออกไซดที์ÉมีฤทธิÍ คลายหลอดเลือด แตงโมมีฤทธิÍ ทางชีวภาพแต่ยงัไม่
มีผลการศึกษาถึงฤทธิÍ ทางสรีรวิทยาต่อการหดตัวของกล้ามเนืÊอมดลูก ดังนัÊ น การศึกษานีÊ มี
วตัถุประสงคเ์พืÉอศึกษา 1) ผลของสารสกดัจากแตงโมต่อการหดตวัของมดลกูหนู 2) กลไกออกฤทธิÍ
ของสารสกดั และ 3) ฤทธิÍ ของสารสกดัเป็นผลของแอล-ซิทูไลน์และ/หรือแอล-อาร์จินีน เนืÊอและ
เปลือกแตงโมสกัดด้วยเอทิลแอลกอฮอล์ การตอบสนองของการหดตัวต่อสารต่าง ๆ ของมัด
กลา้มเนืÊอมดลกูถกูบนัทึกดว้ยอุปกรณ์ทดสอบการหดตวัของมดักลา้มเนืÊอ ผลการศึกษาพบว่า ความ
เขม้ขน้ของสารสกดัจากเนืÊอทีÉ 6 มก./มล. เปลือก 5 มก./มล. แอล-ซิทูไลน์ 64 ไมโครโมลาร์ และ
แอล-อาร์จินีน 104 ไมโครโมลาร์ สามารถยบัย ัÊงการหดตวัโดยธรรมชาติไดร้้อยละ 50 สารสกดัจาก
แตงโม แอล-ซิทูไลน์และแอล-อาร์จินีนมีฤทธิÍ ยบัย ัÊงการหดตวัทีÉถกูเหนีÉยวนาํดว้ยพรอสตาแกลนดิน
เอฟ 2 แอลฟา ออกซิโทซินและสารละลายโพแทสเซียมคลอไรด ์ในภาวะทีÉปราศจากแคลเซียมนอก
เซลล์พบว่าสารสกัดจากแตงโม แอล-ซิทูไลน์และแอล-อาร์จินีนมีฤทธิÍ ยบัย ัÊ งการหดตัวทีÉถูก
เหนีÉ ยวนําด้วยพรอสตาแกลนดินเอฟ 2 แอลฟาและออกซิโทซินและยงัยบัย ัÊงการหดตัวทีÉถูก
เหนีÉยวนาํดว้ยการเพิÉมปริมาณแคลเซียมนอกเซลลไ์ดบ้างส่วน ในขณะเดียวกนัสารสกดัจากแตงโม 
แอล-ซิทูไลน์และแอล-อาร์จินีนมีฤทธิÍ ยบัย ัÊงการหดตวัแบบโทนิคทีÉถกูเหนีÉยวนาํดว้ยออกซิโทซินใน
สารละลายโพแทสเซียมคลอไรด์ สารสกัดแตงโมสามารถออกฤทธิÍ ร่วมกบัแอล-ซิทูไลน์ในการ
ยบัย ัÊงการหดตวัโดยธรรมชาติและการหดตวัทีÉเหนีÉยวนาํดว้ยพรอสตาแกลนดินเอฟ 2 แอลฟา ออกซิ
โทซินและสารละลายโพแทสเซียมคลอไรด์ การคน้พบครัÊ งนีÊ ชีÊ ให้เห็นว่ากลไกออกฤทธิÍ ของสาร
สกดัจากแตงโม แอล-ซิทูไลนแ์ละแอล-อาร์จินีนผา่นทัÊงวิถีทีÉเกีÉยวขอ้งและไม่เกีÉยวขอ้งกบัแคลเซียม 
ในขณะเดียวกนัฤทธิÍ ยบัย ัÊงการหดตวัของสารสกดัจากแตงโมและแอล-ซิทูไลน์ยงัสามารถผ่านวิถี
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 Watermelon (Citrullus lanatus) is rich in L-citrulline and L-arginine; the 
contents that play an important role in the production of the potent vasodilator, nitric 
oxide (NO). The plant has been studied for its biological activities, but not for its 
physiological activities in uterine smooth muscle. Thus, this study aimed; 1) to 
investigate the effects of watermelon extracts on rat uterine contractions; 2) to 
investigate the mechanisms whereby the extracts exerted their effects; and 3) to verify 
whether the effects of the extracts were due to their major constituents, L-citrulline 
and/or L-arginine. Watermelon flesh and rind were ethanolic extracted. The 
contractile responses of each agent were recorded isometrically with a force 
transducer. The results showed that the EC50 values of flesh, rind, L-citrulline, and   
L-arginine were 6 mg/mL, 5 mg/mL, 64 µM, and 104 µM, respectively. They 
suppressed spontaneous contraction and the contractions induced by prostaglandin F2α 
(PGF2α), oxytocin and potassium chloride solution (KCl). They also reduced PGF2α- 
and oxytocin-induced uterine force in the absence of external calcium (Ca2+) and 
partially inhibited contraction induced by increasing external Ca2+. In addition, they 
caused a marked decrease in tonic contractions produced by oxytocin-induced uterine 
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contraction in the presence of KCl. The combinations of watermelon extracts and       
L-citrulline elicited an additive effect on spontaneous contraction and uterine 
contractions induced by PGF2α, oxytocin, and KCl. These findings indicated that the 
mechanisms of action of watermelon extracts, L-citrulline, and L-arginine were via 
Ca2+-dependent and Ca2+-independent regulation of smooth muscle contraction 
pathways. In addition, the tocolytic effects of watermelon extracts and L-citrulline 
were also via NO-cGMP pathway as well as via the activation of calcium-activated 
potassium channels. In conclusion, the study clearly showed that watermelon has a 
potent tocolytic effect on rat uterine contraction. 
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CHAPTER I 
INTRODUCTION 
 
Scientists have long been investigating the underlying mechanisms of uterine 
contractility. However, they have generally focused on basic phenomena which 
modulate the function of the muscle at each stage of reproductive periods. Moreover, 
the main points of the investigations have been dedicated to the action of agents 
which either inhibit (tocolytic agents) or stimulate (uterotonic agents) uterine 
contractions. Current uses of interventional treatments lack potency and/or selectivity 
and may do harm to the uterus. Thus, new approaches to tocolytic or uterotonic are 
required. Medicinal plants are used as the starting materials for pharmaceutical 
development worldwide. Interestingly, they are safe and have less side-effects. 
Therefore, the work presented in this thesis was carried out to search for a novel plant 
species for use as a tocolytic or uterotonic. 
 
1.1 Uterus and Its Functions 
The uterus (womb) is a complex organ that is specifically adapted for the 
reproductive process. It has 3 compartments: the horns, body and cervix. All of these 
have a different size and shape according to species (Constantinescu, 2007). The 
uterus is supported by cords of the uterine ligaments, located in the pelvis 
immediately dorsal to the urinary bladder and ventral to the rectum. One end is 
2 
 
connected on both sites to the fallopian tube; the other, the cervix, opened to the 
vagina.  In most animals, it is well established that the uterus has 2 horns, a body and 
a cervix, and it is known as the uterus bicornis (Constantinescu, 2007).  In primates, 
including humans, the uterus has only one segment and the cervix, which is classified 
as the uterus simplex.  In the rabbit, for example, the horns, body and cervix are 
paired; this type of uterus is determined as the uterus duplex. Moreover, in cattle, 
sheep and houses, the uterus is of the uterus bipartitus. 
The uterus plays a functional role in the reproductive process: 1) sperm 
transport from the site of ejaculation to the site of fertilization in the oviduct; 2) 
initiation of implantation, pregnancy and parturition; and 3) regulation of the function 
of the corpus luteum (Hafez and Hafez, 2000). 
Knowledge of various types of cells, their functions, interactions, and 
relationships is essential for a complete understanding of uterine physiology. Changes 
which occur in uterine muscle during pregnancy, menstrual period, and estrus cycle 
are important physiological considerations. There is evidence that changes in the 
levels of several hormones, including steroid hormones, oxytocin, and prostaglandins 
play a crucial role in modulating the uterine functions in each stage throughout the 
female reproductive life (Thomson and Norman, 2005). 
  
 1.1.1 Anatomy of the Uterus 
 On a histological basis, the uterus has traditionally been divided into the 
endometrium and the myometrium. The endometrium is a mucosal layer constituted 
by specialized glandular epithelium and a highly cellular stroma which respond with 
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cyclical change of growth, differentiation and shedding in reply to ovarian hormones 
throughout the reproductive life of the female. The myometrium is a muscular tunic 
which comprises of a three-layer smooth muscle: a longitudinal outer layer and 
circular and oblique inner layer. It surrounds the endometrial lining of the uterine 
cavity and forms the major component of the uterine volume (Fusi, Cloke and 
Brosens, 2006). 
 
 1.1.2 Contractile Apparatus 
 Myometrial smooth muscle cells contain the contractile apparatus that respond 
to calcium (Ca2+) oscillations and utilize the chemical energy of adenosine 
triphosphate (ATP) during shortening or tension development. It is widely accepted 
that the major contractile proteins are myosin, actin, tropomyosin, and minor 
components of contractile apparatus include the proteins that are involved in the Ca2+-
dependent regulatory mechanism (Horowitz, Menice, Laporte and Morgan, 1996). 
 
The Thick Filaments  
 Myosin (thick filaments) is the main element of muscle contraction. It is a 
structural protein which interacts with the other major proteins, including actin. 
Myosin is also an enzyme that converses the chemical energy of ATP into force 
generation. In smooth muscle cells, such as the myometrium, the myosin molecule is 
a hexamer molecule composed of two heavy chains (MHCs) and two light chains 
(MLCs) of 20 kDa (MLC20) and 17 kDa (MLC17). The native polymer of myosin 
contains three regions. The tail domain is configured as α-helical coiled tail regions of 
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myosin (rods) forming the thick filament with the globular head regions protruding to 
form cross-bridges. The head domain consists of the globular N-terminal end of the 
MHC that protrudes from the filament. It was found that the head domain contains the 
actin-binding region and the ATP hydrolysis site that serves as a source of the energy 
for force development (Adelstein and Sellers, 1995). The intermediate (neck) domain 
is the region that creates the angle between the head and the tail. It serves as the non-
covalent binding sites of the MLCs. In uterine smooth muscle, MLC20, known as 
regulatory light chain, is essential for regulating muscle contraction. The MLC17 is 
called the essential light chain and its function is unknown. It has been reported that 
phosphorylation of Serine 19 on MLC20 results in a conformational change that 
increases the angle in the neck domain of the MHC, causing the actin thin filament to 
slide along the myosin thick filament (Adelstein and Sellers, 1995). This 
phosphorylation is mediated by myosin light chain kinase (MLCK), which is 
predominantly modulated by the intracellular Ca2+ ion ([Ca2+]i) (Adelstein and Sellers, 
1995; Horowitz et al., 1996; Word and Kamm, 1997). 
 
The Thin Filaments  
 Native thin filament isolated from smooth muscle tissues contains actin and 
tropomyosin. In the presence of Ca2+, thin filament serves as the modulatory protein 
in smooth muscle. It was found that actin filaments slide along the myosin thick 
filament to shorten the cell during a contraction (Lehman, Vibert, Craig and Bárány, 
1995). This process has three basic requirements: 1) a force is required to move the 
actin filaments; 2) the force must be transmitted along the actin filament from the 
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longitudinal poles of the cell towards the cell center; and 3) the actin must be attached 
to the cytoskeleton of the myocyte (Lehman et al., 1995). 
 
Calmodulin 
Calmodulin (CaM), a Ca2+-binding protein, mediates many of the regulatory 
effects of Ca2+, including the contractile state of smooth muscle. The prominent 
function of CaM in smooth muscle is to activate cross-bridge cycling and force 
development in response to a [Ca2+]i oscillation. This process includes 1) the 
activation of MLCK and 2) phosphorylation of myosin. CaM is often referred to as 
EF-hand Ca2+-binding proteins. Crystallographic study indicated that CaM has four 
EF-hands consistent with the presence of four Ca2+ binding sites (Means, 2004). It 
was revealed that the binding of Ca2+ to CaM induces a marked conformational 
change and leads to the interaction with target proteins (Walsh, 1994). It has been 
reported that binding of Ca2+ to three or all four sites is required for activation of 
MLCK (Walsh, 1994; Word and Kamm, 1997). 
 
Myosin Light Chain Kinase 
 Myosin light chain kinase (MLCK) is Ca2+-CaM regulated serine or threonine 
protein kinase that catalyzes the phosphorylation of MLC20. MLCK is activated by the 
binding of 1 mol Ca2+-CaM to 1 mol kinase. It was found that MLCK contains a 
catalytic core that is highly homologous to other protein kinase (Walsh, 1994). The 
catalytic core of MLCK contains two lobes with the smaller lobe binding MgATP. 
The phosphorylation occurs at a cleft between the two lobes, with the larger lobe 
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serving as the binding site for protein substrates. By using tryptic cleavage enzyme 
method, it was indicated that MLCK composes of an inhibitory region and a CaM-
binding region (Blumenthal and Stull, 1980). It was suggested that the inhibitory 
region mimics the light chain substrate, and is a pseudosubstrate prototype that binds 
to the active site of the kinase in the absence of CaM (Blumenthal and Stull, 1980). It 
appears that autoinhibition is associated with the folding of a C-terminal extension of 
the kinase back onto the catalytic core (Kamm and Stull, 2001). Binding of Ca2+-CaM 
to MLCK induces a conformational change, leading to dissociation of the 
pseudosubstrate domain from the substrate binding site and production of force (Stull 
et al., 1995). 
 
Myosin Light Chain Phosphatase 
 Myosin light chain phosphatase (MLCP), a serine and threonine protein 
phosphatase, requires to reverse the activation of smooth muscle myosin by MLC20 
phosphorylation. It is well known that decrease of [Ca2+]i inactivates Ca
2+-dependent 
MLCK, shifting the balance of kinase and phosphatase activities resulting in 
dephosphorylation of MLC and smooth muscle relaxation (Word and Kamm, 1997). 
Inhibition of MLCP activity by some agonists is the main mechanism of Ca2+-
sensitization. It was indicated that inhibition of the phosphatase increases MLC20 
phosphorylation and force production (Erdödi, Ito and Hartshorne, 1995). 
Arachidonic acid is found to be a Ca2+-sensitizing agent (Gong et al., 1992). It 
increases both MLC20 phosphorylation and contraction at constant Ca
2+ by inhibiting 
MLC20 dephosphorylation (Gong et al., 1992). Ca
2+-desensitization phenomena 
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mediated by cGMP and cGMP-dependent protein kinase (PKG) may be due to 
upregulation of MLCP (Somlyo and Somlyo, 1994; 1998).  
 
1.1.3 Uterine Contractile Activity 
Electromechanical and Pharmacological Coupling 
It is well established that modulation of contractile force by changing in 
membrane potential is referred to as electromechanical coupling (Itoh and Kuriyama, 
1994; Somlyo and Somlyo, 1994; 1998). This type of modulation is primary 
associated with a change of [Ca2+]i. Depolarization of smooth muscle (either by 
potassium chloride solution (KCl) or agonists) stimulates several types of Ca2+ 
channels and generates contraction. The relationship between changes in membrane 
potential and force development is based on stimuli. It is indicated that contractile 
agonists must induce contraction with less depolarization than that required by KCl 
(Chen and Rembold, 1995; Rembold, 1995). However, some agonists can increase 
Ca2+ inward current at a constant membrane potential in smooth muscle cells. These 
findings indicated that pharmacomechanical coupling may represent by agonist 
induced increase in [Ca2+]i beyond that expected by the level of depolarization (Chen 
and Rembold, 1995; Rembold, 1995). The mechanisms underlying of this 
circumstance include: 1) an agonist-dependent increase in Ca2+ influx, resulting in 
higher [Ca2+]i; 2) an agonist-dependent increase in the Ca
2+sensitivity of myosin 
phosphorylation; and 3) other unknown processes (Rembold, 1995). 
It is well known that regulation of force independent of changes in membrane 
potential is referred to as pharmacomechanical coupling (Somlyo and Somlyo, 1994; 
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1998). This type of modulation is involved in either changes in [Ca2+]i or changes in 
the cellular response to [Ca2+]i independent of changes in membrane potential (Chen 
and Rembold, 1995; Rembold, 1995). Modulation of myosin phosphorylation 
independent of changes in [Ca2+]i is another pathway of pharmacomechanical 
coupling (Somlyo and Somlyo, 1994; 1998; Rembold, 1995). Apparent alterations in 
the [Ca2+]i sensitivity of force may be caused by: 1) changes in the time course of 
[Ca2+]i and myosin phosphorylation (Rembold, 1995); 2) changes in the [Ca
2+]i 
sensitivity of phosphorylation (Somlyo and Somlyo, 1994); and/or 3) changes in the 
relationship between myosin phosphorylation and force (Rembold, 1995). 
 
Mechanisms of Uterine Contraction 
It is well known that the contraction of uterine smooth muscle is due to Ca2+ 
binding to CaM activating MLCK, leading to the phosphorylation and subsequent 
cross-bridge cycling (Somlyo and Somlyo, 1994). This Ca2+ is from 2 main sources to 
operate this incidence: 1) release from the sarcoplasmic reticulum (SR) via inositol 
(1,4,5)-tris-phosphate (IP3) or ryanodine receptor (RyR)/Ca release channels; and 2) 
from extracellular source via voltage-gated L-type Ca2+ channels or receptor-operated 
Ca2+ channels (Kupittayanant, Luckas and Wray, 2002). In addition, another major 
source of Ca2+ for contraction is from the resulting of action potentials, 
depolarization, and then consequent opening of L-type Ca2+ channels (Matthew, 
Shmygol and Wray 2004). Wray, Kupittayanant, Shmygol, Smith  and Burdyga 
(2001) indicated that nifedipine, a blocker of L-type Ca2+ channels, prevents the 
inward current and there is no rise in Ca2+, leading to abolition of both the 
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contractions and transients of the uterus. Interestingly, the uterine contraction is also 
failed to occur if MLCK is inhibited by wortmannin, a selective inhibitor of MLCK 
(Longbottom, Lukas, Kupittayanant, Badrick, Shmygol and Wray, 2000). This finding 
suggested that Ca2+-calmodulin-MLCK pathway plays a crucial role in regulating the 
uterine contractility (Wray, 2007), as shown in Figure 1.1. 
However, under certain condition, [Ca2+]i
 is not induced to phosphorylate 
MLC and contraction. In the “tonic force” condition, the relation of force and MLC 
phosphorylation levels can be dissociated (Somlyo and Somlyo, 1994). The another 
pathway that free from Ca2+ activities to control smooth muscle contraction has been 
established as the non-Ca2+-CaM-MLCK pathways (Somlyo and Somlyo, 1994). 
Protein kinase C and Rho-associated kinase, for example, are the well-known 
mechanisms to regulate the uterine contractility (Somlyo and Somlyo, 1994).  
 Moreover, caldesmon and calponin, thin filament-associated proteins, can be 
activated by phosphorylation of mitogen-activated protein kinase and/or other kinases 
to regulate myosin MgATPase activity (Somlyo and Somlyo, 1994). 
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Figure 1.1 A schematic diagram of a myometrial smooth muscle cell showing a 
variety of ion channels that are involved in regulation of membrane potential and cell 
excitability. Uterine contraction occurs as the phosphorylation of myosin light chain 
(MLC20) by myosin light chain kinase (MLCK). For more details see the text. ADP = 
adenosine diphosphate; ATP = adenosine triphosphate; KATP = the ATP-sensitive K
+ 
channel; Kv = the Shaker-like voltage-gated potassium channels; SK channel = the 
small-conductance calcium-sensitive potassium channels; BKCa channel = the large-
conductance calcium- and voltage-sensitive K+ channel; SR = sarcoplasmic reticulum; 
Ptase = protein phosphatase; MLCK-P = phosphorylated myosin light chain kinase;  
CamK = calcium calmodulin-dependent protein kinase; KChIP =  Kv channel 
interacting protein; CaM = calmodulin. The schematic diagram is adapted from 
Brainard, Korovkina and England (2007). 
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Mechanisms of Uterine Relaxation 
 Contraction of the myometrial cells is terminated by: 1) dephosphorylation of 
MLC via MLCP; 2) [Ca2+]i returns to resting levels via a sarcolemmal Ca
2+ pump or 
Na+/Ca2+ exchange; and 3) removing Ca2+ from the cytoplasm to the SR via 
sarcoplasmic reticulum Ca2+- ATPase. All these results in dissociation of Ca2+ from 
CaM and inactivation of MLCK lead to uterine relaxation (Wray, 1993; 2007). 
In another pathway, nitric oxide (NO) may cause smooth muscle relaxation 
via: 1) the stimulation of calcium-dependent potassium (KCa) channels; 2) the 
activation of guanylate cyclase; and 3) the stimulation of ADP ribosylation (Lincoln, 
Cornwell, Komallavilas, Macmillan-Crow and Boerth, 1995). The activation of 
guanylate cyclase is probably the mechanism of NO to relax uterine smooth muscle 
(Figure 1.2). As described by Yallampalli, Garfield and Byam-Smith (1993), 
methylene blue, an inhibitor of guanylate cyclase, has been used to inhibit smooth 
muscle relaxation produced by NO. However, this role for guanylate cyclase seems to 
be less sensitive to the relaxant effects of cyclic GMP (cGMP) than vascular smooth 
muscle (Word, Casey, Kamm and Stull, 1991). It was indicated that inhibition of KCa 
channels by using 1 mM tetraethylammonium, a concentration that blocks uterine 
smooth muscle KCa channels when applied to the extracellular side, can cause smooth 
muscle contraction (Anwer, Toro, Oberti, Stefani and Sanborn, 1992). Lastly, Brüne 
and Lapetina (1990) reported that NO causes adenosine diphosphate (ADP) 
ribosylation in platelets, which ultimately may inhibit glycolysis (Kots, Skurat, 
Sergienko, Bulgarina and Severin, 1992). 
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Figure 1.2 A schematic diagram of a myometrial smooth muscle cell relaxation 
mediated by nitric oxide (NO). (1) S-Nitroso-N-acetylpenicillamine (SNAP), a nitric 
oxide donor, generates NO to activate soluble guanylate cyclase (sGC) and the 
accumulation of cGMP. (2) Activation of protein kinase G (PKG) by cGMP results in 
the activation of the kinase and the subsequent phosphorylation of substrate proteins 
in the cell. The interaction of PKG and the myosin phosphatase that leads to its 
activation and ability to dephosphorylate the myosin regulatory light chains (not 
shown) must be questioned in myometrium because elevation of cGMP does not relax 
the tissue. This interaction between PKG and myosin phosphatase is known to be 
critical in other smooth muscles because inhibition of the myosin phosphatase leads to 
increased force for a given concentration of Ca2+ (Ca2+-sensitization). (3) SNAP may 
be caused the uterine relaxation by generating Ca2+ efflux from SR, resulting in the 
activation of KCa channel. The extrusion of K
+ leads to hyperpolarization of the cell 
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membrane. (4) Hyperpolarization of the membrane inhibits the influx of Ca2+ via 
Ca2+channel, leading to decreasing intracellular Ca2+ concentration and relaxing the 
muscle. The schematic diagram is adapted from Buxton (2004). 
       
1.2 Calcium Signaling and Uterine Contraction  
As mentioned above, there are at least 2 pathways for the contraction of 
uterine smooth muscle: 1) Ca2+-CaM-MLCK pathways and 2) non-Ca2+-CaM-MLCK 
pathways. However, Wray et al. (2001) and Wray (2007) have concluded that the 
Ca2+-CaM-MLCK pathway is the major mechanism to maintain uterine force in 
normal physiological conditions. 
 
1.2.1 Ca2+-CaM-MLCK Pathways 
A variety of hormones, neurotransmitters, and pharmacological agents can be 
used to modulate the contractile activity of uterine smooth muscle cells (Wray, 1993). 
Stimuli induce smooth muscle contraction by four mechanisms (Rembold, 1995). 1) 
Both contractile agonists and KCl depolarize smooth muscle and then increase Ca2+ 
influx though voltage-dependent Ca2+ channels. 2) Agonists induce Ca2+ release from 
the SR. 3) Agonists activate both voltage-dependent and voltage-independent Ca2+ 
channels, leading to increase Ca2+ influx that is not associated with depolarization. 4) 
Agonists can increase Ca2+ sensitivity. This means force production can be enhanced 
by agonists in a given [Ca2+]i condition (Rembold, 1995). Immediately after elevation 
of [Ca2+]i, homeostatic mechanisms mediates to restore the resting condition by active 
removal of the excess Ca2+ from intracellular through energy-driven extrusion 
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mechanisms (pumps) and channels present in the plasmamembrane and the 
membranes of the SR (Riemer and Heymann, 1998). 
 
L-Type Ca2+ Channels 
 In smooth muscle cells, two types of Ca2+ channels have been described 
(Riemer and Heymann, 1998; Word and Kamm, 1997); an L-type and a T-type Ca2+ 
channels. The L-type Ca2+ channel inactivates slowly, is permeant more to Ba2+ than 
to Ca2+, and is highly sensitive to dihydropyridine Ca2+ channel blockers or agonists. 
The T-type Ca2+ channel inactivates rapidly, is equally permeant to Ca2+ and Ba2+, 
and is less sensitive to dihydropyrinine Ca2+ channel blockers. L-type Ca2+ channel 
serves as the main site of Ca2+ entry into the smooth muscle cell and the primary 
source of action potential (Word and Kamm, 1997). It is well established that the 
activation of L-type Ca2+ channel and Ca2+ entry will occur when uterine myocyte 
membrane potential is depolarized to -40 mV (Parkington and Coleman, 1990; Wray, 
1993). The increased [Ca2+]i activates K
+ channels, permitting K+ efflux and 
restoration of membrane potential (Hofmann and Krugbauer, 1995; Riemer and 
Heymann, 1998). 
Modulation of Ca2+ channels unrelated to membrane potential has been 
investigated by several investigators (Hofmann and Krugbauer, 1995; Riemer and 
Heymann, 1998). The phosphorylation of Ca2+ channels by protein kinases has been 
reported (Hofmann and Krugbauer, 1995). Studies on cultured rat aortic cells 
indicated that cAMP may reduce the Ca2+ inward current produced from voltage-gated 
Ca2+ channels. The prominent mechanism of cAMP-dependent protein kinase (PKA) 
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and PKG-mediated phosphorylation of voltage-gated Ca2+ is not well understood. It 
was indicated that the α1 and β2a subunits of voltage-gated Ca
2+ channel are the 
phosphorylation sites of PKA and the α1c subunit serves as the phosphorylation site 
of PKG (Hofmann and Klugbauer, 1995).    
 
Calcium Release from SR 
 Agonists interact with a specific G-protein coupled receptor (GPCR) in the 
myocyte plasmamembrane resulting in activation of a trimeric G-protein containing a 
Gαq or Gα11 subunit. Activation of this subunit in the uterine myocyte stimulates a 
specific phospholipase C to hydrolyze PIP2 into IP3 and DAG (Phillippe and Chien, 
1998). In smooth muscles, the physiological agent that induces Ca2+ release for 
contraction upon agonist stimulation is IP3. IP3 interacts with a specific receptor 
(IP3R) to induce release of Ca
2+ from the SR and subsequent rise in [Ca2+]i (Phillippe 
and Chien, 1998). It has been reported that emptying of the SR Ca2+ stores increases 
tone in myometrium (Kupittayanant et al., 2002). In addition, emptying of the SR 
Ca2+ stores in these same experiments had little if any effect on the cytosolic Ca2+ 
concentrations achieved or the force generated following oxytocin stimulation 
(Kupittayanant et al., 2002). This finding indicates that the agonist-stimulated, IP3-
mediated release of Ca2+ is less important than the Ca2+ entry from the extracellular 
space through L-type Ca2+ channels (Kupittayanant et al., 2002). It is suggested that 
the SR may serve as a sink of Ca2+ clearance from the cytosol after action potential 
(Shmigol, Eisner and Wray, 1999; Taggart and Wray, 1998). 
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 1.2.2 non-Ca2+-CaM-MLCK Pathways 
 The contraction of smooth muscle depends on extracellular Ca2+ and 
disappears following Ca2+ removal (Longbottom et al., 2000). Thus, the main force 
production is Ca2+-CaM-MLCK pathway (Longbottom et al., 2000). However, there 
is evidence that uterine force development may be influenced by non-Ca2+-CaM-
MLCK dependent pathways (Kupittayanant, Burdyga and Wray, 2001). Interestingly, 
some agonists exert their effects to activate uterine contractility not only by Ca2+-
dependent but also by Ca2+-independent pathways. Phosphorylation of MLCP by 
Rho-associated kinase (ROK) results in increase in the contraction without a change 
in [Ca2+]i when the uterus was producing force tonically rather than phasically 
(Kupittayanant et al., 2001). This finding suggested that under physiological 
conditions, the Rho-A-ROK pathway may not important for modulation of force 
development in the myometrium (Kupittayanant et al., 2001; Wray et al., 2003).  
 In the absence of external Ca2+, oxytocin produced a small tonic contraction as 
long as oxytocin was present. However, application of wortmannin, an inhibitor of 
MLCK, did not affect this contraction, suggesting that it is not produced by the 
phosphorylation of MLC at Serine 19 by MLCK (Longbottom et al., 2000; Wray et 
al., 2003). 
 
 
 
 
 
17 
 
 1.2.3 Nitric Oxide-Cyclic GMP Pathway 
Nitric Oxide 
 Nitric oxide (NO) is produced by the catalytic action of NO synthases (NOS) 
that convert the precursor amino acid, L-arginine, to NO and L-citrulline (Wu and 
Morris, 1998). NOS exists in three isoforms: endothelial NOS (eNOS), neuronal NOS 
(nNOS), and inducible NOS (iNOS). It is indicated that L-arginine is the only 
physiological substrate for NOS generation (Hoffmann et al., 2003; Norman, 1996; 
Wu and Morris, 1998). NO binds to and activates NO-guanylate cyclase, which 
increases synthesis of cGMP from GTP and results in activation of PKG (Hoffmann 
et al., 2003; Norman, 1996). These processes provide a cascade of reaction to regulate 
various physiological functions. The mechanism of action of NO may cause smooth 
muscle relaxation through: 1) the activation of guanylate cyclase; 2) the stimulation of 
KCa channels; and 3) ADP ribosylation (Norman, 1996). However, the most important 
mechanism is due to the activation of soluble guanylate cycles, which catalyses the 
formation of cGMP. It has been reported that the relaxant property of NO or L-
arginine is mimicked by 8-bromo-cGMP, a plasma permeable form of cGMP, and 
inhibited by methylene blue, an inhibitor of guanylate cyclase (Izumi and Garfield, 
1995; Norman, 1996). In addition, the relaxant action of NO may be due to the 
activation of KCa channels. Inhibition of KCa channels results in increase of force 
development, an increase in [Ca2+]i and a reduction in the cell membrane potential. 
Analogues of L-arginine, such as NG-monomethyl-L-arginine (L-NMMA) and NG-
nitro-L-arginine methyl ester (L-NAME), inhibit the effect of NOS by competitive 
inhibition in vivo (Norman, 1996). 
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Cyclic GMP 
 As mentioned above, cGMP is the second messenger of NO produced by 
soluble guanylate cyclase. The action of cGMP is thought to be due to the inhibition 
of pharmacological coupling and inhibition of the contractile system. In addition, it is 
indicated that the mechanism for cGMP-dependent relaxation pathway is involved in 
the activation of a Ca2+ extrusion system. The pharmacological agents that generate 
cGMP and PKG can be used as the relaxant mediators in smooth muscle (Somlyo and 
Somlyo, 1998). There is evidence that mechanisms for cGMP-mediated decrease in 
[Ca2+]i, including: 1) hyperpolarization by opening K
+ channels (White, Kryman, El-
Mowafy, Han and Carrier, 2000); 2) reduced Ca2+ influx with a constant membrane 
potential (Anwer et al., 1992; White et al., 2000); and 3) increased in Ca2+ efflux 
and/or Ca2+ sequestration (Rembold, 1995; White et al., 2000). Recently, it has been 
demonstrated that cGMP-induced relaxation is predominantly on the inhibition of 
Gq/11/PLCβ/IP3 pathway (Izumi and Garfield, 1995). 
 
Potassium Channels 
 It is well known that resting membrane potential is modulated by the K+ 
conductance of the membrane (Brainard et al., 2007; Wray et al., 2003). It is indicated 
that the biological functions of K+ channels are maintenance of the resting membrane 
potential, termination of the action potential, modulation of the electrolyte balance 
(Brainard et al., 2007). Many different types of K+ channels have been identified in 
the cell membrane of smooth muscle cells (Parkington and Coleman, 1990). The KCa 
channels are one of the different categories of K+ channels found in the myometrium 
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(Anwer et al., 1992; Buxton, 2004). They are activated by an increase in [Ca2+]i. The 
KCa channels play a key role in modulating the action potential and controlling the 
cell membrane excitability (Anwer et al., 1992; Norman, 1996). It has been reported 
that NO itself and PKG appear to be activated KCa channels to promote relaxation 
(Brainard et al., 2007; Izumi and Garfield, 1995). Periods of uterine quiescence 
throughout pregnancy are predominantly associated with an increase in KCa channel 
expression. Conversely, during labor, the expression of KCa channels appears to be 
decreased (Anwer et al., 1992; Wray et al., 2003). 
 
1.3 Watermelon 
 Medicinal plants have been used with varying success to treat and prevent 
diseases throughout history. In developing countries, ethnobotanical remedies serve as 
their primary medicines, leaving almost 75% of the world population without access 
to the modern healthcare products. In developed counties, many important industrial 
and pharmaceutical products are either extracted from medicinal plants directly or 
synthesized from precursors that are extracted from plants (Souza Brito, 1996). 
Watermelon (Citrullus lanatus.), family Cucurbitaceae, refers to both fruit and 
plant of a trailing herb originally from southern Africa and one of the most common 
types of watermelon. Phytochemical studies indicate that watermelon contains high 
levels of citrulline, lycopene, and β-carotene (Perkins-Veazie, Collins, Clevidence and 
Wu, 2007). It has been used for treatment of various ailments and improvement of 
sexual function in man. Rao, Ray and Rao (2006) indicated that lycopene in 
watermelon, an antioxidant carotenoid, can prevent the prostate cancer, osteoporosis, 
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hypertension, and also male infertility. As mentioned above, watermelon is an 
excellent source of citrulline, an amino acid of great interest because citrulline can be 
transformed to arginine via argininosuccinate synthase and lyase in all animal cells 
(Maarsingh, Leusink, Zaangsma and Meurs, 2006). Arginine is required for the 
formation of NO which is released during sexual stimulation by parasympathetic 
neurons in the penis and also by the endothelial cells lining the blood vessels and the 
lacunar spaces of the corpus cavernosum (Toda, Ayajiki and Okamura, 2005). NO 
activates soluble guanylate cyclase leading to an increased conversion of GTP to 
cGMP, which provides the signal for smooth muscle relaxation, including corpus 
cavernosum of the penis (Toda et al., 2005) and the myometrium (Izumi and Garfield, 
1995; Norman, 1996).  
Furthermore, watermelon is one of few foods rich in lycopene, a non 
provitamin A carotenoid that has up to twice the antioxidant capacity of β-carotene   
in vitro (Miller, Sampson, Candeias, Bramley and Rice-Evans, 1996). Data from 
epidemiological studies suggest lycopene may have protective effects against certain 
types of cancers and cardiovascular diseases (Rimando and Perkins-Veazie, 2005). 
Wu et al. (2007) used Zucker diabetic fatty (ZDF) rats as an animal model of 
noninsulin-dependent diabetes mellitus. ZDF rats received L-arginine 0.24%, 
watermelon juice 63%, lycopene 0.01%, or citrus pectin 0.05% and water served as a 
negative control for 4 weeks supplementation period. Heart, aortic ring and blood 
sample were collected for physiological analysis. The results exhibited that the groups 
which received watermelon juice and L-arginine reduced fat accretion; increased 
serum concentrations of arginine; lowered serum concentrations of glucose, free fatty 
acids, homocysteine, and dimethylarginines; enhanced GTP cyclohydrolase-I activity 
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and tetrahydrobiopterin concentrations in the heart; and improved acetylcholine-
induced vascular relaxation, when compared with the control group. These results 
provide the knowledge for beneficial effect of watermelon juice as a functional food 
for increasing reducing serum concentrations of cardiovascular risk factors arginine 
availability, improving glycemic control and ameliorating vascular dysfunction in 
obese animals with type-II diabetes.  
In addition, Raghavan and Dikshit (2001) investigated the relaxant effects of 
L-citrulline in phenylephrine pre-contracted endothelium intact thoracic aortic rings 
compared between control and lipopolysaccharide-treated rats. The result indicated 
that L-citrulline significantly increased the relaxant effects on both control and 
lipopolysaccharide-treated rings by supplementing the release of NO due to its 
recycling to L-arginine. Interestingly, arginine in watermelon is used in the NO 
pathway to help in vasodilatation and overall cardiovascular health (Collins et al., 
2007). Anti-allergic potential activity of watermelon has also been postulated (Tabata, 
Cho, Shimakura and Ito, 1993). 
 
1.4 Aims 
To the best of our knowledge, the tocolytic effects of watermelon on rat 
uterine contraction have not yet been elucidated. As there is a clinical need to find 
better drugs with fewer undesirable side effects to modulate uterine activity. One of 
such plants claimed to have tocolytic potential is watermelon (C. lanatus). Thus, this 
thesis aimed; 1) to investigate the effects of the extracts from watermelon on rat 
uterine contractions; 2) to investigate the mechanisms whereby the extracts exerted 
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their effects; and 3) to examine whether the effects of the extracts were due to their 
major constituents, L-citrulline and/or L-arginine. 
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CHAPTER II 
GENERAL MATERIALS AND METHODS 
 
This chapter will provide a general description of the equipment, materials and 
methodology performed in the work represented in this thesis. More details important 
to each study are presented in the individual chapter concerned. 
 
2.1 Plant Preparation 
2.1.1 Plant Material Collection 
The fruits of watermelon (Figure 2.1) were collected in the Province of 
Nakhon Ratchasima, Thailand, where the plant was cultivated under natural 
conditions. Voucher specimen (BKF No. 165073) was identified and deposited at the 
Royal Forest Department of Thailand, Bangkok, Thailand. 
 
2.1.2 Plant Extraction  
Watermelons were cleaned and cut transversely between blossoms and stem 
ends. Fruit flesh, rind, and peel were separated. Flesh samples were collected from 
center, locule, and heart. Rind samples were collected from the white area of the fruit. 
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Peel samples (approximately 2 mm thickness) were removed by peeler before being 
chopped into pieces approximately 1 × 3 × 7 mm3. Dried watermelon flesh (500 mg) 
and rind (500 mg) were subjected to Soxhlet extraction with 70% ethanol (500 mL) 
for 24 h. The extracts were filtered using Whatman paper No. 1. The filtrates were 
evaporated in a rotary evaporator under reduced pressure and low temperature. The 
resultant residue was lyophilized by lyophilizer and kept at -20C in a refrigerator 
until use (Figure 2.2). The yields were 45% for flesh and 65% for rind (w/w based on 
the dried starting weight), respectively. 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Morphology of watermelon (C. lanatus) (A), leaves (B), flower and pulp 
(C), and fruit (D). 
A B 
C D 
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Figure 2.2 The apparatus used in the extraction process. (A) Soxhlet extractor, (B) 
rotary evaporator and (C) lyophilizer. 
 
A B 
C 
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2.2 Animal Preparations 
2.2.1 Animal Ethics and Regulations 
In this thesis, animal care and use were conducted in accordance with 
guidelines of the Committee on Care and Use of Laboratory Animal Resources, 
National Research Council of Thailand. The procedures of the experiment were 
performed in accordance with the advice of the Institutional Animal Care and Use 
Committee, Suranaree University of Technology, Nakhon Ratchasima, Thailand. 
 
2.2.2 Housing 
Female Wistar rats were used for the present experiments. Rats were 
individually housed in 24 × 15 × 15 cm3 cages under a 12:12-hour light-dark 
illumination cycles at a constant temperature of 25 ± 0.5C and humidity (45-50%). 
Rats were given a standard laboratory food containing 0.8% calcium (CP. Co. Ltd., 
Thailand), and provided to water ad libitum. 
 
2.2.3 Myometrial Tissue Preparations 
Female Wistar rats (200-250 g) were sacrificed by asphyxiation with CO2 and 
the uterine horns were isolated. Uterine strips were dissected from both cervical and 
ovarian segments of each uterine horn, immediately placed in Krebs’ solution of the 
following composition (mM): NaCl: 154.0; KCl: 5.4; CaCl2: 2.0; MgSO4: 1.2; 
glucose: 8.0; HEPES: 10.0 (37C, pH = 7.4). 
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2.2.4 Measurements of Tension 
The uterus strip was cut into longitudinal strips of 1-2 mm × 0.5 mm × 10 mm 
and attached at each end to metal hooks and another hook was fixed to a transducer 
(AD Instruments Pty Ltd., Spain) in the organ bath that contained Krebs’ solution     
(37C, pH = 7.40). An equilibration time of 30 min was applied for all tissues before 
the application of any chemical studied. The change in isometric force was measured 
during 10 min with PowerLab system software (AD Instruments Pty Ltd., Australia). 
The relaxation was expressed as a percentage of reduction of the contractile tension 
induced by each agonist. The effects were measured as changes in isometric force and 
recorded with a force-displacement transducer connected to a computer using Chart 
software (Figure 2.3). 
 
Figure 2.3 Representation of the equipment used for tension measurement. (A) 
Monitor, (B) CPU, (C) Keyboard, (D) Thermostat, (E) Force Transducer, (F) Organ 
Bath, (G) Bridge Amplifier, (H) PowerLab System and (I) Peristaltic Pump. 
 
C 
A 
B 
D 
E 
F 
G 
H 
I 
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2.3 Chemicals 
Most chemicals were obtained from Sigma®, Singapore. All the stock 
solutions were prepared and stored in accordance with the guideline of the producer. 
A KCl (40 mM) Krebs’ solution was made by isoosmotic replacement of sodium 
chloride (Noble and Wray, 2002). Oxytocin was dissolved in distilled water and used 
at concentration of 10 nM to produce a phasic contraction (Kupittayanant, Luckas, 
and Wray, 2002). Prostaglandin F2α, (PGF2α-tris; (5Z,9α,11α,13E,15)-9,11,15-
trihydroxyprosta-5,13-dienoic acid tris salt), was dissolved in the absolute ethanol and 
used at the concentration of 1 µM (Buddhakala, Talubmook, Sriyotha, Wray and 
Kupittayanant, 2008). Watermelon flesh (6 mg/mL) or rind (5 mg/mL) extract was 
used and dissolved in physiological solution. The positive control agents, L-citrulline 
(64 µM) and L-arginine (104 µM), were dissolved in physiological solution directly. 
NG-nitro-L-arginine methyl ester (L-NAME), a non-selective inhibitor of NOS, was 
dissolved in distilled water and used at a concentration of 100 M (Yallampalli, 
Garfield and Byam-Smith, 1993). LY 83583, the inhibitor of guanylate cyclase, was 
dissolved in distilled water and used at a concentration of 1 M (Bradley, Buxton, 
Barber, McGaw and Bradley, 1998). Tetaethylamonim chloride, an inhibitor of 
calcium-dependent potassium channels (TEA) was dissolved in distilled water and 
used at a concentration of 5 mM (Kupittayanant et al., 2002). Bay K8644, the L-type 
Ca2+ channel activator; S-(−)-1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)-
phenyl]-3 pyridinecarboxylic acid methyl ester, was dissolved in absolute ethanol and 
used at the concentration of 1 µM (Kupittayanant, Kupittayanant and Suwannachat, 
2008). In some experiments 0-Ca solutions were used; physiological solution in which 
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CaCl2 had been omitted and ethylene glycol tetraacetic acid (EGTA, 1 mM) added 
(Kupittayanant et al., 2002). The physiological Krebs’ solution (pH = 7.4) contained 
the following (mM): NaCl 154.0, KCl 5.4, MgSO4 1.2, glucose 8.0, CaCl2 2.0, and N-
2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) 10.0. 
  
2.4 Statistical Analysis 
 The data were analyzed using Microcal Origin Software, Singapore. The 
following parameters of contraction were measured; force integral, frequency, and 
amplitude. The phasic contractions in the extracts were measured over 30 min after 
their application. Results were expressed as percentages of control contractions (i.e. 
the control is 100%). To test the effects of applications of L-NAME, LY 83583, Bay 
K8644, 5 mM CaCl2, or TEA following the extracts, contractions were compared for 
the 30 min in the extracts (i.e. 30-60 min after start of the extract exposure), to the 60-
90 min in the extracts with an addition of L-NAME, LY 83583, Bay K8644, 5 mM 
CaCl2, or TEA. Integrated force (area under the contraction) was measured. In some 
experiments, the maximal tension of oxytocin- or PGF2α-induced contractions in the 
absence of the external calcium in the control group (without the extracts or positive 
control agents) was considered as 100%. Data were presented as mean ± S.E.M. and 
“n” represents the number of sample, each one from a different animal. Significance 
was tested using appropriate t-test. The P < 0.05 was considered to be significant. 
Results were then expressed as percentages of control contractions (i.e. the control is 
100%). Dose response curves were plotted by using a nonlinear curves fitting 
program, Microcal Origin Software (Vergara-Galicia et al., 2010). 
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CHAPTER III 
DOSE DEPENDENCY OF WATERMELON 
(CITRULLUS LANATUS) EXTRACTS AND 
OBSERVATIONS ON SPONTANEOUS  
CONTRACTION 
 
3.1 Abstract 
Watermelon (Citrullus lanatus) is rich in L-citrulline and L-arginine, 
substrates for nitric oxide synthase in the production of a potential vasodilator, nitric 
oxide (NO). However, the effects of watermelon on uterine smooth muscle have not 
been studied. Thus, this study was aimed to investigate dose dependency of 
watermelon extracts on uterine contraction. Watermelon flesh and rind were ethanolic 
extracted. Isometric force was measured in isolated rat uterine strips and cumulative 
concentrations of watermelon extracts on spontaneous contractions examined. The 
results showed that watermelon flesh and rind (2-8 mg/mL) inhibited spontaneous 
contraction. The EC50 values of flesh and rind were 6 mg/mL and 5 mg/mL, 
respectively. The flesh extract is less potent than that the rind extract, and this might 
be due to lower amount of L-citrulline and L-arginine.  
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3.2 Introduction 
 
The World Health Organization survey indicates that 70-80% of world 
populations have utilized a non-conventional medicine mainly of herbal sources in 
their therapeutic proposes (Chan, 2003). Plants have importantly served as a source of 
investigation for novel drug compounds and plant medicines have supported large 
contributions to human health and well being. The use of herbal plants is very 
common in developing countries, particularly in rural settings. During the last decade, 
an increase in the use of plants has been revealed in metropolitan areas of developed 
countries (Harnack, Rydell and Stang, 2001). The prevalence of harmful side effects 
from plant derived medicines, when used in an appropriate procedure, are relatively 
less frequent when compared to synthetic drugs. However, clinical data are still 
required to assess their safety (Calixto, 2000). 
Some plants and their phytochemical constituents have been reported to have a 
beneficial effect on modulation of uterine contractility (Buddhakala, Talubmook, 
Sriyotha, Wray and Kupittayanant, 2008; Lijuan, Kupittayanant, Chudapongse, Wray 
and Kupittayanant, 2011; Promprom, Kupittayanant, Indrapichate, Wray and 
Kupittayanant, 2010). It is well known that medicinal plants are present as numerous 
chemical constituents, which usually exert their therapeutic effects through muti-
targets and muti-pathways (Cao et al., 2008). The nature of these actions results in 
either the stimulation (uterotonic) or inhibition (tocolytic) of uterine smooth muscle 
contractions. As there is a clinical need to find better drugs with fewer undesirable 
side effects to inhibit uterine activity (Buddhakala et al., 2008), one of such plants 
claimed to have tocolytic potential such as watermelon (C. lanatus) (Figueroa, 
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Sanchez-Gonzalez, Perkins-Veazie and Arjmandi, 2010; Jayaprakasha, Murthy and 
Patil, 2011) has been receiving attention. 
Watermelon (C. lanatus) belongs to the family of Cucurbitaceae and is a 
native tropical and subtropical plant and extensively cultivated in Africa, the United 
States, India, China, and Thailand (Robinson and Decker-Walters, 1997). The plant is 
characterized by a spreading, hairy, tendril-bearing vine, 3-5 meters in length. The 
stems are thin, hairy, angular, grooved, and have branched tendrils at each node. 
Leaves are oblong-ovate 8-20 cm long containing 3-7 lobes. Flowers of watermelon 
are 2 cm in diameter, monoecious, yellow in color. Fruits are large, green-mottled or 
deep green, round to cylindrical and have a rind 10 to 40 mm thick. Roots are 
extensive but shallow, with a tap root and many lateral roots (Robinson and Decker-
Walters, 1997). Watermelon is commonly known in Thai as Taeng-Mo. Its fruit has 
been consumed as both dessert fruit and vegetable proposes. Some chemical 
constituents and biological activity of watermelon have been reported (Figueroa et al., 
2010; Jayaprakasha et al., 2011). Watermelon is one of the few foods naturally rich in 
specific amino acids, L-citrulline and L-arginine (Tlili, Hdider, Lenucci, Ilahy, Jebari 
and Dalessandro, 2011a; Wu et al., 2007). Dietary antioxidants such as carotenoids 
and phenolic compounds have been isolated. These secondary metabolites have been 
found to be effective in promoting peroxyl-radical scavenging activity, reducing the 
risk of some types of cancers, cardiovascular diseases and age-related degenerative 
pathologies (Tlili, Hdider, Lenucci, Ilahy, Jebari and Dalessandro, 2011b; Wu et al., 
2007). It was found that watermelon juice can protect against CCl4-induced 
hepatotoxicity and oxidative stress in rats (Altas, Kızıl, Kızıl, Ketani and Haris, 
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2011). In addition, watermelon supplement has a beneficial effect on prehypertension 
(Figueroa et al., 2011) and diabetes (Ahn, Choi, Kim and Ha, 2011; Wu et al., 2007). 
As the ethnopharmacological potential described to watermelon is largely 
based on empirical data, more research is required to scientifically prove its action 
and efficacy. It has been reported that watermelon extract induces the relaxation of 
smooth muscle cells through NO pathway modulation and reduction of intracellular 
Ca2+ [Ca2+]i (Jayaprakasha et al., 2011). However, no measurements of its effects on 
agonists-induced contractions have been made so far in isolated rat uteri. In addition, 
the mechanisms underlying contractility changes are incompletely understood. Thus, 
this study was aimed to investigate dose dependency of watermelon flesh and rind 
extracts on spontaneous uterine contractions using isolated rat uteri.  
 
3.3 Materials and Methods 
 3.3.1 Myometrial Tissue Preparations and Measurements of Tension 
 Myometrial tissue preparations were dissected and force measurements 
measured as those described in Chapter II (Sections 2.2.3 and 2.2.4, respectively). 
 
 3.3.2 Dose Dependency of Watermelon Extracts 
Following a 30-min equilibration time, watermelon flesh or rind extract         
(2-8 mg/mL) was added into the bathing solution in a cumulative increase in 
concentration manner. The median effective concentrations (EC50 values, 
concentration required to produce 50% of the maximum inhibition of the amplitude of 
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contraction) were calculated by using a nonlinear curves fitting program, Microcal 
Origin Software (Vergara-Galicia et al., 2010). 
 
3.3.3 Chemicals and Physiological Solution 
All chemicals were purchased from Sigma®, Singapore. The measurement of 
tension was made whilst the tissue was continually perfused with physiological 
solution (control).  
 
 3.3.4 Preparation of Watermelon Flesh and Rind Extracts 
 As described in Chapter II (Section 2.1.2), stocks of watermelon extracts were 
kept at -20°C. Fruit flesh or rind extract was dissolved in Krebs’ solution just before 
use. 
 
 3.3.5 Statistical Analysis 
The data were analyzed using Microcal Origin Software. The integral force 
was used as the parameter of contraction. Results were expressed as percentages of 
control contractions (i.e. the control is 100%). Throughout, data are presented as  
mean ± S.E.M. and “n” represents the number of samples, each one from a different 
animal. Significances were tested using appropriate t tests. The P value < 0.05 was 
taken to be significant. 
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3.4 Results 
3.4.1 Dose Dependency of Watermelon Flesh Extract 
To investigate whether the effect of flesh extract was dose-dependent, 2, 4, 6, 
or 8 mg/mL of flesh extract was added to the phasic spontaneous contractions in a 
cumulative increase in concentration manner. It can be seen that greater decrements of 
force occurred as the dose of watermelon flesh extract increased. Compared with 
control peak amplitude (100%), the mean amplitudes were reduced to 91.49 ± 7.55%, 
82.61 ± 9.37%, 55.64 ± 9.05%, and 8.48 ± 5.64% with 2, 4, 6, and 8 mg/mL flesh 
extract, respectively. The cumulative concentrations of watermelon flesh extract also 
induced an increased frequency of uterine contractions. As shown in Figure 3.1, the 
EC50 value of flesh extract was 6.12 ± 1.02 mg/mL. Therefore, the concentration of    
6 mg/mL was selected and used throughout the remainder of the study. The inhibitory 
effects of cumulative doses of watermelon flesh extract on the amplitude, frequency, 
and AUC of contractions are summarized in Table 3.1.     
 
3.4.2 Dose Dependency of Watermelon Rind Extract 
After the equilibration period, the uterine strip was exposed to cumulative 
doses of rind extract (2, 4, 6, or 8 mg/mL). It was found that the addition of increasing 
concentrations of rind extract produced a marked decrease in the amplitude of 
contractions compared with control (100%). The amplitudes produced by rind extract 
measured after 10 min of application were 92.98 ± 7.94%, 72.27 ± 9.35%, 41.81 ± 
7.65%, and 6.57 ± 3.14% with 2, 4, 6, and 8 mg/mL, respectively. The cumulative 
concentrations of watermelon rind extract induced an increased frequency of uterine 
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contractions. As shown in Figure 3.1, the EC50 value of rind extract was 5.26 ± 1.08 
mg/mL. Therefore, the concentration of 5 mg/mL was selected and used throughout 
the remainder of the study. The inhibitory effects of cumulative doses of watermelon 
rind extract on the amplitude, frequency, and AUC of contractions are summarized in 
Table 3.2. 
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Figure 3.1 Dose dependency of watermelon flesh and rind extracts. The effects of 
increasing cumulative concentrations of flesh and rind extracts (2-8 mg/mL) on 
spontaneous contractions of non-pregnant rat uterus are shown. Symbol represents 
means. Vertical lines represent standard errors of the means (n = 6 for each extract). 
 
 
 
 
 
Table 3.1 The effects of watermelon flesh extract at various concentrations on spontaneous contraction. 
 
 
 
Amplitude 
(% Mean ± S.E.M.) 
 
Frequency 
(% Mean ± S.E.M.) 
 
AUC 
(% Mean ± S.E.M.) 
 
 
n 
 
Watermelon flesh (mg/mL) 
0 (Control) 
2 
4 
6 
8 
 
 
100 
91.49 ± 7.55 
82.61 ± 9.37 
55.64 ± 9.05* 
8.48 ± 5.64* 
 
 
100 
125.57 ± 4.90* 
120.18 ± 1.94* 
115.55 ± 3.21* 
8.61 ± 5.26* 
 
 
100 
95.38 ± 5.90 
85.10 ± 6.22 
63.12 ± 4.49* 
3.94 ± 2.55* 
 
 
6 
6 
6 
6 
6 
The P-values for amplitude, frequency and AUC of watermelon flesh extract performed are significantly different from the 
control (*P < 0.05). Mean ± S.E.M. are given; n is number of animals. 
 
 
 
Table 3.2 The effects of watermelon rind extract at various concentrations on spontaneous contraction. 
 
 
 
Amplitude 
(% Mean ± S.E.M.) 
 
Frequency 
(% Mean ± S.E.M.) 
 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon rind (mg/mL) 
0 (Control) 
2 
4 
6 
8 
 
 
100 
92.98 ± 7.94 
72.27 ± 9.35* 
41.81 ± 7.65* 
6.57 ± 3.14* 
 
 
100 
124.56 ± 1.03* 
119.64 ± 8.65* 
113.35 ± 1.35* 
10.76 ± 1.32* 
 
 
100 
92.98 ± 7.94 
72.27 ± 9.35* 
41.81 ± 7.65* 
6.59 ± 3.14* 
 
 
6 
6 
6 
6 
6 
The P-values for amplitude, frequency and AUC of watermelon rind extract performed are significantly different from the control        
(*P < 0.05). Mean ± S.E.M. are given; n is number of animals. 
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3.4.3 Effects of Watermelon Flesh Extract on Spontaneous Contraction 
The application of watermelon flesh extract (6 mg/mL) to the rat myometrial 
preparations produced a significant decrease in the amplitude of force (67.52 ± 6.43% 
compared with control, 100%, P < 0.05). As shown in Figure 3.3, the frequency of the 
contraction produced by flesh extract was significantly increased to 116.25 ± 4.70% 
when compared with control (100%, P < 0.05). 30 min later, the uterine strip was then 
washed with Krebs’ solution. It was found that the phasic spontaneous contractions of 
the uterus were reversed. Thus, this finding indicates that the tocolytic effects of flesh 
extract on the uterus were reversible. The effects of watermelon flesh extract at the 
dose of 6 mg/mL on spontaneous contraction are summarized in Table 3.3. 
 
3.4.4 Effects of Watermelon Rind Extract on Spontaneous Contraction 
The application of watermelon rind extract (5 mg/mL) to the rat myometrial 
preparations produced a significant decrease in the amplitude of force (58.02 ± 7.68% 
compared with control, 100%, P < 0.05). As shown in Figure 3.4, the frequency of the 
contraction produced by rind extract was significantly increased to 115.49 ± 4.26% 
when compared with control (100%, P < 0.05). 30 min later, the uterine strip was then 
washed with Krebs’ solution. It was found that the phasic spontaneous contractions of 
the uterus were reversed. Thus, this finding indicates that the tocolytic effects of rind 
extract on the uterus were reversible. The effects of watermelon rind extract at the 
dose of 5 mg/mL on spontaneous contraction are summarized in Table 3.3. 
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Figure 3.2 The effects of watermelon flesh (6 mg/mL; A) and rind (5 mg/mL; B) 
extracts on spontaneous contractions (n = 6 for each extract). 
 
 
B 
A 
 
 
Table 3.3 The effects of watermelon flesh (6 mg/mL) and rind (5 mg/mL) extracts on spontaneous contraction. 
 
 
 
 
 
 
 
 
 
 
 
The P-values for amplitude, frequency and AUC of watermelon flesh and rind extracts performed are significantly different from 
the control (*P < 0.05). Mean ± S.E.M. are given; n is number of animals. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
n 
 
Watermelon flesh  
Control 
Watermelon flesh 
Recovery 
Watermelon rind 
Control 
Watermelon rind 
Recovery 
 
 
100 
67.52 ± 6.43* 
94.25 ± 5.37 
 
100 
58.02 ± 7.68* 
90.63 ± 7.39 
 
 
100 
116.25 ± 4.70* 
99.11 ± 3.12 
 
100 
115.49 ± 4.26* 
100.00 ± 4.02 
 
 
100 
70.44 ± 4.10* 
94.42 ± 7.27 
 
100 
66.63 ± 2.83* 
96.77 ± 3.75 
 
 
6 
6 
6 
 
6 
6 
6 
52 
 
3.5 Discussion 
 
This study is the first to investigate the dose-dependent effects of watermelon 
extracts on rat uterine contraction. The data show that the inhibitory effects of 
watermelon flesh and rind extracts (2-8 mg/mL) were dose-dependent. The EC50 
values of flesh and rind extracts were 6.13 ± 1.35 and 5.26 ± 1.08 mg/mL, 
respectively. The effects of flesh extract at the dose of 6 mg/mL and rind extract at the 
dose of 5 mg/mL were also examined. It was found that at these concentrations, both 
flesh and rind extracts were significantly decreased in the amplitude and the mean 
integral force but not the frequency of the contractions. 
It is generally accepted that Ca2+ ion plays a crucial role in modulation of 
force development (Somlyo and Somlyo, 1994). The increase of [Ca2+]i for the 
myometrium contraction comes from two sources: the extracellular through L-type 
Ca2+ channels and the intracellular source from the SR. It has been reported that 
uterine smooth muscle contraction can be generated by several mechanisms, but the 
main mechanism depends on Ca2+-calmodulin (CaM)-myosin light chain kinase 
(MLCK) pathway (Longbottom, Luckas, Kupittayanant, Badrick, Shmigol and Wray, 
2000). 
The watermelon flesh and rind (2-8 mg/mL) extracts caused an inhibition of 
spontaneous contractions in dose-dependent manner. In addition, the application of 
flesh (6 mg/mL) and rind (5 mg/mL) to spontaneously generated contractions of 
uterine smooth muscle produced a marked decrease in the mean integral force and the 
amplitude of contractions. Interestingly, the amplitude of the contractions produced 
by flesh was less than that produced by rind. Thus, this finding suggests that 
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watermelon extracts can exert their effects in rat isolated uterine strips by inhibiting 
Ca2+ influx and some of the Ca2+ signaling element involved in the smooth muscle 
contraction. It has been reported that some agents which reduce spontaneous 
contractile activity 1) may be associated with the decrease of Ca2+ entry and/or 2) may 
have an influence on mechanisms which follow the influx of Ca2+ (Wray, Duggins, 
Ilfs, Nyman and Osman, 1992). Thus, it is possible to speculate that the plant extracts 
may depress force production through the inhibition of extracellular Ca2+ influx which 
is mediated by one or combined mechanisms as described before. There is evidence 
that watermelon extracts can decrease the levels of [Ca2+]i by using Flou-4 AM dye, a 
specific fluorescent probe for [Ca2+]i, in smooth muscle cell line (Jayaprakasha et al., 
2011). The results indicated that smooth muscle relaxation is mainly through the 
reduction of [Ca2+]i (Jayaprakasha et al., 2011). 
The application of watermelon flesh and rind extracts to spontaneous 
contractions increased the frequency of contractions. This finding suggests that the 
plant extracts may 1) increase the intrinsic pacemaking mechanism in the uterus and 
2) shorten the action potential (Wray, 1993). However, the mechanism underlying of 
this prevalence is unclear. 
In this present study, it was also found that the tocolytic potency of the 
watermelon rind extract was greater than that produced by watermelon flesh extract. 
Watermelon is a rich source of the non-essential amino acid L-citrulline in nature. It 
has been reported that the L-citrulline content based on a dry weight of the rind was 
higher than that of the flesh (Rimando and Perkins-Veazie, 2005). According to the 
plant extraction in the present study, the amount of L-citrulline contained in the flesh 
extract should be less than in the rind extract. This could be the reason why the 
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tocolytic potency of the rind extract in this present study was higher than that 
produced by the flesh extract. If the flesh extract contained very small amount of      
L-citrulline, other different compounds from that contained in rind extract might 
contribute to the actions of the flesh extract (see below). 
In addition, it has been reported that L-arginine is also found in watermelon 
and served as the precursor for the substrate in NO production (Hayashi et al., 2005). 
L-citrulline produced pharmacological effects that closely resembled those of           
L-arginine administration and NO action. It has been exhibited that the influx of Ca2+ 
through L-type Ca2+ channels may be due to the influence of NO-cGMP-cGMP-
dependent protein kinase (PKG) signaling pathway (Carvajal et al., 2000). The PKG 
phosphorylation site of L-type Ca2+ channel is at Serine 533 which localized in α1c 
subunit (Jiang et al., 2000). It is possible to hypothesize that NO produced by the 
plant extracts may partially inhibit Ca2+ entry of uterine smooth muscle via NO-
cGMP-PKG signaling pathway, leading to the reduction of force (Carvajal et al., 
2000; Jiang et al., 2000). From this assessment, the inhibitory effects of watermelon 
extracts might also be attributed to L-arginine found in the extracts (Tlili et al., 2011a; 
2011b). 
Medicinal plants showing NO production can be served as the tocolytic drug, 
which may have potential for the prevention and treatment of miscarriage and/or other 
disorders related to NO in reproductive function, including dysmenorrhea and preterm 
labor. The results of this present study could be useful for further study to define the 
effects of watermelon on human myometrium in vitro. 
In conclusion, this study investigated the dose dependency of watermelon 
extracts on isolated rat uterus. The results suggest that watermelon extracts had a 
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dose-dependent relaxing effect on the isolated rat uterine strips. The inhibitory effects 
of watermelon extracts might be mediated through NO-cGMP-dependent pathway 
modulation. In addition, the plant extracts may inhibit the Ca2+ influx via inhibition of 
L-type Ca2+ channels possibly through cGMP signaling and decrease the production 
of force. Watermelon must be submitted to further studies that help to identify other 
major bioactive compounds and/or determine optimal conditions for possible 
development of phytomedicine that improved this worldwide prevalent disease. 
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CHAPTER IV 
EFFECTS OF WATERMELON (CITRULLUS LANATUS) 
EXTRACTS ON AGONISTS-INDUCED  
UTERINE CONTRACTIONS 
 
4.1 Abstract 
Watermelon (Citrullus lanatus) has a potent vasodilatory effect. However, the 
effects of watermelon on uterine contraction have not yet been elucidated. Thus, this 
study was aimed to investigate the effects of watermelon extracts on agonists-induced 
uterine contractions. The contractile responses in the presence of watermelon flesh or 
rind extract were recorded isometrically with a force transducer. The results showed 
that watermelon extracts depressed the contractions induced by prostaglandin F2α 
(PGF2α), oxytocin, and potassium chloride solution (KCl). They also reduced PGF2α- 
and oxytocin-induced uterine force in the absence of external calcium and partially 
inhibited contraction induced by increasing external calcium. In addition, they caused 
a marked decrease in tonic contractions produced by oxytocin-induced contraction in 
the presence of KCl. These findings suggested that watermelon had a potent tocolytic 
and that the inhibitory effects of watermelon extracts were via the inhibition of both 
Ca2+-dependent and Ca2+-independent pathways of force regulation.    
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4.2 Introduction  
 Plants are known to produce a variety of metabolites with novel structures and 
interesting biological activities. The potential use of isolated plant metabolites for the 
treatment of several diseases has been the subjects of a number of investigations 
(Jayaprakasha, Murthy and Patil, 2011; Tarazona-Díaz, Viegas, Moldao-Martin and 
Aguayo, 2011). Based on ethnopharmacological data, highly selective and potent 
antagonists or even agonists are required for the development of natural-based 
chemical compounds. 
 Watermelon is becoming increasing popular due to its potential health benefits 
and refreshing flavor (Tlili, Hdider, Lenucci, Riadh, Jebari and Dalessandro, 2011). 
Phytochemical studies indicated that watermelon contains number of essential 
micronutrients and vitamins (Tarazona-Díaz et al., 2011; Tlili et al., 2011).                
L-citrulline and L-arginine are also found in a high content (Jayaprakasha et al., 2011; 
Rimando and Perkins-Veazie, 2005). In addition, flesh watermelon provides a good 
source of carotenoids and phenolic compounds (Tarazona-Díaz et al., 2011; Tlili et 
al., 2011). Ethnopharmacological relevance demonstrated that watermelon supple-
mentation can improve aortic hemodynamics in patient with prehypertension, 
suggesting that watermelon has a potent vasodilator (Figueroa, Sanchez-Gonzalez, 
Perkins-Veazie and Arjmandi, 2010). Altas, Kızıl, Kızıl, Ketani and Haris (2011) 
found that watermelon juice can protect against CCl4-induced hepatotoxicity and 
oxidative stress in rats. Wu et al. (2007) indicated that watermelon supplementation to 
Zucker diabetic fatty rats, an animal model of noninsulin-dependent diabetes mellitus 
can increase arginine availability, decrease serum concentrations of cardiovascular 
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risk factors. Recently, smooth muscle relaxant effects of watermelon extracts has been 
reported (Jayaprakasha et al., 2011).      
 As indicated in Chapter III, the effects of watermelon flesh and rind extracts 
were dose-dependent. In addition, the application of watermelon extracts to 
spontaneous phasic contractions was reversible. It was of interest to verify the 
mechanism underlying of action of watermelon extracts on the uterine contractions-
induced by agonists and KCl. Thus, the aims of this study were to investigate the 
effects of watermelon extracts on the agonists (e.g. PGF2α and oxytocin)-induced and 
KCl-induced uterine contractions. 
 
4.3 Materials and Methods  
 4.3.1 Myometrial Tissue Preparations and Measurements of Tension 
 Myometrial tissue preparations were dissected and force measurements 
measured as those described in Chapter II (Sections 2.2.3 and 2.2.4, respectively). 
 
  4.3.2 Experimental Procedures 
  4.3.2.1 Effects on Bay K8644- and Increasing CaCl2 Concentration-
  Induced Uterine Contractions 
To investigate whether the tocolytic effects of watermelon extracts were 
dependent upon external Ca2+entry through voltage-gated L-type Ca2+ channels,     
Bay K8644, the L-type Ca2+ agonist, or 5 mM CaCl2 was used. In the experiment, 
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Bay K8644 or 5 mM CaCl2 was applied for 30 min and then flesh or rind extract 
added, in the continued presence of Bay K8644 or 5 mM CaCl2. In addition, the 
experiments were done the other way round. To do so, watermelon flesh or rind 
extract was applied for 30 min and then Bay K8644 or 5 mM CaCl2 added, in the 
continued presence of the extract. 
 
  4.3.2.2 Effects on PGF2α-, Oxytocin- and KCl-Induced Uterine 
Contractions 
The effects of watermelon extracts on PGF2α-, oxytocin- and KCl-induced 
uterine contractions were evaluated as follows. After equilibration period in Krebs’ 
solution, the uterine strip was stimulated with PGF2α (1 µM), oxytocin (10 nM) or 
KCl (40 mM) for 40 min and then washed. 30 min later PGF2α, oxytocin or KCl was 
then added into the bathing solution, and 20 min later watermelon flesh or rind extract 
was incubated for 20 min in the continued presence of agonists or KCl. At the end of 
the experiment, the bathing solution was replaced by Krebs’ solution and tension 
monitored up to 30 min. The results of these experiments were compared with the 
contraction without the extracts. 
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 4.3.2.3 Effects on PGF2α- and Oxytocin-Induced Uterine Contrac-
tions in the Absence of External Ca2+ 
The uterine strip was incubated with 0-Ca (1 mM EGTA) solution containing 
watermelon flesh or rind extract for 15 min, then 1 µM PGF2α or 10 nM oxytocin was 
added to stimulate the release of Ca2+ from the sarcoplasmic reticulum (SR). The 
maximal tension produced by PGF2α or oxytocin in the control group (without 
watermelon extracts) was considered as 100%. 
 
  4.3.2.4 Effects on Oxytocin-Induced Uterine Contractions in the 
  Presence of KCl 
The uterine strip was incubated with KCl for 15 min. Then the solution in the 
bath was replaced by KCl containing 10 nM oxytocin and equilibrated for 15 min. 
After the maximum contractile response to KCl containing oxytocin was obtained, 
watermelon flesh or rind extract was then applied for 15 min. At the end of the 
experiment, the bathing solution was replaced by Krebs’ solution and tension 
monitored up to 30 min. 
 
 4.3.3 Chemicals and Physiological Solutions 
All chemicals were purchased from Sigma®, Singapore. Bay K8644, (the     
L-type Ca2+ channel activator; S-(−)-1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoro-
methyl)phenyl]-3-pyridine-carboxylic acid methyl ester), was dissolved in absolute 
ethanol and used at the concentration of 1 µM (Kupittayanant, Kupittayanant and 
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Suwannachat, 2009). A 5 mM CaCl2 solution was made by increasing the concentra-
tion of Ca2+ from 2 to 5 mM into Krebs’ solution (Buddhakala, Talubmook, Sriyotha, 
Wray and Kupittayanant, 2008). The agonist oxytocin was dissolved in distilled water 
and used at concentration of 10 nM to produce a phasic contraction (Kupittayanant, 
Luckas and Wray, 2002). Prostaglandin F2α, (PGF2α-tris; (5Z,9α,11α,13E,15)-9,11,15-
trihydroxyprosta-5,13-dienoic acid tris salt), was dissolved in the absolute ethanol and 
used at the concentration of 1 µM (Buddhakala et al., 2008). A KCl (40 mM) Krebs’ 
solution was made by isoosmotic replacement of sodium chloride (Noble and Wray, 
2002). In some experiments 0-Ca solutions were used; physiological solution in which 
CaCl2 had been omitted and ethylene glycol tetraacetic acid (EGTA, 1 mM) added 
(Kupittayanant et al., 2002). The physiological Krebs’ solution (pH 7.4) contained the 
following (mM): NaCl 154.0, KCl 5.4, MgSO4 1.2, glucose 8.0, CaCl2 2.0, and N-2-
hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) 10.0. 
 
 4.3.4 Preparation of Watermelon Flesh and Rind Extracts 
 As described in Chapter II (Section 2.1.2), stocks of watermelon extracts were 
kept at -20°C. Fruit flesh or rind extract was dissolved in Krebs’ solution just before 
use. 
  
4.3.5 Statistical Analysis 
The data were analyzed using Microcal Origin Software. The integral force 
was used as the parameter of contraction. Results were expressed as percentages of 
control contractions (i.e. the control is 100%). Throughout, data are presented as  
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mean ± S.E.M. and “n” represents the number of samples, each one from a different 
animal. Significances were tested using appropriate t tests. The P value < 0.05 was 
taken to be significant. 
 
4.4 Results 
 4.4.1 Effects of Watermelon Flesh and Rind Extracts on Rat Uterine 
 Contractions in the Presence of L-type Ca2+ Channel Activator 
Watermelon Flesh Extract  
In the myometrium, L-type Ca2+ channels are essential for the 
electromechanicl coupling that initiates the extracellular Ca2+ cycle (Chien, Saunders 
and Phillippe, 1996; Wray et al., 2003). To investigate whether the tocolytic effects of 
watermelon flesh extract may be due to the inhibition of L-type Ca2+ channels,       
Bay K8644 (1 µM), the L-type Ca2+ activator, was used (Kupittayanant et al., 2009). 
As shown in Figure 4.1A, pretreatment of the uterine strip with Bay K8644 produced 
a significant increase in the contraction amplitude (135.04 ± 1.23%, P < 0.05) 
compared with spontaneous contraction (100%, n = 6). Addition of watermelon flesh 
extract to the myometrial strips in the continued presence of Bay K8644 produced a 
marked decrease in contraction amplitude and the mean integral force to              
57.05 ± 5.37% and 64.17 ± 2.27%, (P < 0.05) respectively, compared with 
spontaneous contraction (100%). When Bay K8644 was added after flesh extract, it 
reversed the inhibitory effects of flesh extract, but the amplitude of contractions did 
not return to the control level. The amplitude and the mean integral force produced by 
the combination of flesh extract and Bay K8644 measured after 10 min application 
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were 81.75 ± 2.37% and 83.80 ± 2.15%, (P < 0.05) respectively, compared with 
spontaneous contraction (100%, n = 6). The samples of experimental traces are shown 
in Figure 4.1 and data summarized in Table 4.1. 
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Figure 4.1 The effects of watermelon flesh extract on uterine contraction in the 
presence of the L-type Ca2+ channel activator. Bay K8644 (1 µM) was added before 
(A) and after (B) watermelon flesh extract (6 mg/mL; n = 6 for each). 
 
 
B 
A 
 
 
Table 4.1 The effects of watermelon flesh extract on uterine contraction in the presence of L-type Ca2+ channel activator. 
 
The P-values for amplitude, frequency and AUC of Bay K8644 treated are significantly different from the control (*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon flesh (after) 
Control 
Bay K8644 
Bay K8644 + watermelon flesh 
Watermelon flesh (before) 
Control 
Watermelon flesh  
Watermelon flesh + Bay K8644 
 
 
100 
135.04 ± 1.23* 
57.05 ± 5.37* 
 
100 
61.80 ± 7.73* 
81.75 ± 2.37* 
 
 
100 
122.23 ± 6.70* 
   88.08 ± 6.16 
 
100 
114.40 ± 5.00* 
100.52 ± 5.02 
 
 
100 
148.54 ± 6.70* 
64.17 ± 2.27* 
 
100 
52.05 ± 3.87* 
83.80 ± 2.15* 
 
 
6 
6 
6 
 
6 
6 
6 
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Watermelon Rind Extract  
The effects of rind extract on rat uterine contraction in the presence of        
Bay K8644 was also examined. As can be seen in Figure 4.2A, the application of rind 
extract in the continued presence of Bay K8644 caused a marked decrease of force 
(48.98 ± 5.57%, P < 0.05, compared with spontaneous contraction (100%, n = 6). The 
amplitude and the mean integral force produced by the combination of rind extract 
and Bay K8644 measured after 10 min application were 48.90 ± 5.43% and          
70.35 ± 7.90%, (P < 0.05) respectively when compared with Bay K8644 alone. The 
application of Bay K8644 in the continued presence of the rind extract produced a 
significant increase in force. The amplitude and the mean integral force produced by 
the combination of rind extract and Bay K8644 measured after 10 min of application 
were 81.75 ± 2.37% and 80.61 ± 3.29%, (P < 0.05) respectively, compared with 
spontaneous contraction (100%, n = 6). The samples of experimental traces are shown 
in Figure 4.2 and data summarized in Table 4.2. 
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Figure 4.2 The effects of watermelon rind extract on uterine contraction in the 
presence of the L-type Ca2+ channel activator. Bay K8644 (1 µM) was added before 
(A) and after (B) watermelon rind extract (5 mg/mL; n = 6 for each). 
B 
A 
 
 
Table 4.2 The effects of watermelon rind extract on uterine contraction in the presence of L-type Ca2+ channel activator. 
 
The P-values for amplitude, frequency and AUC of Bay K8644 treated are significantly different from the control (*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon rind (after) 
Control 
Bay K8644 
Bay K8644 + watermelon rind 
Watermelon rind (before) 
Control 
Watermelon rind  
Watermelon rind + Bay K8644 
 
 
100 
138.04 ± 6.43* 
48.98 ± 5.57* 
 
100 
59.51 ± 4.53* 
81.75 ± 2.37* 
 
 
100 
120.15 ± 4.75* 
   84.08 ± 3.14* 
 
100 
116.88 ± 3.65* 
66.63 ± 7.97* 
 
 
100 
140.68 ± 4.49* 
64.17 ± 2.27* 
 
100 
65.51 ± 3.87* 
80.61 ± 3.29* 
 
 
5 
5 
5 
 
5 
5 
5 
72 
 
 4.4.2 Effects of Watermelon Flesh and Rind Extracts on Rat Uterine 
 Contractions in the Presence of High Ca2+ 
Watermelon Flesh Extract  
 It has been indicated that Ca2+ are important for regulating the contraction-
relaxation process in smooth muscle, including the myometrium (Kupittayanant et al., 
2002; Wray et al., 2003). Thus, it was of interest to investigate whether the inhibitory 
effects of watermelon is dependent upon external Ca2+ entry. To do so, the solution 
was changed to one with 5 mM CaCl2 (Buddhakala et al., 2008) and then watermelon 
flesh extract added. As can be seen in Figure 4.3A, the application of high Ca2+ 
solution substituted for normal Krebs’ solution (2 mM CaCl2) caused a significant 
increase in force. The addition of watermelon flesh extract (6 mg/mL) to the uterus in 
the presence of high Ca2+ solution produced a marked rapid fall of force. The 
amplitude and the mean integral force of the contractions were 68.76 ± 3.40% and 
67.29 ± 2.93%, (P < 0.05) respectively, compared with spontaneously contracting 
uterus (100%, n = 5). As expected, the application of high Ca2+ solution in the 
presence of flesh extract partially revered the inhibitory effects (Figure 4.3B). The 
amplitude of force produced by the combination of flesh extract and high Ca2+ 
solution measured after 10 minutes of application was 86.73 ± 2.71% (P < 0.05), 
when compared with spontaneous contraction (100%, n = 5). The samples of 
experimental traces are shown in Figure 4.3 and data summarized in Table 4.3. 
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Figure 4.3 The effects of watermelon flesh extract on uterine contraction in the 
presence of high Ca2+. 5 mM CaCl2 solution was added before (A) and after (B) 
watermelon flesh extract (6 mg/mL; n = 5 for each). 
A 
B 
 
 
Table 4.3 The effects of watermelon flesh extract on uterine contraction in the presence of high Ca2+. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon flesh (after) 
Control 
5 mM CaCl2  
5 mM CaCl2 + watermelon flesh 
Watermelon flesh (before) 
Control 
Watermelon flesh  
Watermelon flesh + 5 mM CaCl2 
 
 
100 
110.62 ± 1.52* 
68.76 ± 3.40* 
 
100 
67.02 ± 4.91* 
86.73 ± 2.71* 
 
 
100 
125.25 ± 2.51* 
116.66 ± 1.09* 
 
100 
114.00 ± 1.57* 
109.33 ± 4.80 
 
 
100 
118.40 ± 0.95* 
67.29 ± 2.93* 
 
100 
70.02 ± 3.51* 
85.80 ± 2.15* 
 
 
5 
5 
5 
 
5 
5 
5 
The P-values for amplitude, frequency and AUC of 5 mM CaCl2 treated are significantly different from the control (
*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
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Watermelon Rind Extract 
 The inhibitory effects of rind extract on the response to high Ca2+ were also 
investigated. As can be seen in Figure 4.4A, high Ca2+ solution produced a significant 
increase in force. With high Ca2+, rind extract significantly reduced the amplitude of 
contractions to 66.36 ± 3.66% (P < 0.05), compared to spontaneous contraction 
(100%, n = 5). Application of high Ca2+ solution in the continued presence of rind 
extract partially prevented the tocolytic effects of the rind extract (Figure 4.4B). The 
amplitude of  force produced by the combination of rind extract and high Ca2+ 
solution measured after 10 minutes of addition was 86.20 ± 2.13%  (P < 0.05), when 
compared with spontaneous contraction (100%, n = 5). The samples of experimental 
traces are shown in Figure 4.4 and data summarized in Table 4.4.   
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Figure 4.4 The effects of watermelon rind extract on uterine contraction in the 
presence of high Ca2+. 5 mM CaCl2 solution was added before (A) and after (B) 
watermelon rind (5 mg/mL) extract (n = 5). 
 
B 
A 
 
 
Table 4.4 The effects of watermelon rind extract on uterine contraction in the presence of high Ca2+. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon rind (after) 
Control 
5 mM CaCl2 
5 mM CaCl2 + watermelon rind 
Watermelon rind (before) 
Control 
Watermelon rind  
Watermelon rind + 5 mM CaCl2 
 
 
100 
115.58 ± 4.11* 
66.36 ± 3.66* 
 
100 
57.36 ± 7.62* 
86.20 ± 2.13* 
 
 
100 
114.28 ± 3.84* 
114.63 ± 2.60* 
 
100 
114.33 ± 3.66* 
113.33 ± 1.33* 
 
 
100 
123.88 ± 8.09* 
67.29 ± 2.93* 
 
100 
61.46 ± 5.00* 
86.15 ± 2.48* 
 
 
5 
5 
5 
 
5 
5 
5 
The P-values for amplitude, frequency and AUC of 5 mM CaCl2 treated are significantly different from the control (
*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
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 4.4.3 Effects of Watermelon Flesh and Rind Extracts on PGF2α-Induced 
 Uterine Contraction 
Watermelon Flesh Extract  
 PGF2α binds to prostaglandin FP receptor to stimulate uterine contractions 
through the activation of Ca2+ release from the SR (Hollingsworth, Downing, Cheuk, 
Piper and Hughes, 1993). As can be seen in Figure 4.5A, PGF2α (1 µM) significantly 
increased the amplitude, the frequency and the mean integral force of the contractions. 
Application of flesh extract to the myometrial strips in the continued presence of 
PGF2α produced a marked decrease in the amplitude and the mean integral force       
(n = 7). The samples of experimental traces are shown in Figure 4.5A and data 
summarized in Table 4.5.   
 
Watermelon Rind Extract  
 As can be seen in Figure 4.5B, 1 µM PGF2α significantly increased the 
amplitude, the frequency and the mean integral force of the contractions. Application 
of 5 mg/mL rind extract to the uterine strips in the continued presence of PGF2α 
exerted significant inhibitory effects on both amplitude and the mean integral force   
(n = 7). The samples of experimental traces are shown in Figure 4.5B and data 
summarized in Table 4.5.   
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Figure 4.5 The effects of watermelon flesh and rind extracts on PGF2α-induced 
uterine contraction. The effects of 6 mg/mL flesh (A) and 5 mg/mL rind extracts (B) 
on uterine contraction-induced by 1 µM PGF2α are shown (n = 7 for each). 
 
 
A 
B 
 Table 4.5 The effects of watermelon flesh and rind extracts on PGF2α-induced uterine contraction. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon flesh 
Control 
PGF2α 
PGF2α + watermelon flesh  
Watermelon rind 
Control 
PGF2α  
PGF2α + watermelon rind  
 
 
100 
120.64 ± 0.91* 
60.37 ± 5.44* 
 
100 
127.03 ± 1.09* 
55.74 ± 4.40* 
 
 
100 
132.42 ± 0.83* 
114.46 ± 2.47* 
 
100 
130.32 ± 1.33* 
116.66 ± 3.23* 
 
 
100 
149.43 ± 8.53* 
65.80 ± 1.96* 
 
100 
140.85 ± 4.02* 
54.78 ± 3.40* 
 
 
7 
7 
7 
 
7 
7 
7 
The P-values for amplitude, frequency and AUC of 1 µM PGF2α treated are significantly different from the control (
*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
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 4.4.4 Effects of Watermelon Flesh and Rind Extracts on Oxytocin-
 Induced Uterine Contraction 
Watermelon Flesh Extract  
 Oxytocin is a nonapeptide hormone produced by the pituitary (Gimpl and 
Fahrenholz, 2001). It increases uterine force by acting on oxytocin receptor, which 
results in the Ca2+ influx through L-type Ca2+ channel and the release of Ca2+ from the 
SR (Gimpl and Fahrenholz, 2001; Phillippe and Chien, 1998; Shmygol, Gullam, 
Blanks and Thornton, 2006). As can be seen in Figure 4.6A, the addition of oxytocin 
(10 nM) significantly increased the amplitude, the frequency and the mean integral 
force of the contractions. Application of 6 mg/mL flesh extract to the myometrial 
strips in the continued presence of 10 nM oxytocin produced a decrease of force       
(n = 8). The samples of experimental traces are shown in Figure 4.6A and data 
summarized in Table 4.6. 
 
Watermelon Rind Extract  
 As can be seen in Figure 4.6B, 10 nM oxytocin significantly increased 
contractile amplitude (110.59 ± 3.59%, P < 0.05) compared with control spontaneous 
contractions (100%, n = 8). Application of rind extract (5 mg/mL) to the myometrium 
in the continued presence of oxytocin caused a significant inhibition on both the 
amplitude and the mean integral force (n = 8). The samples of experimental traces are 
shown in Figure 4.6B and data summarized in Table 4.6. 
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Figure 4.6 The effects of watermelon flesh and rind extracts on oxytocin-induced 
uterine contraction. The effects of 6 mg/mL flesh (A) and 5 mg/mL rind extracts (B) 
on uterine contraction-induced by 10 mM oxytocin are shown (n = 8 for each). 
 
A 
B 
 
 
Table 4.6 The effects of watermelon flesh and rind extracts on oxytocin-induced uterine contraction. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon flesh 
Control 
Oxytocin 
Oxytocin + watermelon flesh 
Watermelon rind 
Control 
Oxytocin  
Oxytocin + watermelon rind  
 
 
100 
114.03 ± 3.61* 
55.39 ± 1.03* 
 
100 
110.59 ± 3.59* 
49.88 ± 9.45* 
 
 
100 
175.74 ± 6.31* 
116.73 ± 2.20* 
 
100 
170.91 ± 2.21* 
114.42 ± 1.75* 
 
 
100 
179.47 ± 7.49* 
50.19 ± 1.22* 
 
100 
173.91 ± 3.52* 
44.82 ± 6.43* 
 
 
8 
8 
8 
 
8 
8 
8 
The P-values for amplitude, frequency and AUC of 10 nM oxytocin treated are significantly different from the control                
(*P < 0.05). Mean ± S.E.M. are given; n is number of animals. 
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 4.4.5 Effects of Watermelon Flesh and Rind Extracts on KCl-Induced 
 Uterine Contraction 
Watermelon Flesh Extract  
 KCl solution-induced contraction is predominantly mediated by depolarization 
of the surface membrane and Ca2+ entry through voltage-dependent Ca2+ channels 
(Ausina, Savineau, Pinto, Martin and Candenas, 1996). As can be seen in Figure 
4.7A, the addition of KCl produced an initial rapid phasic contraction followed by a 
sustained tonic contraction. Upon return to control solution, uterine tension 
reappeared after a delay of approximately 5 min. 30 min later, the solution was 
changed to KCl again. This resulted initially in a rise of tension to approximately the 
same level as seen with the first treatment of KCl. The flesh extract (6 mg/mL) was 
added to the myometrium during the sustained tonic contraction. It produced a 
significant inhibition of the contraction (n = 6). This value was 73.19 ± 4.67%          
(P < 0.05) compared to the KCl control (100%). 
 
Watermelon Rind Extract 
 As can be seen in Figure 4.7B, isoosmotic KCl (40 mM) solution significantly 
increased uterine force. The contraction was maintained as long as KCl was present. 
Application of 5 mg/mL rind extract to the myometrium in the continued presence of 
KCl produced a significant inhibition on force (n = 6). This value was 56.12 ± 1.25% 
(P < 0.05) compared to the KCl control (100%).  
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Figure 4.7 The effects of watermelon flesh and rind extracts on KCl-induced uterine 
contraction. The effects of 6 mg/mL watermelon flesh (A) and 5 mg/mL rind extracts 
(B) on uterine contraction-induced by KCl (40 mM) solution are shown (n = 6 for 
each). 
 
A 
B 
86 
 
 4.4.6 Effects of Watermelon Flesh and Rind Extracts on PGF2α-Induced 
 Uterine Contraction in the Absence of External Ca2+ 
Watermelon Flesh Extract  
It is well known that in the absence of external Ca2+, force was rapidly 
abolished (Buddhakala et al., 2008; Matthew, Kupittayanant, Burdyga and Wray, 
2004; Kupittayanant et al., 2002). Under this condition, some agonists can generate 
the contractile force through the release of Ca2+ from the SR (Matthew et al., 2004; 
Kupittayanant et al., 2002; Wray et al., 2003). Thus, it was of interest to investigate 
whether the flesh extract could alter this contraction. PGF2α was added in the absence 
of external Ca2+ entry. This protocol was performed to ensure that the only source of 
Ca2+ was from the SR (Matthew et al., 2004; Kupittayanant et al., 2002). As can be 
seen in Figure 4.8A, phasic contractions abolished upon changing to 0-Ca solution. In 
the continued presence of 0-Ca solution, 1 µM PGF2α produced a small tonic force as 
long as this agonist was present. Upon return to control solution, spontaneous phasic 
contractions reappeared. 30 min later, the solution was changed to one containing     
0-Ca and flesh extract (6 mg/mL). Force abolished rapidly and PGF2α added. It was 
revealed that very little if any force was produced (Figure 4.8A, n = 6). This value 
was 30.35 ± 5.25% (P < 0.05) compared to PGF2α-induced contraction in the absence 
of external Ca2+ alone (100 %, n = 6). 
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Watermelon Rind Extract  
The effects of watermelon rind extract on PGF2α-induced uterine contraction 
in the absence of external Ca2+ were also examined. The effects were similarly to the 
effects of flesh extract. As can be seen in Figure 4.8B, PGF2α produced a small tonic 
force in 0-Ca solution. It was found that watermelon rind extract impeded this 
contraction to 25.42 ± 4.13% (P < 0.05, n = 6) compared to PGF2α-induced 
contraction in the absence of external Ca2+ alone (100 %, n = 6). 
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Figure 4.8 The effects of watermelon flesh and rind extracts on PGF2α-induced 
uterine contraction in the absence of external Ca2+. The effects of 6 mg/mL 
watermelon flesh (A) and 5 mg/mL rind extracts (B) on uterine contraction-induced 
by 1 µM PGF2α in 0-Ca solution are shown (n = 6 for each). 
 
 
B 
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 4.4.7 Effects of Watermelon Flesh and Rind Extracts on Oxytocin-
 Induced Uterine Contraction in the Absence of External Ca2+ 
Watermelon Flesh Extract  
The same protocol was used as described above for PGF2α. In the absence of 
external Ca2+, 10 nM oxytocin produced a small tonic force, indicating that oxytocin 
can release Ca2+ from the SR (Matthew et al., 2004; Kupittayanant et al., 2002). As 
can be seen in Figure 4.9A, application of 6 mg/mL watermelon flesh extract to the 
uterine strips caused a significant inhibition of the contraction induced by oxytocin in 
the absence of external Ca2+. This value was 35.63 ± 2.52% (P < 0.05, n = 6) 
compared to oxytocin-induced contraction in the absence of external Ca2+ alone    
(100 %, n = 6). 
  
Watermelon Rind Extract  
As can be seen in Figure 4.9B, application of watermelon rind extract            
(5 mg/mL) to uterine contraction-induced by oxytocin in the absence of external Ca2+ 
produced a marked significant inhibition of the contraction. This value was          
30.83 ± 5.18% (P < 0.05, n = 6) compared to oxytocin-induced contraction in the 
absence of external Ca2+ alone (100 %, n = 6). 
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Figure 4.9 The effects of watermelon flesh and rind extracts on oxytocin-induced 
uterine contraction in the absence of external Ca2+. The effects of 6 mg/mL 
watermelon flesh (A) and 5 mg/mL rind extracts (B) on uterine contraction-induced 
by 10 nM oxytocin in 0-Ca solution are shown (n = 6 for each). 
 
 
B 
A 
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 4.4.8 Effects of Watermelon Flesh and Rind Extracts on Oxytocin-
 Induced Uterine Contraction in the Presence of KCl 
Watermelon Flesh Extract 
 It has been reported that, when Ca2+ was high or maintained, smooth muscle 
contraction may be modulated by Ca2+-independent pathway. For example, 
application of oxytocin in the presence of KCl generated a tonic component of force, 
indicating the release of Ca2+ from the SR. In addition, it was demonstrated that the 
production of force by oxytocin may due to the modulation of myosin light chain 
phosphatase (MLCP) activity through rho-associated kinase (ROK) pathway 
(Kupittayanant, Burdyga and Wray, 2001; Somlyo and Somlyo, 1998). ROK 
stimulated by oxytocin produced a marked increase in force without a change in 
intracellular Ca2+ (Kupittayanant et al., 2001). It was of interest to verify whether 
watermelon flesh extract may alter this kind of contraction; oxytocin-induced uterine 
contraction in the presence of KCl. As can be seen in Figure 4.10A, application of 
oxytocin (10 nM) in the continued presence of KCl produced a small tonic 
contraction, suggesting the release of Ca2+ from the SR. Upon return to control 
solution, uterine tone quickly returned to baseline and spontaneous phasic 
contractions reappeared. 30 min later, the solution was then changed to KCl and 
oxytocin added. In addition, 6 mg/mL flesh extract was added to the uterine strip 
during the sustained tonic contraction. It produced a marked decrease in force. Thus, 
after 10 min, force had fallen to 74.98 ± 3.80% of control force development            
(P < 0.05, 100% force was the level of maintained force that was produced during the 
application of 10 nM oxytocin in the presence of KCl, n = 6).        
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Watermelon Rind Extract 
 The same protocol was used as described above for the flesh extract. As can 
be seen in Figure 4.10B, application of 5 mg/mL rind extract was able to decrease 
force upon oxytocin application to the uterus in the presence of KCl. After 10 min, 
force had fallen to 73.81 ± 1.59% of control force development (P < 0.05, 100% force 
was the level of maintained force that was produced during the application of 10 nM 
oxytocin in the presence of KCl, n = 6). 
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Figure 4.10 The effects of watermelon flesh and rind extracts on oxytocin-induced 
uterine contraction in the presence of KCl. The effects of 6 mg/mL watermelon flesh 
(A) and 5 mg/mL rind extracts (B) on oxytocin-induced uterine contraction in the 
presence of 40 mM KCl solution are shown (n = 6 for each). 
 
A 
B 
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4.5 Discussion 
To the best of our knowledge, this study is the first to demonstrate the effects 
of watermelon extracts on agonists-induced uterine contractions. The prominent 
effects of watermelon on force partially mediate through the inhibition of L-type Ca2+ 
channels. In addition, watermelon flesh and rind extracts potentially inhibit uterine 
contractions-induced by PGF2α, oxytocin, and KCl. In the absence of external Ca
2+, 
both watermelon flesh and rind extracts impede the contraction-induced by PGF2α and 
oxytocin. In addition, they caused a marked decrease in tonic contractions produced 
by oxytocin-induced contraction in the presence of KCl. The relaxation of force 
produced by the extracts was dependent upon (1) Ca2+-dependent, (2) Ca2+-
independent regulation of smooth muscle contraction as well as, (3) NO-cGMP 
pathway modulation.  
It is generally accepted that in uterine smooth muscle cells, a rise of [Ca2+]i 
plays a crucial role in the mechanism of contraction. Ca2+ for the contraction is due to 
the release of the SR and the influx of extracellular Ca2+ through the L-type Ca2+ 
channels (Matthew et al., 2004; Kupittayanant et al., 2002). The increased in [Ca2+]i 
results in calmodulin activation of myosin light chain kinase. This kinase 
phosphorylates the regulatory light chains of myosin, leading to the activation of 
myosin MgATPase and force generation and/or shortening of the muscle fibers. 
(Kupittayanant et al., 2002; Phillippe and Edward, 1998; Wray, 1993; 2007; Wray et 
al., 2003).  
     Bay K8644 was used to activate the L-type Ca2+ channels (Chien et al., 
1996). Opening of cell membrane Ca2+ channels mediates the influx of Ca2+ ion to 
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generate force (Chien et al., 1996). These present studies were performed to test the 
hypothesis that Bay K8644 can inhibit or prevent the inhibitory effects of watermelon 
extracts on rat uterine contraction. Application of Bay K8644 (1 µM) to spontaneous 
contractions produced an increase in the amplitude, the frequency, and the mean 
integral force of phasic contractions when compared with the control period. 
Watermelon flesh (6 mg/mL) or rind (5 mg/mL) extract partially inhibited uterine 
contractions induced by Bay K8644. Thus, this finding suggests that watermelon 
extracts partially inhibit force production through the interruption of extracellular 
Ca2+ influx. In addition, it also indicates that other mechanisms could take part in the 
tocolytic effects of watermelon extracts on uterine contraction (see below).  
In other set of experiments, application of high Ca2+ was also used to 
investigate the effects of watermelon extracts on L-type Ca2+ channels (Buddhakala et 
al., 2008). Similarly, in Bay K8644, the addition of 5 mM CaCl2 solution to the organ 
bath caused a significant increase in contractile activity. Application of watermelon 
extracts suppressed uterine contraction-induced by 5 mM CaCl2, suggesting that the 
tocolytic effects of watermelon rat uterine contraction may partially be due to the 
inhibition of Ca2+ entry through L-type Ca2+ channels (Buddhakala et al., 2008). 
Exposure of the uterine strips to KCl induces a rapid rise in [Ca2+]i through 
depolarization of the cell membrane, leading to the opening of L-type Ca2+ channels 
and muscle contraction (Ausina et al., 1996; Kupittayanant et al., 2001). This tonic 
contraction is diminished by some agents that interfere at the levels of excitation-
contraction coupling, such as Ca2+ channel blocking agents (Ausina et al., 1996; 
Ivorra, Chuliá, Noguera and D'Ocon, 1994). The addition of watermelon extracts to 
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the uterus was able to decrease force in the presence of KCl, supporting the 
hypothesis that watermelon extracts possess a Ca2+ entry blocking activity. 
PGF2α and oxytocin increase uterine contractile activity by acting on 
prostaglandin FP and oxytocin receptors, respectively (Gimpl and Fahrenholz, 2001; 
Phillippe and Edward, 1998; Soloff, 1990). These receptors were connected with 
Gαq/11 subunit to membrane phospholypase Cβ (PLCβ). Hydrolysis of 
phosphatidylinositol 4,5-bisphosphate (PIP2) produces 1,2-diacylglycerol (DAG) and 
inositol 1,4,5-trisphosphate (IP3). IP3 binds to its receptor on the SR membrane and 
causes release of Ca2+ into the cytoplasm (Gimpl and Fahrenholz, 2001; Phillippe and 
Edward, 1998; Soloff, 1990). Moreover, oxytocin itself can activate L-type Ca2+ 
channels and chloride (ClCa) channels directly, resulting in the increase in phasic 
contractions (Arnaudeau, Lepretre and Mironneau, 1994; Wray et al., 2003). The 
application of PGF2α and oxytocin to the uterine strips produced a marked increase of 
the contractile force. The addition of watermelon flesh or rind extract in the presence 
of PGF2α or oxytocin decreased uterine contractility. Thus, these findings suggest that 
the spasmolytic activity of watermelon extracts may be due to the interruption of 
Gαq/11-PLCβ-IP3 pathway and the decrease of Ca
2+ entry.  
The mechanisms of action by which natural products produce tocolytic effects 
are also associated with the NO system (Drewes, George and Khan, 2003; 
Jayaprakasha et al., 2011). It has been reported that NO induces changes in target 
proteins through the activation of cGMP (Drewes et al., 2003; Jayaprakasha et al., 
2011). There is evidence that watermelon extract can decrease the levels of [Ca2+]i by 
using Flou-4 AM dye, a specific fluorescent probe for [Ca2+]i in smooth muscle cell 
line (Jayaprakasha et al., 2011). It has been hypothesized that the mechanisms 
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underlying of NO and cGMP could affects [Ca2+]i in four different ways: 1) by 
reducing Ca2+; 2) by increasing Ca2+efflux; 3) by enhancing Ca2+ sequestration; and 
4) by decreasing Ca2+ mobilization (Lincoln, Cornwell, Komallavilas, Macmillan-
Crow and Boerth, 1995; McDonald and Murad, 1995; Norman, 1996). Based on these 
scientific evidences, it is possible to speculate that NO-cGMP pathway modulation 
may also be involved in the inhibitory effects of watermelon flesh and rind extracts on 
rat uterine contraction in this present study. 
  In 0-Ca solution, PGF2α and oxytocin can elicit a small tonic contraction, 
suggesting the release of Ca2+ from the SR. Pre-incubation of watermelon extracts 
with 0-Ca solution altered the contraction triggered by PGF2α or oxytocin. It has been 
demonstrated that cGMP-dependent protein kinase (PKG Iβ) can decrease              
IP3-induced elevations in [Ca
2+]i through the phosphorylation of the IP3R-associated 
cGMP kinase substrate (IRAG) (Schlossmann et al., 2000). IRAG was found in many 
tissues, including the uterus (Schlossmann et al., 2000). It is indicated that IRAG may 
be associated with the dynamics of Ca2+ release by either by modulating IP3R function 
or by regulating mechanisms that provide electroneutrality of Ca2+ release (Nguyen, 
Chin and Verdugo, 1998). Co-expression of IRAG and PKG Iβ in the presence of 
cGMP inhibited the release of Ca2+ induced by bradykinin (Schlossmann et al., 2000). 
Based on these scientific data, it is possible to assume that watermelon extracts 
affected a reduction on the SR release by interrupting Gαq/11-PLCβ-IP3 pathway. 
It has been demonstrated that, when Ca2+ was high or maintained, smooth 
muscle contraction may be modulated by Ca2+-independent pathway (Kupittayanant 
et al., 2001). For example, application of oxytocin in the presence of KCl produced a 
tonic component of force, indicating release of Ca2+ from the SR. In addition, it was 
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suggested that oxytocin may modulate of MLCP activity through the ROK pathway to 
increase the contractile force (Kupittayanant et al., 2001; Shmygol et al., 2006; 
Somlyo and Somlyo, 1998). ROK activated by oxytocin produced a marked increase 
in force without a change in [Ca2+]i
 (Kupittayanant et al., 2001). In this prevalence, 
the application of watermelon extracts to oxytocin-induced contraction in the presence 
of KCl produced a marked decrease in uterine force. This finding indicates that 
watermelon extracts might inhibit, at least in part, the ROK pathway induced a Ca2+ 
desensitization. 
There is a significant clinical need for uterine relaxants in the treatment of 
primary dysmenorrhea and preterm labor (Gruber and O’Brien, 2011; Hollingsworth 
et al., 1993). However, etiologies of these disorders are unknown because they are 
influenced by many aspects (Hollingsworth et al., 1993). Thus, drugs could achieve 
tocolytic effects by several mechanisms. It is well known that medicinal plants 
contain various phytochemical constituents that exert their effects through multi- 
cellular targets in the body (Kunnumakkara et al., 2009). This could be the reason 
why the medicinal plants have effective in the treatment of various diseases. The 
results of this present study indicate that watermelon extracts produce a tocolytic 
effect on uterine contractions-induced by PGF2α and oxytocin. Therefore, these 
findings provide scientific evidence supporting the therapeutic uses of watermelon in 
the treatment of primary dysmenorrhea and preterm labor.      
In conclusion, this study investigated the inhibitory effects of watermelon 
extracts on isolated rat uterus. The results indicate that watermelon flesh and rind 
extracts produced tocolytic effects by inhibiting both Ca2+-dependent and             
Ca2+-independent regulation of smooth muscle contraction pathways as well as by 
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stimulating NO-cGMP pathway modulation. It is suggested that watermelon has the 
spasmolytic potency for the prevention of dysmenorrhea and preterm labour.  
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CHAPTER V 
EFFECTS OF L-CITRULLINE AND L-ARGININE ON 
SPONTANEOUS AND AGONISTS-INDUCED  
UTERINE CONTRACTIONS 
 
5.1 Abstract 
Watermelon (Citrullus lanatus) is rich in L-citrulline and L-arginine; the 
contents that play an important role in the production of the potent vasodilator, nitric 
oxide (NO). As shown in the previous chapters, watermelon extracts seem to have 
tocolytic effects as they inhibited uterine contraction. Thus, the present study was 
designed to investigate whether the tocolytic effects of watermelon extracts was due 
to those of the potent vasodilators; L-citrulline and L-arginine. The contractile 
responses in the presence of L-citrulline and L-arginine were recorded isometrically 
with a force transducer. The results showed that L-citrulline and L-arginine (1 × 10-6 
to 1 × 10-3 M) had a dose-dependent effect on spontaneous contraction. The EC50 
values of L-citrulline and L-arginine were 64 µM and 104 µM, respectively. In 
addition, L-citrulline and L-arginine impeded uterine contractions induced by 
prostaglandin F2α (PGF2α), oxytocin, and potassium chloride solution (KCl). They 
also reduced PGF2α- and oxytocin-induced uterine force in the absence of external 
calcium (Ca2+) and partially inhibited contraction induced by increasing external
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Ca2+. In addition, they caused a marked decrease in tonic contractions produced by 
oxytocin-induced contraction in the presence of KCl. These data indicated that the 
tocolytic effects of L-citrulline and L-arginine were via the inhibition of both       
Ca2+-dependent and Ca2+-independent pathways of force regulation. The effects of            
L-citrulline and L-arginine were similar to those produced by watermelon extracts. 
Thus, the results suggest that the inhibitory effects of watermelon could be due to     
L-citrulline and L-arginine contents. 
 
5.2 Introduction 
 Fruit and vegetable consumption has been associated with reduced incidence 
of some chronic diseases such as atherosclerosis and cancers. Watermelon is rich in 
phytoneutrients such as lycopene, which is a well known antioxidant and has a 
potential role in prevention of prostate cancer (Perkins-Veazie, Maness and Roduner, 
2002). Watermelon is also an excellent source of vitamins and minerals. It has been 
reported that watermelon contains a high level of amino acids, L-citrulline and         
L-arginine (Tlili, Hdider, Lenucci, Ilahy, Jebari and Dalessandro, 2011). These two 
amino acids play a crucial role in NO system by eliciting a wide range of such as 
vasorelaxation, vascular functions, anti-inflammatory, and anti-platelet activity (Flam, 
Hartmann, Harrell-Booth, Solomonson and Eichler, 2001; Norman, 1996). 
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 5.2.1 L-Citrulline 
L-citrulline (C6H13N3O3) is water soluble α-amino acid with an asymmetric 
carbon. It is a natural precursor for L-arginine to produce NO (Lincoln, Cornwell, 
Komallavilas, Macmillan-Crow and Boerth, 1995; Romero, Platt, Caldwell and 
Caldwell, 2006). Thus, under pathological conditions, L-citrulline may relatively 
substitute for L-arginine. L-citrulline can be converted to L-arginine in all cell types 
(Flam et al., 2001; Romero et al., 2006). It was shown that L-citrulline plays an 
important role in providing L-arginine to NO synthase (NOS) as it bypasses 
metabolism in the liver (Flam et al., 2001; Romero et al., 2006). The normal range of 
plasma levels of L-citrulline in humans is 22.9 - 65 µM (Ochiai et al., 2010). In recent 
decades, little scientific evidence has been reported the use of L-citrulline as the 
therapeutic agent (Cormio et al., 2011; Ochiai et al., 2010; Romero et al., 2006). As 
mentioned above, L-citrulline can be used to substitute and/or convert to L-arginine. 
Thus, L-citrulline may be served as a new important substance for new treatments 
(Cynober, Moinard and De Bandt, 2010; Flam et al., 2001). 
It has been suggested that short-term L-citrulline supplementation can improve 
arterial stiffness in humans (Ochiai et al., 2010). It was indicated that oral L-citrulline 
supplementation can attenuate brachial blood pressure and aortic pulse pressure 
responses to cold presser test in young men (Figueroa, Sanchez-Gonzalez, Perkins-
Veazie and Arjmandi, 2010). Ranghavan and Dikshit (2001) was undertaken to 
investigate the relaxant effects of L-citrulline mediated relaxation in the 
lipopolysaccharide (1 mg/kg)-treated rat aortic rings. The results showed that            
L-citrulline produced 40 ± 3% and 60 ± 5% relaxant in control and lipopolysaccha-
ride-treated rats, respectively. The relaxant effects of L-citrulline in rabbit vascular 
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smooth muscle were also reported (Ruiz and Tejerina, 1998). This study indicated that 
L-citrulline mediated vascular relaxation thought the production of cGMP mediated 
by NO and the opening of calcium-activated potassium (KCa) channels (Ruiz and 
Tejerina, 1998). 
 
5.2.2 L-Arginine 
L-arginine (C6H14N4O2) is a basic amino acid in physiological fluids.             
L-arginine is involved in various metabolic pathways, such as synthesis of creatinine, 
L-ornithine, L-glutamate, and polyamines (Norman, 1996). L-arginine is also 
involved in NO production by serving as the substrate of a family of NOS (Norman, 
1996). It is well known that NO plays a critical role in regulating the function of many 
organs throughout the body (Norman, 1996). The normal range of plasma L-arginine 
levels in healthy volunteers is 49 - 236 µM (Romero et al., 2006). 
It has been found that L-arginine supplementation can improve reproductive, 
cardiovascular, pulmonary, renal, gastrointestinal, liver, and immune functions 
(Flynn, Meininger, Haynes and Wu, 2002; Racké and Warnken, 2010). Thus,           
L-arginine may provide novel and effective therapies for obesity, diabetes, and the 
metabolic syndrome (Racké and Warnken, 2010). L-arginine is associated with 
endothelial dysfunction in preeclamptic women. It is indicated that L-arginine levels 
and placental endothelial NOS abundance are decreased in preeclamptic compared to 
healthy pregnant women (Roberts, 1999). Infusion of L-arginine at the dose of 30 g 
over 30 min into women with the preterm labour can decrease spontaneous uterine 
contractility (Facchinetti, Saade and Neri, 2007). It has been reported that L-arginine 
0.01 mM caused a significant decrease in the uterine contractility (Hoffmann, Stanke-
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Labesque, Fanchin, Dilaï, Ponsand and Ayoubi, 2003). However, pre-treatment the 
myometrial strip with methylene blue, a soluble guanyltate cyclase inhibitor, can 
prevent the inhibitory effects of L-arginine. In addition, L-NAME, a non-specific 
NOS synthase inhibitor, significantly inhibited the L-arginine-induced relaxation 
(Hoffmann et al., 2003). 
There are number of compounds found in watermelon (Rimando and Perkins-
Veazie, 2005; Tlili et al., 2011). Based on epidemiological and clinical data, it was of 
interest to investigate whether the tocolytic effects of watermelon may be due to       
L-citrulline and L-arginine. Thus, the aim of this chapter was to examine the effects of 
L-citrulline and L-arginine on rat uterine contractions based on Ca2+-dependent and 
Ca2+-independent regulation of smooth muscle contraction. 
 
5.3 Materials and Methods 
 5.3.1 Myometrial Tissue Preparations and Measurements of Tension 
 Myometrial tissue preparations were dissected and force measurements 
measured as those described in Chapter II (Sections 2.2.3 and 2.2.4, respectively). 
 
 5.3.2 Experimental Procedures 
  5.3.2.1 Dose Dependency of L-Citrulline and L-Arginine 
Following a 30-min equilibration time, L-citrulline or L-arginine was added 
into the bathing solution in a cumulative increase in concentration manner. 
Concentration-response curves were plotted and calculated the median effective 
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concentrations (EC50 values, concentration required to produce 50% of maximum 
inhibition of the amplitude of contraction) by a nonlinear curves fitting program 
(Vergara-Galicia et al., 2010). The EC50 values of each agent were applied throughout 
the experiments. 
 
 5.3.2.2 Effects on Spontaneous Uterine Contraction 
Following a 30-min equilibration time, the EC50 values of L-citrulline or       
L-arginine were added into the bathing solution and incubated for 30 min. At the end 
of the experiment, the bathing solution was replaced by Krebs’ solution and tension 
monitored up to 30 min. 
 
5.3.2.3 Effects on Bay K8644- and Increasing CaCl2 Concentration-
Induced Uterine Contractions 
To investigate whether the effects of L-citrulline and L-arginine were 
dependent upon external Ca2+entry through voltage-gated L-type Ca2+ channels,       
Bay K8644, an L-type Ca2+ agonist, or increasing CaCl2 concentration up to 5 mM 
was used to induce uterine contraction and the effects of L-citrulline and L-arginine 
studied. To do so, Bay K8644 or 5 mM CaCl2 was applied for 30 min and then the 
extracts applied, in the continued presence of Bay K8644 or 5 mM CaCl2. In addition, 
the experiments were done the other way round. To do so, L-citrulline or L-arginine 
was applied for 30 min and then Bay K8644 or 5 mM CaCl2 added, in the continued 
presence of Bay K8644 or 5 mM CaCl2. 
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 5.3.2.4 Effects on PGF2α-, Oxytocin- and KCl-Induced Uterine 
Contractions 
The effects of L-citrulline and L-arginine on PGF2α-, oxytocin- and KCl-
induced uterine contractions were evaluated as follows. After equilibration period in 
Krebs’ solution, the uterine strip was stimulated with PGF2α (1 µM), oxytocin         
(10 nM) or KCl (40 mM) for 40 min and then washed. 30 min later PGF2α, oxytocin 
or KCl was then added into the bathing solution, and 20 min later L-citrulline or       
L-arginine was incubated for 20 min in the continued presence of agonists or KCl. At 
the end of the experiment, the bathing solution was replaced by Krebs’ solution and 
tension monitored up to 30 min. The results of these experiments were compared with 
the contraction without L-citrulline or L-arginine. 
 
  5.3.2.5-Effects on PGF2α- and Oxytocin-Induced Uterine 
 Contractions in the Absence of External Ca2+ 
The uterine strip was incubated with 0-Ca (1 mM EGTA) solution containing 
L-citrulline or L-arginine during 15 min, then 1 µM PGF2α or 10 nM oxytocin was 
added to stimulate the release of Ca2+ from the SR. The maximal tension produced by 
PGF2α or oxytocin in the control group (without the L-citrulline or L-arginine) was 
considered as 100%. 
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  5.3.2.6 Effects on Oxytocin-Induced Uterine Contractions in the 
  Presence of KCl 
The uterine strip was incubated with KCl for 15 min. Then the solution in the 
bath was replaced by KCl containing 10 nM oxytocin and equilibrated for 15 min. 
After the maximum contractile response to KCl containing oxytocin was obtained,   
L-citrulline or L-arginine was then applied for 15 min. At the end of the experiment, 
the bathing solution was replaced by Krebs’ solution and tension monitored up to 30 
min. 
 
 5.3.3 Chemicals and Physiological Solutions 
All chemicals were purchased from Sigma®, Singapore. L-citrulline and       
L-arginine were dissolved in Krebs’ solution just before use. Bay K8644, (the L-type 
Ca2+ channel activator; S-(−)-1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)-
phenyl]-3-pyridine-carboxylic acid methyl ester), was dissolved in absolute ethanol 
and used at the concentration of 1 µM (Kupittayanant, Kupittayanant and 
Suwannachat, 2008). A 5 mM CaCl2 solution was made by increasing the 
concentration of Ca2+ (CaCl2) from 2 to 5 mM into Krebs’ solution (Buddhakala, 
Talubmook, Sriyotha, Wray and Kupittayanant, 2008). The agonist oxytocin was 
dissolved in distilled water and used at concentration of 10 nM to produce a phasic 
contraction (Kupittayanant, Luckas and Wray, 2002). Prostaglandin F2α, (PGF2α-tris; 
(5Z,9α,11α,13E,15)-9,11,15-trihydroxyprosta-5,13-dienoic acid tris salt), was 
dissolved in the absolute ethanol and used at the concentration of 1 µM (Buddhakala 
et al., 2008). A KCl (40 mM) Krebs’ solution was made by isoosmotic replacement of 
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sodium chloride (Noble and Wray, 2002). In some experiments, 0-Ca solutions were 
used; physiological solution in which CaCl2 had been omitted and ethylene glycol 
tetraacetic acid (EGTA, 1 mM) added (Kupittayanant et al., 2002). The physiological 
Krebs’ solution (pH 7.4) contained the following (mM): NaCl 154.0, KCl 5.4, MgSO4 
1.2, glucose 8.0, CaCl2 2.0, and N-2-hydroxyethylpiperazine-N'-2-ethanesul-fonic 
acid (HEPES) 10.0.  
 
5.3.4 Statistical Analysis 
The data were analyzed using Microcal Origin Software. The integral force 
was used as the parameter of contraction. Results were expressed as percentages of 
control contractions (i.e. the control is 100%). Throughout, data are presented as  
mean ± S.E.M. and “n” represents the number of samples, each one from a different 
animal. Significances were tested using appropriate t tests. The P value < 0.05 was 
taken to be significant. 
 
5.4 Results 
 5.4.1 Dose Dependency of L-Citrulline 
 The effects of increasing cumulative concentrations of L-citrulline (1 × 10-6 to            
1 × 10-3 M) were added into the bathing solution; each concentration was applied for 
30 min. It produced concentration-dependent decreases in the amplitude of contractile 
activity of the isolated rat uterus. At the highest dose (1 × 10-3 M), L-citrulline 
abolished all spontaneous activity. The EC50 value of L-citrulline was 64 ± 4.06 µM 
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(Figure 5.1, n = 6). Thus, the concentration of 64 µM was selected and used 
throughout the remainder of the study. The inhibitory effects of cumulative doses of 
L-citrulline on the amplitude, frequency, and AUC are summarized in Table 5.1. 
 
 5.4.2 Dose Dependency of L-Arginine  
The effects of increasing cumulative concentrations of L-arginine (1 × 10-6 to 
1 × 10-3 M) were added into the bathing solution; each concentration was applied for 
30 min. As with L-citrulline, it produced concentration-dependent decreases in the 
amplitude of contractile activity of the isolated rat uterus. The EC50 value of             
L-arginine was 104.12 ± 2.03 µM (Figure 5.1, n = 6). Thus, the concentration of        
104 µM was selected and used throughout the remainder of the study. The inhibitory 
effects of cumulative doses of L-arginine on the amplitude, frequency, and AUC of 
contractions are summarized in Table 5.2. 
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Figure 5.1 Dose dependency of L-citrulline and L-arginine on isolated uterine 
contraction. Symbol represents means. Vertical lines represent standard errors of the 
mean (n = 6 for each).  
 
 
 
 
 
 
Table 5.1 The effects of L-citrulline at various concentrations on spontaneous contraction. 
 
 
 
 
 
 
 
 
 
 
 
The P-values for amplitude, frequency and AUC of L-citrulline performed are significantly different from the control (*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
 
 
 
 
Amplitude 
(% Mean ± S.E.M.) 
 
Frequency 
(% Mean ± S.E.M.) 
 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
L-citrulline (M) 
0 (Control) 
1 × 10-6 
1 ×10-5 
1 × 10-4 
1 × 10-3 
 
 
100 
107.78 ± 6.12 
99.83 ± 4.36 
37.62 ± 5.77* 
0.00 ± 0.00* 
 
 
100 
87.49 ± 5.28 
79.76 ± 3.86* 
22.43 ± 3.17* 
0.00 ± 0.00* 
 
 
100 
91.88 ± 4.46 
78.87 ± 6.23* 
22.43 ± 5.65* 
0.00 ± 0.00* 
 
 
6 
6 
6 
6 
6 
 
 
Table 5.2 The effects of L-arginine at various concentrations on spontaneous contraction. 
 
 
 
 
 
 
 
 
 
 
 
The P-values for amplitude, frequency and AUC of L-arginine performed are significantly different from the control (*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
 
 
 
Amplitude 
(% Mean ± S.E.M.) 
 
Frequency 
(% Mean ± S.E.M.) 
 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
L-arginine (M) 
0 (Control) 
1 × 10-6 
1 ×10-5 
1 × 10-4 
1 × 10-3 
 
 
100 
106.55 ± 6.45 
96.31 ± 3.08 
55.43 ± 5.77* 
0.00 ± 0.00* 
 
 
100 
100.25 ± 5.28 
72.22 ± 4.36* 
63.33 ± 6.15* 
0.00 ± 0.00* 
 
 
100 
103.56 ± 1.98 
73.91 ± 4.17* 
43.48 ± 3.68* 
0.00 ± 0.00* 
 
 
6 
6 
6 
6 
6 
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 5.4.3 Effects of L-Citrulline and L-Arginine on Spontaneous Contraction 
L-Citrulline  
The application of L-citrulline (64 µM) to the rat myometrial preparations 
produced a significant decrease in the amplitude of force (56.45 ± 5.74% compared 
with spontaneous contraction, 100%, P < 0.05, n = 6). 30 min later, the uterine strip 
was then washed with Krebs’ solution. It was found that the phasic spontaneous 
contractions of the uterus were reversed. Thus, this finding indicates that the tocolytic 
effects of L-citrulline on the uterus were reversible. The samples of experimental 
traces are shown in Figure 5.2A and data summarized in Table 5.3. 
 
L-Arginine  
As shown in Figure 5.2B, the application of L-arginine (104 µM) to the rat 
myometrial preparations produced a significant decrease in the amplitude of force 
(61.42 ± 1.05% compared with spontaneous contraction, 100%, P < 0.05, n = 6).      
30 min later, the uterine strip was then washed with Krebs’ solution. As with            
L-citrulline, it was found that the phasic spontaneous contractions of the uterus were 
reversed. Thus, this finding indicates that the tocolytic effects of L-arginine on the 
uterus were reversible. The samples of experimental traces are shown in Figure 5.2B 
and data summarized in Table 5.3. 
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Figure 5.2 The effects of L-citrulline and L-arginine on rat uterine contraction. The 
applications of 64 µM L-citrulline (A) and 104 µM L-arginine (B) to spontaneous are 
shown (n = 6 for each). 
 
 
 
B 
A 
 
 
Table 5.3 The effects of L-citrulline (64 µM) and L-arginine (104 µM) on spontaneous contraction. 
 
 
 
 
 
 
 
 
 
 
 
 
The P-values for amplitude, frequency and AUC of L-citrulline and L-arginine performed are significantly different from the 
control (*P < 0.05). Mean ± S.E.M. are given; n is number of animals. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
L-citrulline 
Control 
L-citrulline 
Recovery 
L-arginine 
Control 
L-arginine 
Recovery 
 
 
100 
56.45 ± 5.74* 
95.46 ± 6.03 
 
100 
61.42 ± 1.05* 
96.48 ± 4.23 
 
 
100 
117.05± 4.28* 
101.22 ± 1.58 
 
100 
90.05 ± 4.92 
92.21 ± 5.38 
 
 
100 
57.95 ± 6.10* 
93.60 ± 7.01 
 
100 
60.81 ± 5.68* 
94.37 ± 3.99 
 
 
6 
6 
6 
 
6 
6 
6 
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 5.4.4 Effects of L-Citrulline and L-Arginine on Rat Uterine Contractions 
 in the  Presence of L-type Ca2+ Channel Activator 
L-Citrulline  
Uterine contractile force is directly related to the influx of extracellular Ca2+ 
through L-type Ca2+ channels (Somlyo and Somlyo, 1998). Thus, the question arose 
whether the inhibitory effects of L-citrulline on spontaneous contractions were due to 
the inhibition of L-type Ca2+ channels. To do so, the L-type Ca2+ channels were 
activated by using Bay K8644 (1 µM) and the effects of L-citrulline studied. 
Application of Bay K8644 produced a significant increase in the contraction 
amplitude (110.09 ± 2.19%) compared with spontaneous contraction (100%, P < 0.05, 
n = 5). Addition of L-citrulline (64 µM) in the continued presence of Bay K8644 
produced a marked decrease in the amplitude and the mean integral force to 46.69 ± 
4.24% and 49.09 ± 3.53% (P < 0.05), respectively, compared with spontaneous 
contraction (100%). In addition, when Bay K8644 was added after an addition of     
L-citrulline, it reversed the inhibitory effects of L-citrulline, but the amplitude of 
contractions did not return to the control level. The amplitude and the mean integral 
force produced by the combination of L-citrulline and Bay K8644 measured after     
10 min application were 83.86 ± 4.38% and 74.00 ± 5.15%, (P < 0.05) respectively, 
compared with spontaneous contraction (100%, n = 8). The samples of experimental 
traces are shown in Figure 5.3 and data summarized in Table 5.4. 
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Figure 5.3 The effects of L-citrulline on uterine contraction in the presence of the    
L-type Ca2+ channel activator. Bay K8644 (1 µM) was added before (A, n = 5) and 
after (B, n = 8) L-citrulline (64 µM). 
 
 
A 
B 
 
 
Table 5.4 The effects of L-citrulline on uterine contraction in the presence of L-type Ca2+ channel activator. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
L-citrulline (after) 
Control 
Bay K8644 
Bay K8644 + L-citrulline 
L-citrulline (before) 
Control 
L-citrulline 
L-citrulline + Bay K8644 
 
 
100 
110.09 ± 2.19* 
46.69 ± 4.24* 
 
100 
63.25 ± 1.64* 
83.86 ± 4.38* 
 
 
100 
140.44± 8.09* 
120.63 ± 6.13* 
 
100 
98.09 ± 9.94 
104.75 ± 4.75 
 
 
100 
142.44 ± 6.80* 
49.09 ± 3.53* 
 
100 
60.81 ± 7.58* 
74.00 ± 5.15* 
 
 
5 
5 
5 
 
8 
8 
8 
The P-values for amplitude, frequency and AUC of Bay K8644 treated are significantly different from the control (*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
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L-Arginine  
The effects of L-arginine on uterine contractions in the presence of Bay K8644 
were also studied (Figure 5.4). Application of Bay K8644 produced a significant 
increase in the contraction amplitude (110.10 ± 2.25%, P < 0.05) compared with 
spontaneous contraction (100%, n = 5). Addition of L-arginine in the continued 
presence of Bay K8644 produced a marked decrease in contraction amplitude and 
AUC to 51.90 ± 6.27% and 80.91 ± 3.68%, (P < 0.05) respectively, compared with 
spontaneous contraction (100%, n = 5). When Bay K8644 was added after the 
addition of L-arginine, it did not produce an increase in force. The amplitude and the 
mean integral force produced by the combination of L-arginine and Bay K8644 
measured after 10 min application were 63.15 ± 3.55% and 75.23 ± 3.22%, (P < 0.05) 
respectively, compared with spontaneous contraction (100%, n = 6). The samples of 
experimental traces are shown in Figure 5.4 and data summarized in Table 5.5. 
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Figure 5.4 The effects of L-arginine on uterine contraction in the presence of the     
L-type Ca2+ channel activator. Bay K8644 (1 µM) was added before (A, n = 5) and 
after (B, n = 6) L-arginine (104 µM).  
A 
B 
 Table 5.5 The effects of L-arginine on uterine contraction in the presence of L-type Ca2+ channel activator. 
 
Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
n 
 
L-arginine (after) 
Control 
Bay K8644 
Bay K8644 + L-arginine 
L-arginine (before) 
Control 
L-arginine 
L-arginine + Bay K8644 
 
 
100 
110.10 ± 2.25 
51.90 ± 6.27* 
 
100 
70.46 ± 4.37* 
63.15 ± 3.55* 
 
 
100 
120.12± 2.51* 
100.57 ± 5.29 
 
100 
116.25 ± 3.47* 
125.13 ± 3.95* 
 
 
100 
130.22 ± 6.57* 
80.91 ± 3.68* 
 
100 
80.48 ± 2.83* 
75.23 ± 3.22* 
 
 
5 
5 
5 
 
6 
6 
6 
The P-values for amplitude, frequency and AUC of Bay K8644 treated are significantly different from the control (*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals.  
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 5.4.5 Effects of L-Citrulline and L-Arginine on Rat Uterine Contractions 
 in the  Presence of High Ca2+ 
L-Citrulline  
 The experiments were performed to verify whether a rise in intracellular Ca2+ 
([Ca2+]i)  could reverse the inhibitory effects of L-citrulline. As can be seen in Figure 
5.5A, the application of L-citrulline in the continued presence of high Ca2+ decreased 
the amplitude of contraction to 57.70 ± 5.20% (P < 0.05, n = 5) when compared with 
100% of spontaneous contraction. When high Ca2+ was added after the addition of              
L-citrulline, it produced an increase in force. The amplitude and the mean integral 
force produced by the combination of L-citrulline and high Ca2+ measured after        
10 min application were 77.33 ± 3.30% and 72.59 ± 4.56%, (P < 0.05) respectively 
when compared with spontaneous contraction (100%, n = 5). The samples of 
experimental traces are shown in Figure 5.5 and data summarized in Table 5.6. 
 
 
 
 
 
 
 
127 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 The effects of L-citrulline on uterine contraction in the presence of            
5 mM CaCl2.  5 mM CaCl2 was added before (A) and after (B) L-citrulline (64 µM)  
(n = 5 for each). 
 
 
B 
A 
 
 
Table 5.6 The effects of L-citrulline on uterine contraction in the presence of high Ca2+. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
L-citrulline (after) 
Control 
5 mM CaCl2 
5 mM CaCl2 + L-citrulline 
L-citrulline (before) 
Control 
L-citrulline 
L-citrulline + 5 mM CaCl2 
 
 
100 
114.13 ± 1.44* 
57.70 ± 5.20* 
 
100 
74.13 ± 4.51* 
77.33 ± 3.30* 
 
 
100 
116.66± 1.16* 
114.12 ± 4.33* 
 
100 
100.25 ± 4.97 
106.59 ± 4.22 
 
 
100 
128.38 ± 1.16* 
65.17 ± 5.63* 
 
100 
69.89 ± 6.12* 
72.59 ± 4.56* 
 
 
5 
5 
5 
 
5 
5 
5 
The P-values for amplitude, frequency and AUC of 5 mM CaCl2 treated are significantly different from the control (
*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
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L-Arginine  
The effects of L-arginine on uterine contraction in the presence of high Ca2+ 
were also studied (Figure 5.6). Addition of L-arginine in the continued presence of 
high Ca2+ produced a decrease in contraction amplitude and the mean integral force to 
51.90 ± 6.27% and 80.91 ± 3.68%, (P < 0.05) respectively, when compared with 
spontaneous contraction (100%, n = 5). When high Ca2+ was added after the addition 
of L-arginine, it did not produce an increase in force. The amplitude and the mean 
integral force produced by the combination of L-arginine and Bay K8644 measured 
after 10 min application were 69.00 ± 1.05% and 85.26 ± 2.93%, (P < 0.05) 
respectively when compared with spontaneous contraction (100%, n = 6). The 
samples of experimental traces are shown in Figure 5.6 and data summarized in  
Table 5.7. 
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Figure 5.6 The effects of L-arginine on uterine contraction in the presence of             
5 mM CaCl2. 5 mM CaCl2 was added before (A) and after (B) L-arginine (104 µM)  
(n = 5 for each). 
 
 
A 
B 
 
 
Table 5.7 The effects of L-arginine on uterine contraction in the presence of high Ca2+. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
L-arginine (after) 
Control 
5 mM CaCl2 
5 mM CaCl2 + L-arginine 
L-arginine (before) 
Control 
L-arginine 
L-arginine + 5 mM CaCl2 
 
 
100 
111.96 ± 3.29* 
69.00 ± 1.05* 
 
100 
76.86 ± 6.55* 
83.17 ± 3.25* 
 
 
100 
125.36± 3.65* 
125.10 ± 3.06* 
 
100 
120.64 ± 6.46* 
125.25 ± 3.25* 
 
 
100 
115.70 ± 3.96* 
75.23 ± 3.06* 
 
100 
79.28 ± 2.60* 
85.26 ± 2.93* 
 
 
5 
5 
5 
 
6 
6 
6 
The P-values for amplitude, frequency and AUC of 5 mM CaCl2 treated are significantly different from the control (
*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
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 5.4.6 Effects of L-Citrulline and L-Arginine on PGF2α-Induced Uterine 
 Contraction 
L-Citrulline  
 PGF2α causes uterine contraction by acting on prostaglandin FP receptor, 
which results in the release of Ca2+ from the intracellular store (SR) (Phillippe and 
Chien, 1998). As can be seen in Figure 5.7A, the application of PGF2α (1 µM) 
significantly increased the amplitude, the frequency and the mean integral force of the 
contractions. Application of L-citrulline (64 µM) to the myometrium in the continued 
presence of PGF2α exerted significant inhibitory effects on both amplitude and the 
mean integral force (n = 5). The samples of experimental traces are shown in Figure 
5.7A and data summarized in Table 5.8. 
 
L-Arginine  
 As can be seen in Figure 5.7B, 1 µM PGF2α was significantly increased the 
amplitude, the frequency and the mean integral force of the contractions. Application 
of L-arginine (104 µM) to the myometrium in the continued presence of PGF2α 
exerted significant inhibitory effects on both amplitude and the mean integral force   
(n = 5). The samples of experimental traces are shown in Figure 5.7B and data 
summarized in Table 5.8. 
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Figure 5.7 The effects of L-citrulline and L-arginine on PGF2α-induced uterine 
contraction. The effects of 64 µM L-citrulline (A) and 104 µM L-arginine (B) on 
uterine contraction-induced by 1 µM PGF2α are shown (n = 5 for each). 
 
A 
B 
 Table 5.8 The effects of L-citrulline and L-arginine on PGF2α-induced uterine contraction. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
L-citrulline 
Control 
PGF2α 
PGF2α + L-citrulline 
L-arginine 
Control 
PGF2α  
PGF2α + L-arginine 
 
 
100 
125.39 ± 1.15* 
56.92 ± 5.44* 
 
100 
128.20 ± 1.23* 
61.48 ± 4.74* 
 
 
100 
130.54 ± 1.17* 
116.23 ± 4.29* 
 
100 
128.57 ± 3.20* 
114.28 ± 3.48* 
 
 
100 
134.76 ± 5.40* 
76.78 ± 3.79* 
 
100 
143.76 ± 8.14* 
60.43 ± 7.05* 
 
 
5 
5 
5 
 
5 
5 
5 
The P-values for amplitude, frequency and AUC of 1 µM PGF2α treated are significantly different from the control              
(*P < 0.05). Mean ± S.E.M. are given; n is number of animals. 
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 5.4.7 Effects of L-Citrulline and L-Arginine on Oxytocin-Induced Uterine 
 Contraction 
L-Citrulline  
 Oxytocin is a nonapeptide hormone, which is known to mediate both directly 
and indirectly to stimulate uterine smooth muscle contraction (Phillippe and Chien, 
1998). Oxytocin causes uterine contraction by acting on oxytocin receptor, which 
results in the Ca2+ influx through L-type Ca2+ channel and the release of Ca2+ from the 
SR (Phillippe and Chien, 1998). As can be seen in Figure 5.8A, 10 nM oxytocin 
significantly increased the amplitude, the frequency and the mean integral force of the 
contractions. Application of L-citrulline (64 µM) to the myometrium in the continued 
presence of 10 nM oxytocin produced a significant inhibition on both the amplitude 
and the mean integral force (n = 5). The samples of experimental traces are shown in 
Figure 5.8A and data summarized in Table 5.9. 
 
L-Arginine  
 As can be seen in Figure 5.8B, 10 nM oxytocin significantly increased the 
amplitude, the frequency and the mean integral force of the contractions. Application 
of L-arginine (104 µM) to the myometrium in the continued presence of oxytocin 
caused a significant inhibition on both the amplitude and the mean integral force       
(n = 5). The samples of experimental traces are shown in Figure 5.8B and data 
summarized in Table 5.9.  
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Figure 5.8 The effects of L-citrulline and L-arginine on oxytocin-induced uterine 
contraction. The effects of 64 µM L-citrulline (A) and 104 µM L-arginine (B) on 
uterine contraction-induced by 10 nM oxytocin are shown (n = 5 for each). 
 
 
 
A 
B 
 
 
Table 5.9 The effects of L-citrulline and L-arginine on oxytocin-induced uterine contraction. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
L-citrulline 
Control 
Oxytocin 
Oxytocin + L-citrulline 
L-arginine 
Control 
Oxytocin  
Oxytocin + L-arginine 
 
 
100 
128.63 ± 4.09* 
65.51 ± 3.64* 
 
100 
125.35 ± 5.03* 
68.46 ± 5.63* 
 
 
100 
150.05± 6.72* 
120.82 ± 6.09* 
 
100 
150.42 ± 4.76* 
116.12 ± 2.80* 
 
 
100 
158.05 ± 2.80* 
78.46 ± 1.56* 
 
100 
148.26± 8.36* 
65.59 ± 4.34* 
 
 
5 
5 
5 
 
5 
5 
5 
The P-values for amplitude, frequency and AUC of 10 nM oxytocin treated are significantly different from the control               
(*P < 0.05). Mean ± S.E.M. are given; n is number of animals. 
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 5.4.8 Effects of L-Citrulline and L-Arginine on KCl-Induced Uterine 
 Contraction 
L-Citrulline  
 In most tissues, the KCl-induced contraction is highly sensitive to the 
inhibitors of Ca2+ channels and abolishes in 0-Ca solution. Thus, isoosmotic KCl 
solution-induced contraction is mainly mediated by Ca2+ entry through voltage-
dependent Ca2+ channels (Ausina, Savineau, Pinto, Martin and Candenas, 1996). 
Figure 5.9A shows a representative tracing of the KCl (40 mM)-induced uterine 
contraction. The addition of KCl elicited an initial rapid phasic contraction followed 
by a sustained tonic contraction. Upon return to control solution, spontaneous phasic 
contractions reappeared after a delay of approximately 5 min. 30 min later, the 
solution was changed to KCl. This resulted initially in a rise of tension to 
approximately the same level as seen with the first treatment of KCl. L-citrulline    
(64 µM) was applied to the myometrium during the sustained tonic contraction. It 
produced a significant inhibition of the contraction (n = 7). This value was           
62.66 ± 4.66% (P < 0.05) compared to the KCl control (100%). The samples of 
experimental traces are shown in Figure 5.9A. 
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L-Arginine  
 As can be seen in Figure 5.9B, isoosmotic KCl (40 mM) solution significantly 
increased the contractions. Application of L-arginine (104 µM) to the myometrium in 
the continued presence of KCl caused a significant inhibition on force (n = 7). This 
value was 66.38 ± 2.23% (P < 0.05) compared to the KCl control (100%). The 
samples of experimental traces are shown in Figure 5.9B. 
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Figure 5.9 The effects of L-citrulline and L-arginine on KCl-induced uterine 
contraction. The effects of 64 µM L-citrulline (A) and 104 µM L-arginine (B) on 
uterine contraction-induced by KCl (40 mM) are shown (n = 7 for each). 
 
 
B 
A 
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 5.4.9 Effects of L-Citrulline and L-Arginine on PGF2α-Induced Uterine 
 Contraction in the Absence of External Ca2+ 
L-Citrulline  
The contraction of uterine smooth muscles depends on the presence of 
external Ca2+. It has been found that Ca2+-removal rapidly abolished the phasic 
contractions (Matthew, Kupittayanant, Burdyga and Wray, 2004; Kupittayanant et al., 
2002). Interestingly, some agonists can induce contraction in the absence of external 
Ca2+. These contractions are generally interpreted as being due to Ca2+ released from 
the SR (Kupittayanant et al., 2002; Wray et al., 2003). Thus, it was of interest to 
verify whether L-citrulline could alter this contraction. PGF2α (1 µM) was added in 
the absence of external Ca2+ entry. This protocol was performed to ensure that the 
only source of Ca2+ was from the SR (Matthew et al., 2004; Kupittayanant et al., 
2002). As can be seen in Figure 5.10A, phasic contractions abolished upon changing 
to 0-Ca solution. In the continued presence of 0-Ca solution, 1 µM PGF2α produced a 
small tonic force as long as this agonist was present. Upon return to control solution, 
spontaneous phasic contractions reappeared. 30 min later, the solution was changed to 
one containing 0-Ca and L-citrulline. Force abolished rapidly and PGF2α added. It was 
found that very little if any force was produced (Figure 5.10A, n = 6). This value was 
74.33 ± 3.75% (P < 0.05) compared to PGF2α-induced contraction in the absence of 
external Ca2+ alone (100%, n = 6). The samples of experimental traces are shown in 
Figure 5.10A. 
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L-Arginine  
The effects of L-arginine on PGF2α-induced uterine contraction in the absence 
of external Ca2+ were also examined. The effects were similarly to the effects of       
L-citrulline. PGF2α produced a small tonic force. L-arginine reduced this contraction 
to 78.72 ± 2.82% (P < 0.05) compared to PGF2α-induced contraction in the absence of 
external Ca2+ alone (100%, n = 6). The samples of experimental traces are shown in 
Figure 5.10B. 
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Figure 5.10 The effects of L-citrulline and L-arginine on PGF2α-induced uterine 
contraction in the absence of external Ca2+. The effects of 64 µM L-citrulline (A) and 
104 µM L-arginine (B) on uterine contraction-induced by 1 µM PGF2α in 0-Ca 
solution are shown (n = 6 for each). 
 
B 
A 
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 5.4.10 Effects of L-Citrulline and L-Arginine on Oxytocin-Induced 
 Uterine Contraction in the Absence of External Ca2+ 
L-Citrulline  
The same protocol was used as described above for PGF2α. In 0-Ca solution, 
10 nM oxytocin generated a small tonic force, indicating that oxytocin can release 
Ca2+ from the SR. Application of 64 µM L-citrulline caused a significant inhibition of 
the contraction induced by oxytocin in the absence of external Ca2+ (Figure 5.11A). 
This value was 70.25 ± 9.03% (P < 0.05) compared to oxytocin-induced contraction 
in the absence of external Ca2+ alone (100%, n = 6). The samples of experimental 
traces are shown in Figure 5.11A. 
 
L-Arginine  
Application of L-arginine (104 µM) to uterine contraction-induced by 
oxytocin in the absence of external Ca2+ produced a marked significant inhibition of 
the contraction (Figure 5.11B). This value was 77.36 ± 4.07% (P < 0.05) compared to 
oxytocin-induced contraction in the absence of external Ca2+ alone (100%, n = 6). The 
samples of experimental traces are shown in Figure 5.11B. 
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Figure 5.11 The effects of L-citrulline and L-arginine on oxytocin-induced uterine 
contraction in the absence of external Ca2+. The effects of 64 µM L-citrulline (A) and 
104 µM L-arginine (B) on uterine contraction-induced by 10 nM oxytocin in 0-Ca 
solution are shown (n = 6 for each). 
 
 
B 
A 
146 
 
 5.4.11 Effects of L-Citrulline and L-Arginine on Oxytocin-Induced 
 Uterine Contraction in the Presence of KCl 
L-Citrulline  
 It has been reported that, when Ca2+ was high or maintained, smooth muscle 
contraction may be modulated by Ca2+-independent pathway. For example, 
application of oxytocin in the presence of KCl produced a tonic component of force, 
indicating release of Ca2+ from the SR. In addition, it was suggested that the 
potentiation of force by oxytocin may due to the modulation of myosin light chain 
phosphatase (MLCP) activity through rho-associated kinase (ROK) pathway 
(Kupittayanant, Burdyga and Wray, 2001; Somlyo and Somlyo, 1998). ROK 
stimulated by oxytocin produced a marked increase in force without a change in 
[Ca2+]i
 (Kupittayanant et al., 2001). Thus, it was of interest to verify whether             
L-citrulline may alter this kind of contraction; oxytocin-induced uterine contraction in 
the presence of KCl. As can be seen in Figure 5.12A, application of oxytocin (10 nM) 
in the continued presence of KCl produced a small tonic contraction, suggesting the 
release of Ca2+ from the SR. Upon return to control solution, uterine tension quickly 
returned to baseline and spontaneous phasic contractions reappeared. 30 min later, the 
solution was then changed to KCl and oxytocin added. In addition, L-citrulline        
(64 µM) was applied to the myometrium during the sustained tonic contraction. It 
produced a marked decrease in force. Thus, after 10 min, force had fallen to        
60.66 ± 4.66% of control force development (P < 0.05, 100% force was the level of 
maintained force that was produced during the application of 10 nM oxytocin in the 
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presence of 40 mM KCl, n = 6). The samples of experimental traces are shown in 
Figure 5.12A.  
 
L-Arginine  
 The same protocol was used as described above for L-citrulline. Application 
of L-arginine (104 µM) was able to decrease force upon oxytocin application to the 
uterus in the presence of KCl. After 10 min, force had fallen to 65.99 ± 7.46% of 
control force development (P < 0.05, 100% force was the level of maintained force 
that was produced during the application of 10 nM oxytocin in the presence of 40 mM 
KCl solution, n = 6). The samples of experimental traces are shown in Figure 5.12B. 
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Figure 5.12 The effects of L-citrulline and L-arginine on oxytocin-induced uterine 
contraction in the presence of KCl. The effects of 64 µM L-citrulline (A) and 104 µM 
L-arginine (B) on oxytocin-induced uterine contraction in the presence of 40 mM KCl 
solution are shown (n = 6 for each). 
 
A 
B 
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5.5 Discussion 
It has been reported that watermelon is rich in L-citrulline and L-arginine. 
Thus, the aim of this chapter was to verify whether the inhibitory effects of 
watermelon extracts on uterine contraction as shown in the previous chapters were 
due to L-citrulline and L-arginine. This study demonstrated the effects of L-citrulline 
and L-arginine on uterine contraction and revealed that both L-citrulline and             
L-arginine effectively depressed spontaneous contractions. In addition, L-citrulline 
and L-arginine caused inhibition of both the amplitude and the mean integral force of 
the contractions induced by PGF2α, oxytocin and KCl. In the absence of external Ca
2+, 
L-citrulline and L-arginine produced partially inhibition of contraction induced by 
PGF2α and oxytocin. Moreover, L-citrulline and L-arginine altered the tonic 
component of force produced by the application of oxytocin to the uterus in the 
continued presence of KCl. These findings suggest that the tocolytic effects of          
L-citrulline and L-arginine on myometrial contractions were dependent upon       
Ca2+-dependent and Ca2+-independent regulation of smooth muscle contraction that 
were similarly to those of watermelon extracts. 
Myometrial contractions are phasic in nature (Kupittayanant et al., 2001). The 
mechanism that causes phasic activity is alteration of the potential across the 
myometrial cell membrane (Wray et al., 2003). It is indicated that the level of [Ca2+]i 
is important for the modulation of force (Kupittayanant et al., 2002). The main 
sources of Ca2+ are 1) the release of the SR and 2) the influx of extracellular Ca2+ 
through the L-type Ca2+ channels. The increased in [Ca2+]i results in calmodulin 
activation of myosin light chain kinase (MLCK). This kinase phosphorylates the 
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regulatory light chains of myosin, leading to the activation of myosin MgATPase and 
force development (Kupittayanant et al., 2002; Phillippe and Edward, 1998; Somlyo 
and Somlyo, 1998). The application of L-citrulline and L-arginine to the uterine strips 
produced a dose dependent inhibition of spontaneous phasic contractions. These 
findings suggest that L-citrulline and L-arginine inhibit the contraction mainly by 
interrupting the influx of Ca2+. 
The activation of L-type Ca2+ channels by some agonists or high Ca2+ leads to 
the influx of Ca2+ into the cell and contractions (Buddhakala et al., 2008; 
Kupittayanant et al., 2008; Wray et al., 2003). The addition of L-citrulline or            
L-arginine to the myometrium in the continued presence of 5 mM CaCl2 and Bay 
K8644 caused a marked decrease in uterine force. Moreover, adding of 5 mM CaCl2 
or Bay K8644 to the uterus in the presence of L-citrulline or L-arginine partially 
reversed the inhibitory effects of these two amino acids. Thus, these findings suggest 
that the tocolytic effects of L-citrulline and L-arginine may be associated with, at least 
in part, the inhibition of L-type Ca2+ channels. 
It is well established that KCl induces a rapid rise in [Ca2+]i through 
depolarization of the cell membrane, leading to the opening of L-type Ca2+ channels 
and muscle contraction (Ausina et al., 1996; Kupittayanant et al., 2001). Some 
substances that inhibit the KCl-induced contractions mediate through blocking 
voltage-dependent Ca2+ channels (Gharib Naseri and Yahyavi, 2007). The addition of 
L-citrulline and L-arginine to the uterus was able to partially inhibit contractility in 
the presence of KCl, supporting the hypothesis that these two amino acids possess a 
Ca2+ entry blocking activity. 
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Oxytocin and PGF2α produce uterine contractions by acting on oxytocin and 
prostaglandin FP receptors, respectively (Phillippe and Edward, 1998; Soloff, 1990). 
These receptors are connected with Gαq/11 subunit to membrane phospholypase Cβ 
(PLCβ). It is well established that the catalyzed PLCβ hydrolyses the membrane 
phosphatidylinositol-4,5-bisphosphate, resulting in the creation of two parallel 
signaling pathway: IP3 and DAG (Phillippe and Edward, 1998; Soloff, 1990). IP3 
binds to its receptor on the SR membrane and causes release of Ca2+ into the 
cytoplasm (Phillippe and Edward, 1998; Soloff, 1990). In addition, it has been 
reported that oxytocin itself elevates [Ca2+]i by activating the L-type Ca
2+ channels 
and chloride (ClCa) channels (Arnaudeau, Lepretre and Mironneau, 1994; Wray et al., 
2003). The activation of ClCa channels will result in depolarization, as Cl
- leaves the 
cell. Thus, these channels may play a crucial role in regulating membrane excitability 
and increasing the Ca2+ entry through voltage-dependent Ca2+ channels (Arnaudeau et 
al., 1994; Wray et al., 2003).    
The application of PGF2α and oxytocin to spontaneous phasic contractions 
induced a rapid rise in the amplitude, the frequency, and the mean integral force of the 
contractions. The application of L-citrulline and L-arginine to PGF2α-induced or 
oxytocin-induced uterine contraction caused a marked inhibition of the force of 
contraction. These findings indicate that the spasmolytic activity of L-citrulline and  
L-arginine may be due to the interruption of Gαq/11-PLCβ-IP3 pathway and the 
inhibition of Ca2+ entry. 
It has been reported that L-citrulline and L-arginine mediated relaxation in 
smooth muscle through NO-cGMP pathway modulation (Norman, 1996). NO is 
synthesized by the catalytic action of a family of NO synthase (NOS) that convert the 
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substrate, L-arginine, to NO and L-citrulline (Flam et al., 2001; Lincoln et al., 1995). 
Some investigators indicated that L-citrulline can convert to L-arginine in all cell 
types through specific enzymes, argininosuccinate synthase and argininosuccinate 
lyase (Romero et al., 2006). NO induces changes in target proteins through the 
activation of cGMP. The mechanisms underlying of NO and cGMP could affects 
[Ca2+]i in four different ways: 1) by reducing Ca
2+; 2) by increasing Ca2+ efflux; 3) by 
enhancing Ca2+ sequestration; and 4) by decreasing Ca2+ mobilization (Lincoln et al., 
1995; McDonald and Murad, 1995; Norman, 1996). Based on these scientific 
evidences, it is possible to speculate that NO-cGMP pathway modulation may also be 
involved in the inhibitory effects of L-citrulline and L-arginine on rat uterine 
contraction in this present study.   
In the presence of 0-Ca solution, uterine force was rapidly abolished. The 
application of PGF2α or oxytocin to the myometrium in the absence of external Ca
2+ 
produced a small tonic force, indicating the ability of PGF2α or oxytocin to release 
Ca2+ from the SR and to produce uterine force in these conditions (Matthew et al., 
2004; Kupittayanant et al., 2002). L-citrulline and L-arginine altered the contraction 
triggered by PGF2α or oxytocin in 0-Ca solution, because pre-incubation with           
L-citrulline or L-arginine significantly inhibited PGF2α-or oxytocin-induced 
contraction approximately 70%. These findings suggest that L-citrulline and             
L-arginine provoked a reduction on the SR release by interfering in Gαq/11-PLCβ-IP3 
pathway. Some investigators indicated that the cyclic nucleotide analogue 8-bromo 
cGMP also inhibited contraction through the suppression of phosphatidylinositol 
hydrolysis (Rapoport, 1986). It is thought that inhibition of phosphatidylinositol 
breakdown mediated by cGMP may be due to the activation of cGMP-dependent 
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protein kinase (PKG) (Lincoln et al., 1995; Rapoport, 1986). It was indicated that 
PKG catalyzes the phosphorylation of the IP3 receptor at Serine 1755, resulting in 
inhibition of the release of Ca2+ from the SR (Komalavilas and Lincoln, 1994; Lincoln 
et al., 1995). The present finding demonstrated that L-citrulline and L-arginine 
decreased the contractions-induced by PGF2α and oxytocin in a 0-Ca solution, which 
suggested that these amino acids could inhibit the IP3-dependent Ca
2+ release through 
the mechanisms described above. 
A major modulation of uterine contraction is the level of myosin light chain 
phosphorylation that is modulated by MLCK and MLCP. An increased tension and 
phosphorylation can occur at constant Ca2+ and is usually known as Ca2+ sensitization 
(Somlyo and Somlyo, 1998). This prevalence occurs frequently after stimulation by 
many agonists, including oxytocin. The mechanism underlying of this effect might be 
due to the inhibition of MLCP by the ROK pathway (Somlyo and Somlyo, 1998). It 
has been shown that Rho kinase inhibitors, such as Y-27632, block the agonist-
induced Ca2+ sensitization in human myometrium (Kupittayanant et al., 2001). 
Application of Y-27632 to the phasic spontaneous contraction had very little effect on 
force. However, when the uterine strips were produced a tonic contraction, Y-27632 
significantly decreased in force without a change in [Ca2+]i. This study suggested that 
the Rho pathway is more important in promoting force development during tonic 
rather than phasic contractions (Kupittayanant et al., 2001). In this regard, when the 
myometrium strips were pre-incubated with KCl, then added a physiological dose of 
oxytocin, it potentiated a tonic component of force. Under these conditions it is 
expected that L-type Ca2+ channels will be maximally open by KCl, and oxytocin will 
stimulate receptor and store operated Ca2+ entry pathways and SR Ca2+ release. In 
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addition, it is thought that the inhibition of MLCP mediated by Rho kinase may also 
be served as the mechanisms of oxytocin to induce increases in myometrial 
contractility under these circumstances (Shmygol, Gullam, Blanks and Thornton, 
2006). The application of L-citrulline or L-arginine to oxytocin-induced contraction in 
the presence of KCl produced a marked decrease in force. These findings indicate that 
the tocolytic effects of L-citrulline and L-arginine might be associated with the 
inhibition of the ROK pathway. 
To the best of our knowledge, this present study firstly showed the tocolytic 
effects of L-citrulline on rat uterine contraction. It was observed that the effects of    
L-citrulline were slightly larger than the effects of L-arginine. This assessment may 
be associated with the saturation of the substrate, L-arginine, for NOS (Flam et al., 
2001). It was exhibited that caveolae may be the principle source of L-arginine 
available to NOS (Flam et al., 2001). In addition, the L-citrulline to L-arginine 
recycling pathway is localized to caveolae and may serve as the principle source of 
available L-arginine (Flam et al., 2001). Thus, a key observation was that the 
inhibitory effects of L-citrulline, in part or entirely, shows the L-arginine-like 
pharmacological effects as previously described by several investigators (Cormio et 
al., 2011; Hoffmann et al., 2003; Ochiai et al., 2010; Ranghavan and Dikshit, 2001; 
Romero et al., 2006). 
Based on the results of present study, L-citrulline and L-arginine produced a 
significant suppressive effect on oxytocin-induced contraction, suggesting that         
L-citrulline and L-arginine may be effective in the prevention of preterm labor 
(Shmygol et al., 2006; Soloff, 1990). In addition, both L-citrulline and L-arginine 
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exhibited the inhibitory effects on PGF2α-induced contraction, suggesting that they 
may also be effective in the treatment of primary dysmenorrhea (Harel, 2006).  
In conclusion, this study investigated the tocolytic effects of L-citrulline and 
L-arginine on isolated rat uterus. The results revealed that L-citrulline and L-arginine 
had a dose-dependent effect on the isolated rat uterus. L-citrulline and L-arginine 
produced tocolytic effects by inhibiting both Ca2+-dependent and Ca2+-independent 
regulation of smooth muscle contraction pathways as well as by stimulating           
NO-cGMP pathway modulation. Both L-citrulline and L-arginine have been reported 
to be contained in watermelon flesh and rind. The findings in this chapter were the 
same as those of watermelon extracts described in Chapter IV. Thus, it is possible to 
speculate that the two amino acids might be the active contents of watermelon 
extracts that cause uterine relaxant in the present study. 
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CHAPTER VI 
EFFECTS OF WATERMELON (CITRULLUS LANATUS) 
EXTRACTS AND L-CITRULLINE ON NITRIC OXIDE  
 
6.1 Abstract 
 Watermelon (Citrullus lanatus) is rich in L-citrulline and L-arginine; the 
contents that play an important role in the production of the potent vasodilator, nitric 
oxide (NO). Thus, the aim of this study was to clarify whether the tocolytic effects of 
watermelon extracts and L-citrulline, as shown in previous chapters, were due to NO-
cGMP pathway modulation. This was done in isolated myometrial strips and the 
combination effects of watermelon extracts and L-citrulline measured. The contractile 
responses were recorded isometrically with a force transducer. The results revealed 
that the tocolytic effects of watermelon extracts and L-citrulline partially inhibited by 
L-NAME, a non-selective NO synthase, LY 83583, an inhibitor of soluble guanylate 
cyclase, and tetraethylammonium chloride, an inhibitor of calcium-activated 
potassium (KCa) channels. The combination of watermelon extracts and L-citrulline 
produced an additive effect on spontaneous contraction and the contractions induced 
by prostaglandin F2α (PGF2α), oxytocin, and potassium chloride solution (KCl). These 
findings suggest that the tocolytic effects of watermelon extracts and L-citrulline were 
via NO-cGMP signaling pathway and the activation of KCa channels. Moreover,
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 watermelon extracts and L-citrulline can interact additionally, indicating that the 
inhibitory effects of watermelon extracts may be due to L-citrulline. 
 
   6.2 Introduction 
 There is increasing evidence that nitric oxide (NO) has an important role in 
myometrial function (Yallampalli, Dong, Gangula and Fang, 1998). In living cells, 
NO is synthesized from L-arginine through the catalytic action of NO synthase 
(NOS). Three types of NOSs have been isolated and identified, including eNOS, 
nNOS, and iNOS. It has been reported that both eNOS and iNOS can be detected 
from non-pregnant rats (Yallampalli et al., 1998). However, nNOS was undetectable. 
Several investigations have indicated that NO production is increased during 
pregnancy and markedly decreased during spontaneous and induced preterm labor in 
rats (Yallampalli, Izumi, Byam-Smit and Garfield, 1994). However, there were no 
significant changes in the myometrium of pregnant and non-pregnant woman 
(Buhimschi, Yallampalli, Dong and Garfield, 1995), suggesting that NO-dependent 
uterine relaxation may depend on the species and the stages of menstrual period or 
gestation (Demirkoprulu et al., 2005). The formation of NO is inhibited by analogues 
of L-arginine such as NG-nitro-L-arginine (L-NMMA), as well as aminoguanidine 
(Yallampalli et al., 1998).  
 NO diffuses into smooth muscle to activate soluble guanylate cyclase (sGC), 
leading to the activation of guanosine 3',-5'-cyclic monophosphate (cGMP) levels and 
the relaxation of smooth muscle (Carvajal, Germain, Huidobro-Toro and Weiner, 
2000). Moreover, NO may also stimulate other enzymes that may be associated with 
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relaxation (Carvajal et al., 2000). It has been demonstrated that methylene blue and            
LY 83583 are generally used as sGC inhibitors to verify the involvement of           
NO-cGMP-dependent pathway modulation in many physiological processes (Kuenzli, 
Iain, Buxton and Bradley, 1998). It was indicated that activated cGMP leads to 
stimulate cGMP-dependent protein kinase (PKG), and may also activate             
cAMP-dependent protein kinase (PKA) (Carvajal et al., 2000). The phosphorylation 
of specific target proteins by PKG and PKA produces relaxation of various smooth 
muscles, including the myometrium (Carvajal et al., 2000). It has been reported that 
the relaxant effects of L-arginine on uterine smooth muscle appear to be due to      
NO-cGMP-dependent and NO-cGMP-independent pathways (Kuenzli et al., 1998; 
Norman, 1996). There is evidence that NO-cGMP-independent mechanisms are 
mostly associated with a direct action of NO on calcium-activated potassium (KCa) 
channels and L-type Ca2+ channels (Bradley, Buxton, Barber, Mcgaw and Bradley, 
1998; Carvajal et al., 2000; Norman, 1996).     
 The clinical use of combinations of the component individual or mixtures of 
herbs has been found to be effective in increases of their therapeutic efficacy 
(Williamson, 2001). The aim of the combination is to achieve an additive interaction, 
yielding a sufficient therapeutic effect with low doses and reducing the prevalence of 
serious diseases (Williamson, 2001). As discussed in Chapter IV regarding the 
inhibitory effects of watermelon extracts were similar to those produced by               
L-citrulline and L-arginine (as shown in Chapter V). In addition, it was indicated that 
both fruit flesh and rind of watermelon are an excellent source of L-citrulline and     
L-arginine (Tlili, Hdider, Lenucci, Ilahy, Jebari and Dalessandro, 2011). It was of 
interest to verify whether the effects of the extracts were due to these compounds. 
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Therefore, the aims of this chapter were 1) to investigate whether the tocolytic effects 
of watermelon extracts and L-citrulline were produced by the NO-cGMP pathway 
modulation and 2) to examine whether the effects of watermelon extracts were due to 
L-citrulline. 
 
6.3 Materials and Methods 
 6.3.1 Myometrial Tissue Preparations and Measurements of Tension 
 Myometrial tissue preparations were dissected and force measurements 
measured as those described in Chapter II (Sections 2.2.3. and 2.2.4, respectively). 
 
 6.3.2 Experimental Procedures 
  6.3.2.1 Effects on Endogenous Nitric Oxide Pathway  
To investigate whether the tocolytic effects of watermelon extracts and          
L-citrulline were dependent upon endogenous NO activity, L-NAME (100 µM), a 
non-specific NOS inhibitor, was used. In the experiment, L-NAME was applied for 
30 min and then watermelon extract or L-citrulline added, in the continued presence 
of L-NAME. In addition, the experiments were done the other way round. To do so, 
the extract or L-citrulline was applied for 30 min and then L-NAME added, in the 
continued presence of the extract or L-citrulline. 
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  6.3.2.2 Effects on Guanylate Cyclase Pathway  
To investigate whether the tocolytic effects of watermelon extracts and          
L-citrulline were through the sGC pathway, LY 83583 (1 µM), a specific sGC 
inhibitor, was used. In the experiment, LY 83583 was applied for 30 min and then 
watermelon extract or L-citrulline added, in the continued presence of LY 83583. In 
addition, the experiments were done the other way round. To do so, the extract or     
L-citrulline was applied for 30 min and then LY 83583 added, in the continued 
presence of the extract or L-citrulline. 
 
  6.3.2.3 Effects on Calcium-Activated Potassium Channels  
To investigate whether the tocolytic effects of watermelon extracts and          
L-citrulline were dependent upon the role of KCa channels, tetraethylammonium 
chloride (TEA, 5 mM), a KCa channel inhibitor, was used. In the experiment, TEA 
was applied for 30 min and then watermelon extract or L-citrulline added, in the 
continued presence of TEA. In addition, the experiments were done the other way 
round. To do so, the extract or L-citrulline was applied for 30 min and then TEA 
added, in the continued presence of the extract or L-citrulline. 
 
6.3.2.4-Effects of the Combinations of Watermelon Extracts and  
L-Citrulline 
 To investigate whether the inhibitory effects of watermelon extracts were due 
to L-citrulline, 64 µM L-citrulline was used. In the experiment, flesh or rind extract 
was applied for 30 min and then L-citrulline added, in the continued presence of flesh 
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or rind extract. In addition, the experiments were done the other way round. To do so, 
L-citrulline was applied for 30 min and then flesh or rind extract added, in the 
continued presence of L-citrulline. In some experiments, the effects of the 
combinations of watermelon extracts and L-citrulline on uterine contractions-induced 
by PGF2α, oxytocin, and KCl were also studied. 
 
 6.3.3 Chemicals and Physiological Solutions 
All chemicals were purchased from Sigma®, Singapore. L-citrulline was 
dissolved in Krebs’ solution. L-NAME, a non-specific NOS inhibitor; (NG-
nitroarginine methyl ester), was dissolved in distilled water and used at the 
concentration of 100 µM (Yallampalli, Garfield and Byam-Smith, 1993). LY 83583, a 
sGC inhibitor was dissolved in distilled water and used at concentration of 1 µM 
(Kuenzli et al., 1998). TEA, the calcium-dependent potassium channels inhibitor; 
(tetaethylamonium chloride), was dissolved in distilled water and used at 
concentration of 5 mM (Kupittayanant, Luckas and Wray, 2002). Prostaglandin F2α, 
(PGF2α-tris; (5Z,9α,11α,13E,15)-9,11,15-trihydroxyprosta-5,13-dienoic acid tris salt), 
was dissolved in the absolute ethanol and used at the concentration of 1 µM 
(Buddhakala, Talubmook, Sriyotha, Wray and Kupittayanant, 2008). Oxytocin was 
dissolved in distilled water and used at concentration of 10 nM (Kupittayanant et al., 
2002). A KCl (40 mM) Krebs’ solution was made by isoosmotic replacement of 
sodium chloride (Noble and Wray, 2002). The physiological Krebs’ solution (pH 7.4) 
contained the following (mM): NaCl 154.0, KCl 5.4, MgSO4 1.2, glucose 8.0, CaCl2 
2.0, and N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) 10.0. 
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 6.3.4 Preparation of Watermelon Flesh and Rind Extracts 
 As described in Chapter II (Section 2.1.2), stocks of watermelon extracts were 
kept at -20°C. Fruit flesh or rind extract was dissolved in Krebs’ solution just before 
use. 
  
6.3.5 Statistical Analysis 
The data were analyzed using Microcal Origin Software. The integral force 
was used as the parameter of contraction. Results were expressed as percentages of 
control contractions (i.e. the control is 100%). Throughout, data are presented as  
mean ± S.E.M. and “n” represents the number of samples, each one from a different 
animal. Significances were tested using appropriate t tests. The P value < 0.05 was 
taken to be significant. 
 
6.4 Results 
 6.4.1 Effects of Watermelon Flesh and Rind Extracts on Rat Uterine 
 Contraction in the Presence of NOS Inhibitor    
Watermelon Flesh Extract 
 It is well documented that watermelon contains a high level of L-citrulline and 
L-arginine (Tlili et al., 2011). Clinical data indicated that watermelon 
supplementation produced a marked decrease in blood pressure in hypertensive men 
(Figueroa, Sanchez-Gonzalez, Perkins-Veazie and Arjmandi, 2011). It is believed that 
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L-citrulline and L-arginine found in watermelon may be served as NO precursors to 
mediate vasodilation in human subjects in this report (Figueroa et al., 2011). To 
investigate whether the inhibitory effects of watermelon flesh extract were involved 
with NO, the uterine strip was incubated with L-NAME (100 µM), a non-selective 
NOS inhibitor, and the effects of the watermelon flesh extract studied. The result 
showed that L-NAME markedly altered the inhibitory effects of watermelon flesh 
extract (Figure 6.1A). The amplitude and the mean integral force produced by the 
combination of the extract and L-NAME were 87.90 ± 4.83% and 82.16 ± 6.85%     
(P > 0.05), respectively when compared with spontaneous contraction (100%, n = 6). 
When L-NAME was added after the flesh extract, it reversed the inhibitory effects of 
flesh extract, but the amplitude of contractions did not return to spontaneous phasic 
contractions. The samples of experimental traces are shown in Figure 6.1 and data 
summarized in Table 6.1. 
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Figure 6.1 The effects of watermelon flesh extract on uterine contraction in the 
presence of NOS inhibitor. L-NAME (100 µM) was added before (A) and after (B) 
watermelon flesh extract (6 mg/mL) (n = 6 for each). 
 
 
B 
A 
 
 
Table 6.1 The effects of watermelon flesh extract on uterine contraction in the presence of nitric oxide synthase inhibitor. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon flesh (after) 
Control 
L-NAME 
L-NAME + watermelon flesh 
Watermelon flesh (before) 
Control 
Watermelon flesh 
Watermelon flesh + L-NAME 
 
 
100 
104.14 ± 3.21 
87.90 ± 4.83 
 
100 
53.70 ± 8.22* 
79.88 ± 5.10* 
 
 
100 
101.29 ± 4.43 
113.63 ± 2.24* 
 
100 
114.50 ± 4.76*  
80.34 ± 2.40* 
 
 
100 
82.16 ± 6.85 
84.99 ± 6.66 
 
100 
60.69 ± 7.04* 
109.43 ± 4.62 
 
 
6 
6 
6 
 
6 
6 
6 
The P-values for amplitude, frequency and AUC of L-NAME treated are significantly different from the control (*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
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Watermelon Rind Extract  
 The effects of watermelon rind extract on rat uterine contraction in the 
presence of L-NAME were also examined. As can be seen in Figure 6.2A, the 
application of rind extract in the continued presence of L-NAME did not change any 
force (85.59 ± 7.09%, P > 0.05, n = 6, compared with spontaneous contraction). The 
application of L-NAME in the continued presence of the rind extract produced an 
increase in force. The amplitude and the mean integral force produced by the 
combination of rind extract and L-NAME measured after 10 min of application were 
77.13 ± 4.43% (P < 0.05) and 99.48 ± 7.63% (P > 0.05),  respectively compared with 
spontaneous contraction (100%, n = 7). The samples of experimental traces are shown 
in Figure 6.2 and data summarized in Table 6.2. 
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Figure 6.2 The effects of watermelon rind extract on uterine contraction in the 
presence of NOS inhibitor. L-NAME (100 µM) was added before (A, n = 6) and after 
(B, n = 7) watermelon rind extract (5 mg/mL). 
 
B 
A 
 
 
Table 6.2 The effects of watermelon rind extract on uterine contraction in the presence of nitric oxide synthase inhibitor. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon rind (after) 
Control 
L-NAME 
L-NAME + watermelon rind 
Watermelon rind (before) 
Control 
Watermelon rind 
Watermelon rind + L-NAME 
 
 
100 
102.18 ± 8.75 
85.59 ± 7.09 
 
100 
52.68 ± 3.25* 
77.13 ± 4.43* 
 
 
100 
95.13 ± 3.12 
114.24 ± 4.69* 
 
100 
116.80 ± 3.96* 
131.66 ± 8.22* 
 
 
100 
102.99 ± 5.94 
93.79 ± 9.62 
 
100 
65.27 ± 4.07* 
99.48 ± 7.63 
 
 
6 
6 
6 
 
7 
7 
7 
The P-values for amplitude, frequency and AUC of L-NAME treated are significantly different from the control (*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
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6.4.2 Effects of L-Citrulline on Rat Uterine Contraction in the Presence of 
NOS Inhibitor 
 To investigate whether the tocolytic effects of L-citrulline were due to NO, the 
uterine strip was pre-treated with L-NAME and the effects of L-citrulline studied. As 
can be seen in Figure 6.3A, pre-treatment of the uterine strip with L-NAME abolished 
the inhibitory effects of L-citrulline on rat uterine contraction. The amplitude and the 
mean integral force produced by the combination of L-NAME and L-citrulline 
measured after 10 min of the application were 89.96 ± 4.12% and 94.54 ± 9.68%      
(P > 0.05), respectively when compared with spontaneous contraction (100%, n = 5). 
The addition of L-NAME in the continued presence of L-citrulline reversed the 
inhibitory effects of this amino acid. The samples of experimental traces are shown in 
Figure 6.3 and data summarized in Table 6.3. 
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Figure 6.3 The effects of L-citrulline on uterine contraction in the presence of NOS 
inhibitor. L-NAME (100 µM) was added before (A) and after (B) L-citrulline          
(64 µM) (n = 5 for each). 
 
 
B 
A 
 
 
Table 6.3 The effects of L-citrulline on uterine contraction in the presence of nitric oxide synthase inhibitor. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
L-citrulline (after) 
Control 
L-NAME 
L-NAME + L-citrulline 
L-citrulline (before) 
Control 
L-citrulline 
L-citrulline + L-NAME 
 
 
100 
106.87 ± 3.06 
89.96 ± 4.12 
 
100 
61.02 ± 7.94* 
101.53 ± 8.27 
 
 
100 
88.60 ± 6.98 
82.35 ± 6.35 
 
100 
105.74 ± 5.21 
96.19 ± 6.66 
 
 
100 
96.02 ± 7.59 
94.54 ± 9.68 
 
100 
49.02 ± 5.64* 
90.89 ± 6.66 
 
 
5 
5 
5 
 
5 
5 
5 
The P-values for amplitude, frequency and AUC of L-NAME treated are significantly different from the control (*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
177 
 
 6.4.3 Effects of Watermelon Flesh and Rind Extracts on Rat Uterine 
 Contraction in the Presence of Soluble Guanylate Cyclase Inhibitor 
Watermelon Flesh Extract 
 It has been reported that NO exerts its relaxant effect through the activation of 
sGC, thereby increasing cGMP levels (Carvajal et al., 2000; Norman, 1996). cGMP 
stimulates PKG to regulate many physiological functions (Carvajal et al., 2000; 
Norman, 1996). It was suggested that activated PKG phosphorylates several key 
target proteins, including ion channels, ion pumps, and receptors (Carvajal et al., 
2000; Norman, 1996). Phosphorylation of these target proteins decrease intracellular 
Ca2+ [Ca2+]i and leads to relaxation of smooth muscle (Carvajal et al., 2000; Norman, 
1996). To test whether the tocolytic effects of watermelon flesh extract were 
associated with the production of cGMP, LY 83583, the sGC inhibitor, was used. As 
can be seen in Figure 6.4A, LY 83583 (1 µM) applied to uterine tissue did not cause 
any change in force. The application of watermelon flesh (6 mg/mL) extract in the 
presence of LY 83583 produced a marked decrease in the contractile tension. The 
amplitude and the mean integral force of contractions produced by the combination of 
the flesh extract and LY 83583 measured after 10 min application were                
67.28 ± 3.55% and 81.08 ± 7.86%, (P < 0.05) respectively when compared with 
spontaneous contraction (100%, n = 6). When LY 83583 was added after the flesh 
extract, it produced a small increase in phasic contractions (Figure 6.4B). The 
amplitude and the mean integral force produced by the combination of the flesh 
extract and LY 83583 measured after 10 min application were 69.14 ± 6.14% and 
71.02 ± 8.94%, (P < 0.05) respectively when compared with spontaneous contraction 
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(100%, n = 8). The samples of experimental traces are shown in Figure 6.4 and data 
summarized in Table 6.4. 
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Figure 6.4 The effects of watermelon flesh extract on uterine contraction in the 
presence of soluble guanylate cyclase inhibitor. LY 83583 (1 µM) was added before 
(A, n = 6) and after (B, n = 8) watermelon flesh extract (6 mg/mL). 
 
 
B 
A 
 Table 6.4 The effects of watermelon flesh extract on uterine contraction in the presence of soluble guanylate cyclase inhibitor. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon flesh (after) 
Control 
LY 83583 
LY 83583 + watermelon flesh 
Watermelon flesh (before) 
Control 
Watermelon flesh 
Watermelon flesh + LY 83583 
 
 
100 
109.10 ± 7.73 
67.28 ± 3.55* 
 
100 
49.73 ± 5.89* 
69.14 ± 6.14* 
 
 
100 
93.75 ± 4.26 
111.57 ± 5.93 
 
100 
114.79 ± 5.64 
90.83 ± 7.86 
 
 
100 
95.59 ± 5.17 
81.08 ± 7.86* 
 
100 
59.50 ± 6.29* 
71.02 ± 8.94* 
 
 
6 
6 
6 
 
8 
8 
8 
The P-values for amplitude, frequency and AUC of LY 83583 treated are significantly different from the control (*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
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Watermelon Rind Extract  
 To verify the possible contribution of cGMP to the tocolytic effects of 
watermelon rind extract, LY 83583 was added to the organ bath. 30 min later, 
watermelon rind extract (5 mg/mL) was then added. The result showed that the 
amplitude (73.03 ± 4.14%) and the mean integral force (75.15 ± 8.94%) of the 
contraction were significantly decreased when compared with spontaneous 
contraction (100%, n = 9) (Figure 6.5A). Addition of LY 83583 to uterine tissue in 
the presence the watermelon rind extract partially reversed the tocolytic effects of the 
plant extract (Figure 6.5B). The amplitude of the contraction produced by the 
combination of the rind extract and LY 83583 measured after 10 min application was 
76.13 ± 5.03% (P < 0.05), when compared with spontaneous contraction (100%,        
n = 6). The samples of experimental traces are shown in Figure 6.5 and data 
summarized in Table 6.5. 
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Figure 6.5 The effects of watermelon rind extract on uterine contraction in the 
presence of soluble guanylate cyclase inhibitor. LY 83583 (1 µM) was added before 
(A, n = 9) and after (B, n = 6) watermelon rind extract (5 mg/mL). 
B 
A 
 
 
Table 6.5 The effects of watermelon rind extract on uterine contraction in the presence of soluble guanylate cyclase inhibitor. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon rind (after) 
Control 
LY 83583 
LY 83583 + watermelon rind 
Watermelon rind (before) 
Control 
Watermelon rind 
Watermelon rind + LY 83583 
 
 
100 
108.73 ± 5.40 
73.03 ± 4.14* 
 
100 
52.68 ± 3.25* 
76.13 ± 5.03* 
 
 
100 
92.61 ± 3.63 
104.14 ± 4.50 
 
100 
118.33 ± 2.47* 
119.66 ± 5.48* 
 
 
100 
93.93 ± 7.51 
75.15 ± 8.94 
 
100 
58.13 ± 7.12* 
91.26 ± 3.65 
 
 
9 
9 
9 
 
6 
6 
6 
The P-values for amplitude, frequency and AUC of LY 83583 treated are significantly different from the control (*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
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6.4.4 Effects of L-Citrulline on Rat Uterine Contraction in the Presence of 
Soluble Guanylate Cyclase Inhibitor  
 To define the role of the involvement of cGMP in the inhibitory effects of     
L-citrulline, the uterine strips were pre-incubated with LY 83583 and then L-citrulline 
(64 µM) added. The amplitude (94.89 ± 4.67%) and the mean integral force (82.73 ± 
8.96%) of the contractions did not change when compared with spontaneous phasic 
contractions (100%, n = 5, Figure 6.6A). The application of L-citrulline to 
spontaneous contraction reduced the uterine force. The addition of LY 83583 in the 
continued presence of L-citrulline did not affect the amplitude of the contraction 
(90.43 ± 9.39%, n = 8, compared with spontaneous contraction, 100%). The samples 
of experimental traces are shown in Figure 6.6 and data summarized in Table 6.6. 
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Figure 6.6 The effects of L-citrulline on uterine contraction in the presence of soluble 
guanylate cyclase inhibitor. LY 83583 (1 µM) was added before (A, n = 5) and after 
(B, n = 8) L-citrulline (64 µM). 
 
 
 
A 
B 
 Table 6.6 The effects of L-citrulline on uterine contraction in the presence of soluble guanylate cyclase inhibitor. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
L-citrulline (after) 
Control 
LY 83583 
LY 83583 + L-citrulline 
L-citrulline (before) 
Control 
L-citrulline 
L-citrulline + LY 83583 
 
 
100 
103.61 ± 3.86 
94.89 ± 4.67 
 
100 
69.86 ± 7.84* 
90.43 ± 9.39 
 
 
100 
108.22 ± 5.24 
106.25 ± 9.93 
 
100 
108.85 ± 5.96 
105.85 ± 3.58 
 
 
100 
101.38 ± 7.90 
82.73 ± 8.96 
 
100 
59.23 ± 6.90* 
86.73 ± 4.9* 
 
 
5 
5 
5 
 
8 
8 
8 
The P-values for amplitude, frequency and AUC of LY 83583 treated are significantly different from the control (*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
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6.4.5 Effects of Watermelon Flesh and Rind Extracts on Rat Uterine 
Contraction in the Presence of Calcium-Activated Potassium Channel 
Inhibitor 
Watermelon Flesh Extract 
 It has been revealed that the efflux of K+ through KCa channels is directly 
associated with the level of Ca2+ (Carvajal et al., 2000). It was indicated that the 
opening of KCa channels leads to hyperpolarization of the cell membrane and 
inhibition of Ca2+ entry through voltage-gated Ca2+ channels (Carvajal et al., 2000). 
Decrease of the Ca2+ influx via the voltage-gated Ca2+ channels results in smooth 
muscle relaxation. It was suggested that phosphorylation of KCa channels by PKG also 
decrease smooth muscle tone (Carvajal et al., 2000; Norman, 1996). In addition, there 
is evidence that NO can directly stimulate KCa channels to mediate relaxation 
(Bolotina, Najibi, Palacino, Pagano and Cohen, 1994; Carvajal et al., 2000). This 
mechanism is usually referred to cGMP-independent pathway modulation of smooth 
muscle relaxation (Bolotina et al., 1994; Carvajal et al., 2000). Thus, it was of interest 
to gain insight into the molecular mechanism by which watermelon flesh extract 
activates KCa channels. To do so, TEA, the KCa channel inhibitor, was used in this 
study. The application of TEA (5 mM) to spontaneously active phasic contractions led 
to significant increases in the amplitude and the mean integral force of the contraction 
(Figure 6.7A). The addition of the flesh extract in the presence of TEA produced a 
small decrement of force (89.56 ± 5.41%, P > 0.05) when compared with spontaneous 
contraction (100%, n = 8). When TEA was added after the flesh extract, it partially 
reversed the tocolytic effects of watermelon extract (Figure 6.7B). The amplitude and 
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the mean integral force produced by the combination of the flesh extract and TEA 
measured after 10 min application were 82.90 ± 3.42% (P < 0.05) and 94.18 ± 6.85% 
(P > 0.05), respectively when compared with spontaneous contraction (100%, n = 7). 
The samples of experimental traces are shown in Figure 6.7 and data summarized in 
Table 6.7. 
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Figure 6.7 The effects of watermelon flesh extract on uterine contraction in the 
presence of calcium activated potassium channel inhibitor. TEA (5 mM) was added 
before (A, n = 8) and after (B, n = 7) watermelon flesh extract (6 mg/mL). 
 
 
 
A 
B 
 
 
Table 6.7 The effects of watermelon flesh extract on uterine contraction in the presence of calcium-activated potassium channel 
inhibitor. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon flesh (after) 
Control 
TEA 
TEA + watermelon flesh 
Watermelon flesh (before) 
Control 
Watermelon flesh 
Watermelon flesh + TEA 
 
 
100 
108.78 ± 1.66 
89.56 ± 5.41 
 
100 
66.19 ± 2.83* 
82.90 ± 3.42* 
 
 
100 
123.54 ± 2.84* 
118.75 ± 4.19* 
 
100 
114.49 ± 3.95 
116.92 ± 5.27 
 
 
100 
122.67 ± 5.62* 
90.12 ± 5.19 
 
100 
50.22 ± 3.82* 
94.18 ± 6.85 
 
 
8 
8 
8 
 
7 
7 
7 
The P-values for amplitude, frequency and AUC of TEA treated are significantly different from the control (*P < 0.05).          
Mean ± S.E.M. are given; n is number of animals. 
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  Watermelon Rind Extract  
 The effects of watermelon rind extract on uterine contractions in the presence 
of KCa channel inhibitor were also studied. As can be seen in Figure 6.8A, addition of 
the rind extract in the continued presence of TEA produced a small decrease in 
contraction amplitude of the contraction to 89.90 ± 3.31% (P > 0.05), when compared 
with spontaneous contraction (100%, n = 8). When TEA was added after the addition 
of the rind extract, it caused an increase in force (Figure 6.8B). The amplitude and the 
mean integral force produced by the combination of watermelon rind extract and TEA 
measured after 10 min application were 92.36 ± 3.22% and 109.20 ± 6.37%,             
(P > 0.05) respectively when compared with spontaneous contraction (100%, n = 5). 
The samples of experimental traces are shown in Figure 6.8 and data summarized in 
Table 6.8. 
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Figure 6.8 The effects of watermelon rind extract on uterine contraction in the 
presence of calcium activated potassium channel inhibitor. TEA (5 mM) was added 
before (A, n = 8) and after (B, n = 5) watermelon rind extract (5 mg/mL). 
 
 
 
A 
B 
 
 
Table 6.8 The effects of watermelon rind extract on uterine contraction in the presence of calcium-activated potassium channel 
inhibitor. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon rind (after) 
Control 
TEA 
TEA + watermelon rind 
Watermelon rind (before) 
Control 
Watermelon rind 
Watermelon rind + TEA 
 
 
100 
114.90 ± 2.27* 
89.90 ± 3.31 
 
100 
63.25 ± 3.39* 
92.36 ± 3.22 
 
 
100 
116.99 ± 4.36* 
122.17 ± 8.56* 
 
100 
113.66 ± 4.16 
113.33 ± 5.65 
 
 
100 
124.99 ± 4.80* 
113.09 ± 7.68* 
 
100 
67.39 ± 7.11* 
109.20 ± 6.37 
 
 
8 
8 
8 
 
5 
5 
5 
The P-values for amplitude, frequency and AUC of TEA treated are significantly different from the control (*P < 0.05).         
Mean ± S.E.M. are given; n is number of animals. 
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6.4.6 Effects of L-Citrulline on Rat Uterine Contraction in the Presence of 
Calcium-Activated Potassium Channel Inhibitor  
 As can be seen in Figure 6.9A, the application of L-citrulline in the presence 
of TEA produced a small decrease in contraction amplitude and the mean integral 
force to 89.07 ± 9.49% and 94.48 ± 5.67%, (P > 0.05) respectively, when compared 
with spontaneous contraction (100%, n = 6). When TEA was added after the 
application of L-citrulline, it produced an increase in uterine tension (Figure 6.9B). 
The amplitude and the mean integral force produced by the combination of               
L-citrulline and TEA measured after 10 min application were 94.42 ± 8.24% and 
93.87 ± 6.92%, (P > 0.05) respectively when compared with spontaneous contraction 
(100%, n = 6). The samples of experimental traces are shown in Figure 6.9 and data 
summarized in Table 6.9. 
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Figure 6.9 The effects of L-citrulline on uterine contraction in the presence of 
calcium activated potassium channel inhibitor. TEA (5 mM) was added before (A) 
and after (B) L-citrulline (64 µM) (n = 6 for each). 
 
A 
B 
 
 
Table 6.9 The effects L-citrulline on uterine contraction in the presence of calcium-activated potassium channel inhibitor. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
L-citrulline (after) 
Control 
TEA 
TEA + L-citrulline 
L-citrulline (before) 
Control 
L-citrulline 
L-citrulline + TEA 
 
 
100 
116.37 ± 5.58* 
89.07 ± 9.49 
 
100 
73.11 ± 7.85* 
94.42 ± 8.24 
 
 
100 
118.85 ± 6.42* 
105.57 ± 9.76 
 
100 
100.24 ± 8.83 
115.15 ± 5.98* 
 
 
100 
126.75 ± 5.78* 
94.48 ± 5.67 
 
100 
61.44 ± 6.88* 
93.87 ± 6.92 
 
 
6 
6 
6 
 
6 
6 
6 
The P-values for amplitude, frequency and AUC of TEA treated are significantly different from the control (*P < 0.05).         
Mean ± S.E.M. are given; n is number of animals.  
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 6.4.7 Effects of the Combinations of Watermelon Extracts and L-Citrulline 
 on Spontaneous Contraction  
 As shown in Chapter IV, it is demonstrated that watermelon extracts have a 
potent tocolytic effect. L-citrulline is one of the major compositions found in 
watermelon (Rimando and Perkins-Veazie, 2005), it was worth determining whether 
the effects of watermelon extracts on uterine contraction were due to L-citrulline. 
 
Watermelon Flesh Extract  
 Application of L-citrulline reduced the amplitude and the mean integral force 
of the contractions to 62.18 ± 4.45% and 65.49 ± 3.28%, (P < 0.05) respectively 
compared with spontaneous contraction (100%, n = 5). When watermelon flesh 
extract was added in the continued presence of L-citrulline, it produced a significant 
decrease in the amplitude (35.81 ± 8.02%) and the mean integral force                
(36.22 ± 4.22%) of contractions (Figure 6.10A). As shown in Figure 6.10B, when    
L-citrulline was added after an addition of watermelon flesh extract, it reduced the 
amplitude and the mean integral force of the contractions to 36.93 ± 2.54% and    
37.29 ± 1.68%, (P < 0.05) respectively compared with spontaneous contraction 
(100%,  n = 8). The samples of experimental traces are shown in Figure 6.10 and data 
summarized in Table 6.10. 
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Figure 6.10 The effects of the combination of watermelon flesh extract and              
L-citrulline on spontaneous contractions. L-citrulline (64 µM) was added before     
(A, n = 5) and after (B, n = 8) watermelon flesh extract (6 mg/mL). 
 
 
B 
A 
 
 
Table 6.10 The effects of the combination of watermelon flesh extract and L-citrulline on spontaneous contractions. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon flesh (after) 
Control 
L-citrulline 
L-citrulline + Watermelon flesh 
Watermelon flesh (before) 
Control 
Watermelon flesh 
Watermelon flesh + L-citrulline 
 
 
100 
62.18 ± 4.45* 
35.81 ± 8.02* 
 
100 
63.45 ± 6.64* 
36.93 ± 2.54* 
 
 
100 
95.42 ± 8.09 
101.25 ± 3.23* 
 
100 
112.45 ± 2.94* 
105.75 ± 4.95 
 
 
100 
65.49 ± 3.28* 
36.22 ± 4.22* 
 
100 
60.21 ± 3.58* 
37.29 ± 1.68* 
 
 
5 
5 
5 
 
8 
8 
8 
The P-values for amplitude, frequency and AUC of watermelon flesh extract treated are significantly different from the control    
(*P < 0.05). Mean ± S.E.M. are given; n is number of animals. 
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Watermelon Rind Extract  
 As shown in Figure 6.11A, L-citrulline caused significant decreases in the 
amplitude and the mean integral force of the contractions. When the rind extract was 
applied in the continued presence of L-citrulline, it produced significant decreases in 
the amplitude (20.16 ± 2.20%) and the mean integral force (22.29 ± 3.24%) of the 
contractions, compared with spontaneous contraction (100%, n = 5). When               
L-citrulline was applied after the application of the rind extract, the amplitude and the 
mean integral force had fallen to 21.01 ± 5.63% and 22.27 ± 8.04%, (P < 0.05) 
respectively compared with spontaneous contraction (100%, n = 8). The samples of 
experimental traces are shown in Figure 6.11 and data summarized in Table 6.11. 
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Figure 6.11 The effects of the combination of watermelon rind extract and               
L-citrulline on spontaneous contractions. L-citrulline (64 µM) was added before     
(A, n = 5) and after (B, n = 8) watermelon rind extract (5 mg/mL). 
 
 
 
A 
B 
 
 
Table 6.11 The effects of the combination of watermelon rind extract and L-citrulline on spontaneous contractions. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon rind (after) 
Control 
L-citrulline 
L-citrulline + Watermelon rind 
Watermelon rind (before) 
Control 
Watermelon rind 
Watermelon rind + L-citrulline 
 
 
100 
64.85 ± 1.28* 
20.16 ± 2.20* 
 
100 
60.14 ± 6.37* 
21.01 ± 5.63* 
 
 
100 
100.42 ± 5.89 
102.14 ± 6.98 
 
100 
114.43 ± 2.92* 
98.18 ± 4.59 
 
 
100 
62.44 ± 1.80* 
22.29 ± 3.24* 
 
100 
59.72 ± 3.60* 
22.27 ± 8.04* 
 
 
5 
5 
5 
 
8 
8 
8 
The P-values for amplitude, frequency and AUC of watermelon rind extract treated are significantly different from the control  
(*P < 0.05). Mean ± S.E.M. are given; n is number of animals. 
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 6.4.8 Effects of the Combinations of Watermelon Extracts and L-Citrulline 
 on PGF2α-Induced Uterine Contraction 
Watermelon Flesh Extract and L-Citrulline  
 As can be seen in Figure 6.12A, application of PGF2α (1 µM) to spontaneously 
contracting myometrium produced significant increases in the amplitude and the mean 
integral force of the contractions. Addition of the combination of the flesh extract     
(6 mg/mL) and L-citrulline (64 µM) to the myometrium in the continued presence of 
1 µM PGF2α produced a significant inhibition on both the amplitude and the mean 
integral force (n = 5). The samples of experimental traces are shown in Figure 6.12A 
and data summarized in Table 6.12. 
 
Watermelon Rind Extract and L-Citrulline 
 As can be seen in Figure 6.12B, 1 µM PGF2α significantly increased the 
amplitude, the frequency and the mean integral force of the contractions. Application 
of the combination of the rind extract (5 mg/mL) and L-citrulline (64 µM) to the 
myometrium in the continued presence of PGF2α caused a significant inhibition on 
both the amplitude and the mean integral force (n = 5). The samples of experimental 
traces are shown in Figure 6.12B and data summarized in Table 6.12. 
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Figure 6.12 The effects of the combinations of watermelon extracts and L-citrulline 
on PGF2α-induced uterine contraction. The effects of the combination of watermelon 
flesh extract (6 mg/mL) and 64 µM L-citrulline (A) and the combination of 
watermelon rind extract (5 mg/mL) and 64 µM L-citrulline (B) on uterine contraction-
induced by 1 µM PGF2α are shown (n = 5 for each). 
 
 
B 
A 
 
 
Table 6.12 The effects of the combinations of watermelon extracts and L-citrulline on PGF2α-induced uterine contraction. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon flesh  
Control 
PGF2α 
PGF2α + L-citrulline + watermelon flesh 
Watermelon rind  
Control 
PGF2α 
PGF2α + L-citrulline + watermelon rind 
 
 
100 
120.09 ± 1.19* 
26.29 ± 1.80* 
 
100 
123.25 ± 2.64* 
19.36 ± 4.78* 
 
 
100 
125.44± 3.09* 
112.01 ± 3.96* 
 
100 
126.86 ± 4.80* 
100.15 ± 3.58 
 
 
100 
122.44 ± 5.63* 
28.02 ± 2.15* 
 
100 
125.81 ± 6.78* 
20.73 ± 4.77* 
 
 
5 
5 
5 
 
5 
5 
5 
The P-values for amplitude, frequency and AUC of 1 µM PGF2α treated are significantly different from the control (
*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
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 6.4.9-Effects of the Combinations of Watermelon Extracts and                
L-Citrulline  on Oxytocin-Induced Uterine Contraction 
Watermelon Flesh Extract and L-Citrulline  
 As can be seen in Figure 6.13A, application of oxytocin (10 nM) to 
spontaneously contracting myometrium produced significant increases in the 
amplitude and the mean integral force of the contractions. Addition of the 
combination of the flesh extract (6 mg/mL) and L-citrulline (64 µM) to the 
myometrium in the continued presence of 10 nM oxytocin produced a significant 
inhibition on both the amplitude and the mean integral force (n = 5). The samples of 
experimental traces are shown in Figure 6.13A and data summarized in Table 6.13. 
 
Watermelon Rind Extract and L-Citrulline  
 As can be seen in Figure 6.13B, the addition of oxytocin (10 nM) significantly 
increased the amplitude, the frequency and the mean integral force of the contractions. 
Application of the combination of the rind extract (5 mg/mL) and L-citrulline          
(64 µM) to the myometrium in the continued presence of oxytocin caused a 
significant inhibition on both the amplitude and the mean integral force (n = 5). The 
samples of experimental traces are shown in Figure 6.13B and data summarized in 
Table 6.13. 
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Figure 6.13 The effects of the combinations of watermelon extracts and L-citrulline 
on oxytocin-induced uterine contraction. The effects of the combination of 
watermelon flesh extract (6 mg/mL) and 64 µM L-citrulline (A) and the combination 
of watermelon rind extract (5 mg/mL) and 64 µM L-citrulline (B) on uterine 
contraction-induced by 10 nM oxytocin are shown (n = 5 for each). 
 
A 
B 
 
 
Table 6.13 The effects of the combinations of watermelon extracts and L-citrulline on oxytocin-induced uterine contraction. 
  Amplitude 
(% Mean ± S.E.M.) 
Frequency 
(% Mean ± S.E.M.) 
AUC 
(% Mean ± S.E.M.) 
 
n 
 
Watermelon flesh  
Control 
Oxytocin 
Oxytocin + L-citrulline + watermelon flesh 
Watermelon rind  
Control 
Oxytocin 
Oxytocin + L-citrulline + watermelon rind 
 
 
100 
130.09 ± 2.19* 
28.98 ± 3.24* 
 
100 
135.17 ± 7.62* 
23.05 ± 1.39* 
 
 
100 
150.84± 8.09* 
100.43 ± 6.13* 
 
100 
152.74 ± 8.73* 
105.07 ± 6.92 
 
 
100 
152.44 ± 6.80* 
29.09 ± 5.47* 
 
100 
156.50 ± 9.93* 
22.10 ± 5.18* 
 
 
5 
5 
5 
 
5 
5 
5 
The P-values for amplitude, frequency and AUC of 10 nM oxytocin treated are significantly different from the control (*P < 0.05). 
Mean ± S.E.M. are given; n is number of animals. 
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6.4.10-Effects of the Combinations of Watermelon Extracts and               
L-Citrulline on KCl-Induced Uterine Contraction 
Watermelon Flesh Extract and L-Citrulline  
 As can be seen in Figure 6.14A, application of KCl (40 mM) to spontaneously 
contracting myometrium elicited an initial rapid phasic contraction followed by a 
sustained tonic contraction. Addition of the combination of the flesh extract              
(6 mg/mL) and L-citrulline (64 µM) to the myometrium in the continued presence of 
KCl produced a significant inhibition of the contraction (n = 5). This value was   
40.59 ± 2.83% (P < 0.05) compared to the KCl control (100%). 
 
Watermelon Rind Extract and L-Citrulline  
 As can be seen in Figure 6.14B, application of KCl (40 mM) to spontaneously 
contracting myometrium elicited an initial rapid phasic contraction followed by a 
sustained tonic contraction. Addition of the combination of the rind extract (5 mg/mL) 
and L-citrulline (64 µM) to the myometrium in the continued presence of KCl 
produced a significant inhibition of the contraction (n = 5). This value was           
21.84 ± 2.64% (P < 0.05) compared to the KCl control (100%). 
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Figure 6.14 The effects of the combinations of watermelon extracts and L-citrulline 
on KCl-induced uterine contraction. The effects of the combination of watermelon 
flesh extract (6 mg/mL) and 64 µM L-citrulline (A) and the combination of 
watermelon rind extract (5 mg/mL) and 64 µM L-citrulline (B) on uterine contraction-
induced by 40 mM KCl are shown (n = 5 for each). 
 
 
A 
B 
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6.5 Discussion 
This study is the first to demonstrate the combination effects of watermelon 
extracts and L-citrulline on uterine contraction. The results revealed that the 
mechanisms whereby they exert their effects were dependent upon NO-cGMP-
dependent pathway modulation. These findings suggest that the tocolytic effects of 
watermelon extracts may be due to L-citrulline. In addition, pre-incubation with TEA 
prevented the effects of watermelon extracts and L-citrulline exerting their effects, 
indicating that KCa channels are also served as the targets for their actions.  
It is well established that sGC has been purified from a variety of tissues, 
including myometrium (Syal, Vedernikov, Chwalisz, Saade and Garfield, 1998). This 
protein can be activated by NO, leading to phosphorylation of PKG (Carvajal et al., 
2000; Norman, 1996). This activation and subsequent phosphorylation of key proteins 
has been suggested as a mechanism of the modulation of smooth muscle tone by NO 
(Buhimschi et al., 1995; Carvajal et al., 2000; Yallampalli et al., 1994). It was 
reported that cyclic nucleotide can mediate smooth muscle relaxation by a variety of 
mechanism involving alterations of [Ca2+]i or the sensitivity of the contractile 
apparatus to that cation (Carvajal et al., 2000; Lee, Li and Kitazawa, 1997; Wu, 
Somlyo and Somlyo, 1996). In the present study, watermelon extracts and L-citrulline 
caused the inhibitory effects in rat uterine contraction. By using L-NAME, the 
possible involvement of NO could be examined. The results showed that the 
inhibitory effects of watermelon extracts and L-citrulline were partially inhibited by 
L-NAME. These findings, therefore, indicate that the NO pathway modulation may be 
implicated with the action of the plant extracts and L-citrulline.  
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It is well known that NO is a potent relaxant of uterine smooth muscle with an 
action of mediated by cGMP (Buhimschi et al., 1995; Rizzo, Trisolini, Spedicato, 
Mutinati, Minoia and Sciorsci, 2011; Yallampalli et al., 1994). This current study 
proposed that LY 83583 also markedly reduced the inhibitory effects induced by 
watermelon extracts and L-citrulline. It is well established that cGMP activated by 
NO elicits the relaxation through PKG signaling (Carvajal et al., 2000; Lee et al., 
1997; Wu et al., 1996). However, there is evidence that NO does not require the 
activation of cGMP to impede the contraction (Bradley, Buxton, Barber, Mcgaw and 
Bradley, 1998; Buxton, Kaiser, Malmquist and Tichenor, 2001; Kuenzli et al., 1998). 
Weiner, Knowles, Nelson and Stegink (1994) indicated that during pregnancy, 
increase of myometrial cGMP levels is independent of NO modulation. In addition, 
the increase in cGMP is at least one mechanism in responsible for suppressing the 
myometrial stretch reflex during pregnancy (Weiner et al., 1994). In contrast, in other 
studies revealed that cGMP can modulate myometrial contractile activity (Buhimschi 
et al., 1995; Demirkoprulu et al., 2005; Izumi and Garfield, 1995; Weiner et al., 1994; 
Yallampalli et al., 1994). Demirkoprulu et al. (2005) reported that at the same 
concentrations of YC-1, a NO-independent sGC activator, and DETA/NO, a NO 
donor, the contents of cGMP in myometrial strips pre-incubated with YC-1 were 
greater than myometrial strips pre-incubated with DETA/NO.  In addition, DETA/NO 
was less inhibited the amplitude and the frequency of the contraction when compared 
with YC-1, implying that YC-1 may have multi-targets in responsible for the 
modulation of force. Inhibitory effects of YC-1 may be due to both the stimulation of 
sGC and KCa channels (Cetin, Kaya, Demirkoprulu, Karadas, Duran and Cetin, 2004; 
Demirkoprulu et al., 2005). It is demonstrated that medicinal plants are present as 
213 
 
numerous chemical constituents, which usually exert their effects through muti-targets 
and muti-pathways (Cao et al., 2008). Taken together, it is, therefore, thought that the 
watermelon extracts may exert their effects by two mechanisms (see below). The first 
mechanism is probably via an interaction with the sGC enzyme, causing an increase 
in cGMP and hence relaxation though a decrease in [Ca2+]i (Carvajal et al., 2000). The 
second is by a direct interaction with other targets proteins to decrease in myofilament 
Ca2+ sensitivity (Bolz et al., 2003; Stuart-Smith, Warner and Jones, 1998). As can be 
seen, LY 83583 blocked the tocolytic effects-induced by watermelon extracts and    
L-citrulline; however, substantial relaxation remained. Thus, by using LY 83583, it is 
reasonable to speculate that the resultant inhibitory effects of watermelon and           
L-citrulline on rat myometrium could be due to the stimulation partially and/or 
completely sGC and cGMP may play a role in responsible for the tocolytic action. 
The content of cGMP is regulated by a balance between the ratio of synthesis by 
guanylate cyclase and the hydrolysis breakdown to GMP by cyclic nucleotide 
phosphodiesterase (PDE) enzymes (Carvajal et al., 2000; Wu et al., 1996). PDE5 is 
found in uterine smooth muscle cells and appears to play a significant role in 
regulating smooth muscle tone (Wu et al., 1996). Therefore, further work is necessary 
to examine the role of PDE in the effects of the plant extracts on rat uterine 
contractility and the potentiating of cGMP signaling. 
The role of NO and cGMP in the hyperpolarization of the smooth muscle cell 
membrane remains controversial. However, there is evidence that NO can activate 
KCa channels directly (Bolotina et al., 1994). Moreover, some evidences suggested 
that NO was found to activate KCa channels independent of cGMP concentrations 
(Bradley et al., 1998; Norman, 1996). K+ channels are important target proteins 
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related to the regulation of relaxation of uterine smooth muscle (Bradley et al., 1998; 
Buxton et al., 2001; Hoffmann, Stanke-Labesque, Fanchin, Dilaï, Pons and Ayoubi, 
2003). It was demonstrated that KCa channels are the predominant type expressed in 
human (Khan, Smith, Morrison and Ashford, 1997) and rat (Anwer, Toro, Oberti, 
Stefani and Sanborn, 1992) myometrium. The opening of these channels results in an 
outward current of K+ ions, implying the membrane hyperpolarization of smooth 
muscle cells, and subsequently suppresses Ca2+ entry through L-type Ca2+ channels 
(Anwer et al., 1992; Khan et al., 1997). To investigate the involvement of KCa 
channels in the tocolytic effects of watermelon extracts and L-citrulline, TEA (5 mM) 
was used. The results indicated that TEA can prevent the inhibitory effects of the 
plant extracts and L-citrulline on uterine contractility. Thus, the relaxant effects of 
watermelon extracts and L-citrulline seem to be due to the most selective effect on the 
KCa channels in uterine smooth muscle. 
The combinations of watermelon extracts and L-citrulline produced an 
additive effect on both spontaneous and agonists-induced contractions. In addition, 
the effects of the combinations on uterine force were greater than that produced by 
their individual EC50 values. These findings indicate that the tocolytic effects of 
watermelon extracts may be due to L-citrulline. Moreover, the combinations of 
watermelon extracts and L-citrulline can interact additionally and therefore this drug 
association may represent a therapeutic advantage for the clinical treatment of various 
diseases (Williamson, 2001).    
Medicinal plants showing NO production can be served as the tocolytic drug, 
which may have potential for the prevention and treatment of miscarriage and/or other 
disorders related to NO in reproductive function, including dysmenorrhea and preterm 
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labor (Norman, 1996). The results of this present study could be useful for further 
study to define the effects of watermelon on human myometrium in vitro. 
In conclusion, this study investigated the tocolytic effects of watermelon 
extracts on isolated rat uterus and the possible mechanisms. The results indicated that 
the inhibitory effects of watermelon extracts and L-citrulline were via NO-cGMP-
dependent pathway modulation. In addition, KCa channels may be the target of the 
plant extracts and L-citrulline to exert their tocolytic effects. Finally, watermelon 
extracts and L-citrulline can interact additionally to reduce the contractile force, 
indicating that the tocolytic effects of watermelon extracts may be due to L-citrulline. 
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CHAPTER VII 
CONCLUSION 
 
 Medicinal plants offer new sources of natural molecules that can be used to 
suppress myometrial contractile activity (tocolytic agents). Watermelon (Citrullus 
lanatus) is an interesting target for pharmaceutical investigation due to its specific 
amino acids, L-citrulline and L-arginine. These amino acids are associated with the 
production of nitric oxide (NO), a potent vasodilator. Ethnopharmacological 
relevance indicated that watermelon has antioxidant, cardioprotective, and anti-
inflammatory properties. However, little is known about the tocolytic effects. 
To the best of our knowledge, the inhibitory effects of watermelon extracts on 
rat uterine contraction have not yet been elucidated. Thus, this thesis was aimed; 1) to 
investigate the effects of the extracts from watermelon on rat uterine contractions; 2) 
to investigate the mechanisms whereby the extracts exerted their effects; and 3) to 
examine whether the effects of the extracts were due to their major constituents,        
L-citrulline and/or L-arginine. The major findings can be summarized as follows. 
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7.1 Dose Dependency of Watermelon Extracts 
The inhibitory effects of watermelon flesh and rind extracts (2-8 mg/mL) were 
dose-dependent (Chapter III). The EC50 values of flesh and rind extracts were        
6.13 ± 1.35 and 5.26 ± 1.08 mg/mL, respectively. Flesh extract at the dose of              
6 mg/mL and rind extract at the dose of 5 mg/mL significantly decreased in the 
amplitude and the mean integral force but not the frequency of the contractions. The 
frequency of contractions increased when watermelon extracts were added. This may 
increase the intrinsic pacemaking mechanism in the uterus and shorten the action 
potential. However, the mechanism underlying of this effect is unclear. In addition, it 
was also found that the tocolytic potency of watermelon rind extract was greater than 
that produced by watermelon flesh extract. It has been demonstrated that rind 
contained more L-citrulline than flesh on dry weight basis. Therefore, this could be 
the reason why the tocolytic potency of the rind extract in this present study was 
greater than that produced by the flesh extract. 
 
7.2 Effects of Watermelon Extracts on Agonists-Induced Uterine 
Contractions 
 Watermelon extracts depressed the contractions induced by prostaglandin F2α 
(PGF2α), oxytocin, and potassium chloride solution (KCl) (Chapter IV). They also 
reduced PGF2α- and oxytocin-induced uterine force in the absence of external Ca
2+ 
and partially inhibited contraction induced by increasing external Ca2+. In addition, 
the extracts produced a marked decrease in tonic contractions produced by oxytocin-
induced uterine contraction in the presence of KCl. These findings indicated that the 
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tocolytic effects of watermelon extracts were via the inhibition of both                 
Ca2+-dependent and Ca2+-independent pathways of force regulation. 
 
7.3 Dose Dependency of L-Citrulline and L-Arginine 
 It has been reported that watermelon is rich in L-citrulline and L-arginine; the 
contents that play a crucial role in the production of the potent vasodilator, NO. Thus, 
it was of interest to investigate whether the tocolytic effects of the extracts may be 
due to L-citrulline or L-arginine. The results showed that L-citrulline and L-arginine 
(1 × 10-6 to 1 × 10-3 M) had a dose-dependent effect on spontaneous contraction 
(Chapter V). The EC50 values of L-citrulline and L-arginine were 64 ± 4.06 and 
104.12 ± 2.03 µM, respectively. The tocolytic effect of L-citrulline was greater than 
that produced by L-arginine. This might be due to the saturation of the substrate,      
L-arginine, for NO synthase. It was suggested that the L-citrulline to L-arginine 
recycling pathway is localized to caveolae and may serve as the principle source of 
available L-arginine. 
 
7.4 Effects of L-Citrulline and L-Arginine on Agonists-Induced 
Uterine Contractions 
 L-citrulline and L-arginine suppressed the contractions induced by PGF2α, 
oxytocin, and KCl. They also reduced PGF2α- and oxytocin-induced uterine force in 
the absence of external calcium and partially inhibited contraction induced by 
increasing external Ca2+. In addition, L-citrulline and L-arginine caused a marked 
decrease in tonic contractions produced by oxytocin-induced uterine contraction in the 
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presence of KCl. These data revealed that the tocolytic effects of L-citrulline and      
L-arginine were via the inhibition of both Ca2+-dependent and Ca2+-independent 
pathways of force regulation and that their effects were similarly to those of 
watermelon extracts. 
 
7.5 Effects of Watermelon Extracts and L-Citrulline on Nitric Oxide 
 There is evidence that both fruit flesh and rind of watermelon are the excellent 
sources of in L-citrulline. In addition, L-citrulline produced the relaxant effects on 
rabbit vascular smooth muscle and rat aortic rings mainly through the NO-cGMP 
pathway modulation. Thus, it was of interest to investigate whether the tocolytic 
effects of the extracts and L-citrulline were via NO-cGMP pathway. The results 
exhibited that the tocolytic effects of watermelon extracts and L-citrulline were via 
the production of NO and cGMP. Moreover, TEA partially reversed the inhibitory 
effects of the plant extracts and L-citrulline, suggesting that calcium-activated 
potassium channels may be involved in the mechanism of action of watermelon 
extracts and L-citrulline (Chapter VI).  
 The combination of the extracts and L-citrulline elicited an additive effect on 
spontaneous contraction and the contractions induced by PGF2α, oxytocin, and KCl. 
These findings suggest that the tocolytic effects of watermelon extracts may be due to 
L-citrulline. 
 Based on the results of present study, watermelon extracts, L-citrulline, and  
L-arginine produced a significant suppressive effect on oxytocin-induced contraction, 
suggesting that they may be effective in the prevention of preterm labor. In addition, 
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watermelon extracts, L-citrulline, and L-arginine exhibited the inhibitory effects on 
PGF2α-induced contraction suggested that they may also be effective in the treatment 
of primary dysmenorrhea. 
 In conclusion, the present data clearly showed that watermelon has a potent 
tocolytic effect on uterine contraction. The mechanisms of action were via           
Ca2+-dependent and Ca2+-independent regulation of smooth muscle contraction 
pathways as well as via NO-cGMP pathway modulation. The mechanisms of action 
can be shown in Figure 7.1. However, the experiments were undertaken in an animal 
model in vitro. It would be, therefore, interesting to further investigate such the effects 
in a human model in vitro. 
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Figure 7.1 Schematic representation of the mechanisms underlying of the effects of 
watermelon extracts (WMEs) on rat uterine contraction. Ca2+ enters cells through L-
type Ca2+ channels. MLCK is activated by four Ca2+ ions bound to CaM, leading to 
myosin phosphorylation and subsequent cross-bridge cycling. (1) WMEs may serve 
as a natural nitric oxide (NO) donor or may activate NO synthase (NOS) directly to 
increase the production of NO in uterine smooth muscle cells which was blocked by 
L-NAME, a non-selective NOS inhibitor. NO activates soluble guanylate cyclase 
(sGC) to produce cGMP which was blocked by LY 83583, a soluble guanylate 
cyclase inhibitor. (2) WMEs itself or NO produced by WMEs stimulates calcium-
activated potassium (KCa) channels which were blocked by TEA, a KCa inhibitor. 
WMEs itself or protein kinase G (PKG) inhibits voltage-gated Ca2+ channels (VGCC) 
which was partially reversed by Bay K8644, a specific L-type Ca2+ channel activator, 
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or high Ca2+. (3) WMEs may interrupt the Gαq/11-PLCβ-IP3 pathway mediated by 
PGF2α or oxytocin and may hamper the ROK pathway. Abbreviations: calcium-
calmodulin complex (Ca-CaM), protein kinase G (PKG), cyclic guanosine 
monophosphate (cGMP), soluble guanylyl cyclase (sGC), phospholypase Cβ (PLCβ), 
phosphatidylinositol 4,5-bisphosphate (PIP2), 1,2-diacylglycerol (DAG), inositol 
1,4,5-trisphosphate (IP3), calcium-activated potassium
 channel (KCa channel), nitric 
oxide synthase (NOS), tetaethylamonium chloride (TEA), rho-associated kinase 
(ROK).  
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